data_1oei_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1oei _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo . . . . . 0 N--CA 1.453 -0.911 0 N-CA-C 109.255 -1.094 . . . . 0.0 109.255 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 8.0 t-160 38.76 41.7 0.54 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.699 2.0 . . . . 0.0 115.276 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -67.25 42.17 0.22 Allowed Glycine 0 CA--C 1.521 0.425 0 C-N-CA 126.997 2.237 . . . . 0.0 116.775 176.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 124.04 -20.76 7.09 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-N 119.514 1.657 . . . . 0.0 113.765 165.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 142.93 0.95 1.19 Allowed Glycine 0 N--CA 1.471 0.974 0 CA-C-N 118.708 1.254 . . . . 0.0 115.418 166.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -127.08 -111.98 0.28 Allowed 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.611 1.206 . . . . 0.0 111.069 -159.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -81.61 2.41 82.78 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 124.406 1.003 . . . . 0.0 114.419 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.444 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 3.1 mp0 -99.63 -39.7 0.23 Allowed Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 126.299 1.839 . . . . 0.0 111.454 178.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.444 ' HD2' ' H ' ' A' ' 75' ' ' GLN . 34.5 Cg_endo -67.01 -94.32 0.0 OUTLIER 'Trans proline' 0 CA--C 1.541 0.871 0 N-CA-C 108.254 -1.479 . . . . 0.0 108.254 154.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 18.0 t-160 -31.99 112.03 0.1 Allowed 'General case' 0 C--N 1.341 0.208 0 C-N-CA 128.017 2.527 . . . . 0.0 114.86 -175.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -135.46 36.0 2.1 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-O 117.187 -1.896 . . . . 0.0 112.232 -175.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.74 0 CA-C-N 119.875 1.837 . . . . 0.0 112.294 177.354 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo . . . . . 0 CA--C 1.539 0.746 0 N-CA-C 109.265 -1.091 . . . . 0.0 109.265 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 73.85 -61.26 0.5 Allowed 'General case' 0 C--O 1.234 0.263 0 O-C-N 120.677 -1.264 . . . . 0.0 110.912 -173.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 74.98 -26.19 1.18 Allowed Glycine 0 CA--C 1.525 0.71 0 CA-C-O 118.054 -1.414 . . . . 0.0 115.305 165.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 168.62 -41.37 0.22 Allowed Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.424 1.488 . . . . 0.0 110.928 -175.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 137.52 47.53 0.07 OUTLIER Glycine 0 N--CA 1.474 1.194 0 CA-C-N 119.047 1.424 . . . . 0.0 114.189 176.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -140.39 -118.52 0.12 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.983 0.913 . . . . 0.0 110.806 -164.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -107.08 4.63 35.81 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 125.164 1.364 . . . . 0.0 113.666 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -86.61 -21.55 0.27 Allowed Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 126.764 2.026 . . . . 0.0 112.949 172.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -79.21 -177.96 4.28 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 CA-C-N 123.1 2.143 . . . . 0.0 108.658 148.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.607 ' CD2' ' H ' ' A' ' 78' ' ' GLY . 8.0 t-160 65.03 179.23 0.19 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.519 0.728 . . . . 0.0 111.342 -176.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.607 ' H ' ' CD2' ' A' ' 77' ' ' HIS . . . 147.72 12.26 0.16 Allowed Glycine 0 C--N 1.336 0.559 0 CA-C-O 117.058 -1.968 . . . . 0.0 115.939 -157.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.534 0 CA-C-N 121.081 2.441 . . . . 0.0 110.852 176.1 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo . . . . . 0 N--CA 1.452 -0.918 0 N-CA-C 110.289 -0.697 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . 0.277 5.2 t-160 56.79 -82.48 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.464 1.506 . . . . 0.0 114.329 -169.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 71.69 -63.47 1.18 Allowed Glycine 0 CA--C 1.53 0.977 0 CA-C-N 120.414 1.461 . . . . 0.0 113.425 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -161.74 -2.98 0.05 OUTLIER Glycine 0 CA--C 1.531 1.075 0 C-N-CA 125.626 1.584 . . . . 0.0 114.074 -170.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 116.82 20.21 5.02 Favored Glycine 0 N--CA 1.475 1.295 0 CA-C-N 120.387 2.093 . . . . 0.0 114.482 164.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -114.67 -120.29 0.3 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.274 1.429 . . . . 0.0 110.265 -162.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -90.16 -10.16 64.6 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-N 119.573 1.078 . . . . 0.0 114.248 -177.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -74.44 -39.88 4.07 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 126.155 1.782 . . . . 0.0 113.905 174.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.98 -171.57 0.91 Allowed 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 123.074 2.516 . . . . 0.0 109.961 169.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 60.5 -70.04 0.04 OUTLIER 'General case' 0 C--O 1.232 0.153 0 C-N-CA 126.708 2.003 . . . . 0.0 114.353 -172.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 67.31 -22.1 0.22 Allowed Glycine 0 CA--C 1.533 1.213 0 CA-C-O 117.697 -1.613 . . . . 0.0 116.742 172.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.142 0 CA-C-N 120.049 1.925 . . . . 0.0 114.251 -169.957 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo . . . . . 0 N--CA 1.44 -1.636 0 N-CA-C 110.426 -0.644 . . . . 0.0 110.426 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 21.3 t-160 72.01 -62.39 0.46 Allowed 'General case' 0 C--O 1.236 0.386 0 C-N-CA 127.11 2.164 . . . . 0.0 111.836 -177.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 75.72 -40.89 1.4 Allowed Glycine 0 CA--C 1.529 0.911 0 C-N-CA 124.323 0.963 . . . . 0.0 114.591 174.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 166.6 -9.41 0.06 OUTLIER Glycine 0 CA--C 1.53 1.027 0 CA-C-O 117.844 -1.531 . . . . 0.0 113.953 -169.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 111.85 42.19 1.04 Allowed Glycine 0 N--CA 1.475 1.254 0 CA-C-N 120.047 1.924 . . . . 0.0 113.522 164.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -138.15 -131.97 0.13 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.938 0.895 . . . . 0.0 109.845 -157.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -94.71 -0.45 64.39 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.179 0.895 . . . . 0.0 113.928 -178.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -71.09 -46.36 14.54 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-O 116.937 -1.506 . . . . 0.0 111.334 174.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -77.31 -126.42 0.01 OUTLIER 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 123.894 3.063 . . . . 0.0 109.808 174.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.586 ' CD2' ' H ' ' A' ' 78' ' ' GLY . 9.4 t-80 56.81 -179.69 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.78 0 O-C-N 120.855 -1.153 . . . . 0.0 111.729 -168.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.586 ' H ' ' CD2' ' A' ' 77' ' ' HIS . . . 153.33 9.58 0.08 OUTLIER Glycine 0 CA--C 1.523 0.567 0 CA-C-O 117.509 -1.717 . . . . 0.0 115.298 -161.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.551 0 CA-C-N 120.109 1.954 . . . . 0.0 110.743 175.703 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo . . . . . 0 N--CA 1.456 -0.705 0 N-CA-C 110.886 -0.467 . . . . 0.0 110.886 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . 0.265 3.2 t-160 60.17 -69.91 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.431 1.092 . . . . 0.0 111.875 -166.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 59.07 15.35 28.77 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-O 117.593 -1.671 . . . . 0.0 116.104 159.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 124.96 -14.95 7.45 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-N 119.873 1.836 . . . . 0.0 114.798 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.49 10.54 6.52 Favored Glycine 0 N--CA 1.473 1.145 0 CA-C-N 119.848 1.824 . . . . 0.0 115.393 164.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -118.64 -99.93 0.44 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.501 1.15 . . . . 0.0 112.107 -159.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -102.75 -0.47 49.17 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.436 1.017 . . . . 0.0 114.019 -178.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.465 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 2.0 mp0 -87.17 -38.41 0.5 Allowed Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 127.31 2.244 . . . . 0.0 111.911 173.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 75' ' ' GLN . 36.7 Cg_endo -74.71 -170.38 0.75 Allowed 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.978 2.452 . . . . 0.0 108.576 161.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 19.1 t-160 67.68 -72.36 0.09 Allowed 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 126.38 1.872 . . . . 0.0 111.931 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 58.94 17.89 37.97 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-O 116.996 -2.002 . . . . 0.0 116.215 161.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.072 0 CA-C-N 120.016 1.908 . . . . 0.0 114.262 178.441 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo . . . . . 0 N--CA 1.448 -1.171 0 N-CA-C 108.992 -1.196 . . . . 0.0 108.992 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 19.1 t-160 47.62 62.54 2.39 Favored 'General case' 0 C--O 1.227 -0.127 0 CA-C-O 124.518 2.104 . . . . 0.0 113.343 -176.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.9 36.76 0.29 Allowed Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 111.414 -2.63 . . . . 0.0 115.716 172.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 123.16 -23.51 6.86 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-N 120.665 2.232 . . . . 0.0 115.093 166.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 140.39 8.87 0.81 Allowed Glycine 0 N--CA 1.469 0.871 0 CA-C-N 118.761 1.281 . . . . 0.0 115.561 166.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -133.3 -110.48 0.23 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.604 1.202 . . . . 0.0 110.74 -158.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -78.36 -26.19 59.91 Favored Glycine 0 CA--C 1.525 0.703 0 O-C-N 120.944 -1.097 . . . . 0.0 112.214 -176.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -64.3 -52.81 51.44 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 118.379 1.09 . . . . 0.0 109.978 -177.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.66 78.96 0.94 Allowed 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 122.135 1.89 . . . . 0.0 110.943 170.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.252 23.6 t-160 63.99 67.0 0.62 Allowed 'General case' 0 C--O 1.226 -0.18 0 CA-C-O 124.653 2.168 . . . . 0.0 113.503 168.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.18 27.35 0.32 Allowed Glycine 0 CA--C 1.526 0.748 0 CA-C-N 111.457 -2.61 . . . . 0.0 115.898 172.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.219 0 CA-C-N 121.021 2.411 . . . . 0.0 116.317 167.991 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo . . . . . 0 N--CA 1.447 -1.206 0 N-CA-C 109.381 -1.046 . . . . 0.0 109.381 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.556 ' CD2' ' H ' ' A' ' 70' ' ' GLY 0.272 6.5 t-160 88.08 175.96 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 128.52 2.728 . . . . 0.0 109.921 -157.352 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.556 ' H ' ' CD2' ' A' ' 69' ' ' HIS . . . 158.46 -2.4 0.11 Allowed Glycine 0 CA--C 1.524 0.61 0 CA-C-O 117.474 -1.737 . . . . 0.0 115.431 -157.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 146.27 -57.31 0.51 Allowed Glycine 0 C--N 1.338 0.642 0 CA-C-N 120.714 2.257 . . . . 0.0 111.704 178.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 151.35 51.49 0.01 OUTLIER Glycine 0 C--N 1.34 0.802 0 CA-C-N 117.941 0.871 . . . . 0.0 112.966 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.405 ' CD1' ' OE1' ' A' ' 75' ' ' GLN . 0.0 OUTLIER -149.89 -114.6 0.06 Allowed 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.827 -0.808 . . . . 0.0 110.21 -168.471 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -99.94 -21.6 13.63 Favored Glycine 0 N--CA 1.473 1.162 0 CA-C-N 119.578 1.081 . . . . 0.0 113.394 -175.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.426 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 4.1 mp0 -59.75 -33.74 17.77 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 128.194 2.598 . . . . 0.0 113.211 176.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.426 ' CD ' ' N ' ' A' ' 75' ' ' GLN . 32.1 Cg_endo -80.28 -71.04 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 123.654 2.903 . . . . 0.0 111.575 173.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 50.0 -74.24 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 117.662 2.467 . . . . 0.0 117.662 176.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.1 -79.15 0.51 Allowed Glycine 0 CA--C 1.525 0.681 0 O-C-N 120.986 -1.071 . . . . 0.0 110.615 -169.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.882 0 CA-C-O 117.8 -1.555 . . . . 0.0 114.172 -167.455 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo . . . . . 0 CA--C 1.544 0.982 0 N-CA-C 108.854 -1.248 . . . . 0.0 108.854 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.639 ' CD2' ' H ' ' A' ' 70' ' ' GLY 0.27 7.6 t-160 65.74 174.13 0.22 Allowed 'General case' 0 CA--C 1.536 0.429 0 O-C-N 120.975 -1.078 . . . . 0.0 110.852 -152.032 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.639 ' H ' ' CD2' ' A' ' 69' ' ' HIS . . . 149.27 10.05 0.14 Allowed Glycine 0 C--N 1.337 0.62 0 CA-C-O 117.136 -1.924 . . . . 0.0 116.417 -149.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 139.2 -67.73 0.51 Allowed Glycine 0 CA--C 1.522 0.502 0 CA-C-N 120.739 2.269 . . . . 0.0 111.007 177.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 155.59 44.83 0.02 OUTLIER Glycine 0 C--N 1.335 0.521 0 CA-C-O 119.308 -0.718 . . . . 0.0 112.652 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.03 -120.33 0.05 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 117.998 0.899 . . . . 0.0 110.99 -170.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -70.63 -36.93 67.83 Favored Glycine 0 CA--C 1.526 0.767 0 O-C-N 120.289 -1.507 . . . . 0.0 111.941 -178.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -59.08 -42.45 93.71 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 125.409 1.484 . . . . 0.0 113.088 -174.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -82.69 -20.47 5.56 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.299 2.0 . . . . 0.0 116.446 178.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 22.0 t-80 -16.72 117.71 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 128.552 2.741 . . . . 0.0 115.737 175.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -143.56 28.89 2.03 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-O 117.202 -1.888 . . . . 0.0 113.741 -174.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.534 0 CA-C-N 120.253 2.027 . . . . 0.0 110.012 -179.903 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo . . . . . 0 N--CA 1.449 -1.134 0 CA-C-O 119.059 -0.475 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 17.2 t-160 72.25 -53.92 0.69 Allowed 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.409 1.083 . . . . 0.0 112.362 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 72.7 -25.67 0.76 Allowed Glycine 0 CA--C 1.533 1.217 0 C-N-CA 125.356 1.455 . . . . 0.0 115.034 161.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 152.59 -6.92 0.49 Allowed Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.32 1.438 . . . . 0.0 113.393 -169.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.23 40.44 4.54 Favored Glycine 0 N--CA 1.472 1.084 0 CA-C-N 119.79 1.795 . . . . 0.0 113.222 166.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -140.02 -110.16 0.15 Allowed 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.256 1.023 . . . . 0.0 110.615 -160.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -111.79 -0.62 27.35 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 124.494 1.045 . . . . 0.0 112.945 -172.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.0 -65.38 2.21 Favored Pre-proline 0 N--CA 1.436 -1.172 0 C-N-CA 125.767 1.627 . . . . 0.0 108.256 161.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -78.3 69.69 7.5 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 123.84 3.027 . . . . 0.0 111.516 -160.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.278 28.2 t-80 71.37 102.26 0.06 Allowed 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 125.426 1.491 . . . . 0.0 110.83 -160.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -110.04 18.17 28.89 Favored Glycine 0 C--O 1.223 -0.572 0 CA-C-O 116.787 -2.119 . . . . 0.0 113.977 -178.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.109 0 CA-C-N 120.479 2.139 . . . . 0.0 115.553 173.868 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo . . . . . 0 CA--C 1.543 0.938 0 N-CA-C 109.459 -1.016 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 14.1 t-160 53.01 68.98 0.75 Allowed 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 125.049 2.357 . . . . 0.0 113.937 -172.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -76.24 37.27 1.33 Allowed Glycine 0 C--N 1.318 -0.418 0 CA-C-N 111.717 -2.492 . . . . 0.0 115.154 173.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 120.37 -23.03 8.18 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-N 119.988 1.894 . . . . 0.0 115.434 166.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 148.36 9.17 0.18 Allowed Glycine 0 N--CA 1.471 1.025 0 CA-C-N 119.395 1.597 . . . . 0.0 116.531 163.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -136.55 -112.34 0.19 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 118.879 1.34 . . . . 0.0 110.808 -157.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.12 -44.51 95.64 Favored Glycine 0 CA--C 1.529 0.929 0 O-C-N 121.073 -1.017 . . . . 0.0 111.453 177.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -56.52 -46.91 99.77 Favored Pre-proline 0 N--CA 1.45 -0.442 0 C-N-CA 124.166 0.986 . . . . 0.0 111.597 -170.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.05 55.35 2.33 Favored 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 122.583 2.189 . . . . 0.0 112.737 167.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 20.8 t-160 64.25 69.43 0.52 Allowed 'General case' 0 C--N 1.342 0.249 0 CA-C-O 124.434 2.064 . . . . 0.0 114.042 166.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.41 28.27 0.17 Allowed Glycine 0 CA--C 1.525 0.678 0 CA-C-N 111.457 -2.61 . . . . 0.0 116.569 170.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.028 0 CA-C-N 121.655 2.727 . . . . 0.0 116.442 165.839 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo . . . . . 0 N--CA 1.45 -1.042 0 N-CA-C 109.262 -1.092 . . . . 0.0 109.262 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.649 ' CD2' ' H ' ' A' ' 70' ' ' GLY . 13.9 t-80 57.5 169.54 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.471 1.108 . . . . 0.0 112.037 -164.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.649 ' H ' ' CD2' ' A' ' 69' ' ' HIS . . . 145.55 12.45 0.23 Allowed Glycine 0 C--N 1.338 0.646 0 CA-C-O 117.244 -1.864 . . . . 0.0 115.195 -153.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 139.59 -78.9 0.29 Allowed Glycine 0 C--N 1.335 0.519 0 CA-C-N 120.702 2.251 . . . . 0.0 109.821 178.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 176.21 19.23 0.02 OUTLIER Glycine 0 CA--C 1.526 0.781 0 CA-C-N 117.529 0.664 . . . . 0.0 114.247 -175.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -127.92 -133.2 0.23 Allowed 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 124.142 0.977 . . . . 0.0 109.17 -165.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -78.83 2.4 68.95 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-N 118.957 0.799 . . . . 0.0 114.633 -175.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -81.92 -53.83 0.68 Allowed Pre-proline 0 N--CA 1.438 -1.035 0 C-N-CA 126.923 2.089 . . . . 0.0 110.088 173.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -72.77 -171.37 0.75 Allowed 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 122.512 2.141 . . . . 0.0 110.209 160.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.599 ' CG ' ' H ' ' A' ' 78' ' ' GLY 0.284 7.7 t-160 70.9 -168.55 0.15 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.502 1.121 . . . . 0.0 110.068 -166.248 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.599 ' H ' ' CG ' ' A' ' 77' ' ' HIS . . . 163.25 -45.69 0.33 Allowed Glycine 0 CA--C 1.527 0.816 0 O-C-N 121.271 -0.893 . . . . 0.0 112.335 -167.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.195 0 CA-C-N 118.434 1.117 . . . . 0.0 114.61 -177.248 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo . . . . . 0 N--CA 1.459 -0.523 0 N-CA-C 110.423 -0.645 . . . . 0.0 110.423 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 22.3 t-160 46.12 64.39 1.5 Allowed 'General case' 0 C--N 1.344 0.341 0 CA-C-O 123.708 1.718 . . . . 0.0 113.959 177.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -63.4 24.73 0.08 OUTLIER Glycine 0 CA--C 1.527 0.821 0 C-N-CA 127.535 2.493 . . . . 0.0 116.75 173.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 124.89 -17.04 7.25 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-N 120.624 2.212 . . . . 0.0 114.72 170.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 132.57 12.97 1.71 Allowed Glycine 0 N--CA 1.473 1.153 0 CA-C-N 119.033 1.416 . . . . 0.0 116.026 163.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -125.61 -102.56 0.36 Allowed 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 118.023 0.912 . . . . 0.0 109.836 -162.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -86.5 -32.11 17.0 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-N 118.526 0.603 . . . . 0.0 113.097 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.409 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 4.1 mp0 -60.33 -43.89 94.52 Favored Pre-proline 0 C--O 1.223 -0.31 0 O-C-N 121.36 -1.082 . . . . 0.0 111.506 -177.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.409 ' CD ' ' N ' ' A' ' 75' ' ' GLN . 93.7 Cg_endo -77.87 42.3 1.16 Allowed 'Trans proline' 0 CA--C 1.548 1.217 0 C-N-CA 122.957 2.438 . . . . 0.0 111.656 169.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.545 ' CD2' ' H ' ' A' ' 78' ' ' GLY . 6.2 t-160 83.31 -179.17 0.04 OUTLIER 'General case' 0 C--N 1.346 0.414 0 C-N-CA 126.899 2.08 . . . . 0.0 112.643 173.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.545 ' H ' ' CD2' ' A' ' 77' ' ' HIS . . . 160.23 1.35 0.07 OUTLIER Glycine 0 C--N 1.336 0.53 0 CA-C-O 116.959 -2.023 . . . . 0.0 115.616 -158.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.732 0 CA-C-N 121.103 2.452 . . . . 0.0 111.948 175.341 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo . . . . . 0 N--CA 1.452 -0.965 0 N-CA-C 109.491 -1.004 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.633 ' CD2' ' H ' ' A' ' 70' ' ' GLY . 16.1 t-80 57.57 172.61 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.687 0.795 . . . . 0.0 111.509 -165.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.633 ' H ' ' CD2' ' A' ' 69' ' ' HIS . . . 151.31 14.17 0.08 OUTLIER Glycine 0 C--N 1.337 0.633 0 CA-C-O 117.567 -1.685 . . . . 0.0 115.295 -158.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 142.97 -69.59 0.42 Allowed Glycine 0 C--O 1.224 -0.47 0 CA-C-N 120.359 2.079 . . . . 0.0 110.168 177.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 167.69 18.69 0.02 OUTLIER Glycine 0 CA--C 1.529 0.913 0 N-CA-C 114.687 0.635 . . . . 0.0 114.687 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -127.52 -118.28 0.26 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.093 0.957 . . . . 0.0 110.544 -160.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -94.24 -3.52 63.32 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-N 119.428 1.013 . . . . 0.0 114.444 -178.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.89 -45.82 3.95 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 125.592 1.557 . . . . 0.0 110.567 170.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -75.77 -164.88 0.27 Allowed 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.038 1.825 . . . . 0.0 109.118 157.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.591 ' CD2' ' H ' ' A' ' 78' ' ' GLY 0.268 11.3 t-80 67.46 174.0 0.26 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.04 1.336 . . . . 0.0 110.462 -158.414 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.591 ' H ' ' CD2' ' A' ' 77' ' ' HIS . . . 141.64 9.55 0.63 Allowed Glycine 0 CA--C 1.526 0.751 0 CA-C-O 117.615 -1.659 . . . . 0.0 115.154 -156.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.562 0 CA-C-N 120.787 2.293 . . . . 0.0 110.405 174.691 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo . . . . . 0 CA--C 1.548 1.177 0 CA-C-O 119.004 -0.499 . . . . 0.0 112.613 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.536 ' H ' ' HB3' ' A' ' 76' ' ' PRO . 9.6 t60 -67.75 132.97 48.44 Favored 'General case' 0 N--CA 1.439 -0.997 0 O-C-N 119.833 -1.792 . . . . 0.0 107.273 173.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.35 -26.93 3.31 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 126.042 1.782 . . . . 0.0 112.646 162.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 162.79 -14.31 0.11 Allowed Glycine 0 CA--C 1.524 0.599 0 CA-C-O 119.124 -0.82 . . . . 0.0 112.754 -175.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.69 26.4 6.82 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-N 118.778 1.289 . . . . 0.0 112.854 172.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -95.95 -113.13 0.13 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.499 2.319 . . . . 0.0 110.384 -173.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -94.71 -28.67 9.99 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-N 119.839 1.2 . . . . 0.0 113.092 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -50.5 -39.0 46.26 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 126.78 2.032 . . . . 0.0 115.612 172.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.536 ' HB3' ' H ' ' A' ' 69' ' ' HIS . 14.6 Cg_endo -83.32 50.9 3.42 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.403 2.068 . . . . 0.0 112.715 -172.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 72.82 120.31 0.04 OUTLIER 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.755 1.222 . . . . 0.0 109.942 -162.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -136.55 33.57 2.33 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 125.316 1.436 . . . . 0.0 112.09 -167.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.292 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 -175.716 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo . . . . . 0 N--CA 1.459 -0.524 0 N-CA-C 109.939 -0.831 . . . . 0.0 109.939 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 21.8 t-160 57.43 -73.35 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 115.558 1.688 . . . . 0.0 115.558 175.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 68.87 -23.7 0.3 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 126.9 2.19 . . . . 0.0 116.243 171.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 159.08 -11.74 0.19 Allowed Glycine 0 CA--C 1.531 1.093 0 CA-C-N 119.282 1.541 . . . . 0.0 113.867 -170.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 114.93 29.91 2.47 Favored Glycine 0 N--CA 1.475 1.249 0 CA-C-N 119.931 1.865 . . . . 0.0 114.345 166.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -120.86 -113.12 0.32 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.333 1.453 . . . . 0.0 110.526 -163.162 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -101.43 -4.67 52.79 Favored Glycine 0 CA--C 1.536 1.396 0 CA-C-N 119.93 1.241 . . . . 0.0 114.028 -178.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -83.63 -31.79 0.51 Allowed Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 128.535 2.734 . . . . 0.0 112.707 177.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -82.58 -164.05 0.25 Allowed 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 121.991 1.794 . . . . 0.0 107.452 157.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.561 ' CD2' ' H ' ' A' ' 78' ' ' GLY . 11.7 t-80 58.71 -178.31 0.08 Allowed 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.31 -0.869 . . . . 0.0 110.196 -167.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.561 ' H ' ' CD2' ' A' ' 77' ' ' HIS . . . 138.79 8.76 1.04 Allowed Glycine 0 C--N 1.339 0.699 0 CA-C-O 117.258 -1.857 . . . . 0.0 115.826 -156.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.477 0 CA-C-N 120.679 2.24 . . . . 0.0 110.697 171.832 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo . . . . . 0 N--CA 1.456 -0.703 0 N-CA-C 108.613 -1.341 . . . . 0.0 108.613 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.582 ' CG ' ' H ' ' A' ' 70' ' ' GLY . 8.8 t-160 48.13 -162.04 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.827 1.251 . . . . 0.0 112.418 -175.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.582 ' H ' ' CG ' ' A' ' 69' ' ' HIS . . . 145.29 -15.62 1.88 Allowed Glycine 0 C--O 1.221 -0.674 0 O-C-N 120.139 -1.6 . . . . 0.0 114.871 -172.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 159.41 -20.21 0.27 Allowed Glycine 0 CA--C 1.528 0.866 0 CA-C-N 119.384 1.592 . . . . 0.0 113.994 -177.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 118.65 30.57 1.64 Allowed Glycine 0 N--CA 1.473 1.165 0 CA-C-N 119.217 1.509 . . . . 0.0 113.102 170.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.402 ' CD1' ' NE2' ' A' ' 75' ' ' GLN . 0.0 OUTLIER -127.67 -141.63 0.26 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.883 1.673 . . . . 0.0 109.612 -163.765 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.03 -25.32 67.89 Favored Glycine 0 CA--C 1.534 1.231 0 O-C-N 120.091 -1.631 . . . . 0.0 113.569 -178.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.402 ' NE2' ' CD1' ' A' ' 73' ' ' TRP . 2.2 mp0 -68.32 -51.53 24.44 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 124.789 1.236 . . . . 0.0 112.108 -173.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.66 -50.97 1.05 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 121.714 1.609 . . . . 0.0 111.518 175.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 20.5 t-160 60.03 -71.24 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.052 1.741 . . . . 0.0 114.69 -178.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 64.11 -2.67 2.01 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-O 116.996 -2.002 . . . . 0.0 116.264 173.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.114 0 CA-C-N 120.48 2.14 . . . . 0.0 114.345 -177.349 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo . . . . . 0 N--CA 1.458 -0.608 0 CA-C-O 120.549 0.145 . . . . 0.0 112.02 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 17.5 t-160 50.0 69.05 0.65 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 124.293 1.996 . . . . 0.0 112.224 -176.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.32 24.23 0.12 Allowed Glycine 0 CA--C 1.526 0.725 0 CA-C-N 111.668 -2.515 . . . . 0.0 116.558 174.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 127.0 -17.34 6.32 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 121.426 2.613 . . . . 0.0 116.058 167.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 146.08 12.7 0.21 Allowed Glycine 0 N--CA 1.476 1.312 0 CA-C-N 119.853 1.826 . . . . 0.0 116.632 165.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -140.54 -117.49 0.12 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 118.583 1.191 . . . . 0.0 110.0 -155.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -81.01 -31.48 34.98 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-N 119.42 1.009 . . . . 0.0 113.23 -175.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -50.36 -48.85 79.88 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 125.652 1.581 . . . . 0.0 111.528 -176.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -71.84 54.84 2.14 Favored 'Trans proline' 0 CA--C 1.55 1.313 0 C-N-CA 122.614 2.209 . . . . 0.0 112.65 168.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.264 16.5 t-160 66.9 67.88 0.42 Allowed 'General case' 0 C--N 1.346 0.413 0 CA-C-O 124.545 2.117 . . . . 0.0 113.287 165.239 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.57 31.39 0.27 Allowed Glycine 0 CA--C 1.524 0.635 0 CA-C-N 111.714 -2.494 . . . . 0.0 116.264 172.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.932 0 CA-C-N 121.075 2.438 . . . . 0.0 115.628 167.102 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo . . . . . 0 N--CA 1.453 -0.867 0 N-CA-C 109.443 -1.022 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 23.0 t-160 60.06 -70.97 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.401 1.88 . . . . 0.0 113.42 -175.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 58.01 12.29 10.9 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-O 117.857 -1.524 . . . . 0.0 116.386 164.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 125.24 -9.89 7.81 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 120.03 1.915 . . . . 0.0 114.867 178.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 119.89 14.58 5.57 Favored Glycine 0 N--CA 1.471 1.032 0 CA-C-N 119.795 1.797 . . . . 0.0 115.159 161.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -121.29 -97.45 0.46 Allowed 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 124.629 1.172 . . . . 0.0 111.863 -162.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -108.16 -1.01 33.56 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.323 0.963 . . . . 0.0 114.554 -178.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.449 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 3.7 mp0 -83.47 -35.66 0.64 Allowed Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 126.286 1.834 . . . . 0.0 112.642 167.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.449 ' CD ' ' N ' ' A' ' 75' ' ' GLN . 30.2 Cg_endo -73.79 177.32 8.23 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.473 2.116 . . . . 0.0 108.871 164.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.571 ' CG ' ' H ' ' A' ' 78' ' ' GLY . 9.3 t-80 62.66 176.89 0.14 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.785 0.834 . . . . 0.0 110.71 -167.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.571 ' H ' ' CG ' ' A' ' 77' ' ' HIS . . . 144.67 4.41 0.63 Allowed Glycine 0 CA--C 1.527 0.784 0 CA-C-O 117.674 -1.626 . . . . 0.0 115.178 -157.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.4 ' H ' ' CD2' ' A' ' 77' ' ' HIS . . . . . . . . 0 C--N 1.338 0.676 0 CA-C-N 120.533 2.166 . . . . 0.0 111.195 174.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo . . . . . 0 N--CA 1.454 -0.802 0 N-CA-C 108.653 -1.326 . . . . 0.0 108.653 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . 0.275 13.0 t-160 45.81 68.05 0.65 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 124.575 2.131 . . . . 0.0 115.406 172.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.419 ' H ' ' HB3' ' A' ' 75' ' ' GLN . . . -86.77 20.05 26.08 Favored Glycine 0 CA--C 1.522 0.522 0 CA-C-N 111.582 -2.553 . . . . 0.0 115.034 175.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 137.29 -71.94 0.46 Allowed Glycine 0 C--N 1.337 0.586 0 CA-C-N 120.558 2.179 . . . . 0.0 112.454 175.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -175.62 15.57 0.04 OUTLIER Glycine 0 N--CA 1.467 0.734 0 CA-C-N 118.508 1.154 . . . . 0.0 115.122 -174.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.405 ' HB2' ' H ' ' A' ' 74' ' ' GLY . 0.1 OUTLIER -126.47 -141.25 0.28 Allowed 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 124.845 1.258 . . . . 0.0 108.413 -168.736 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.405 ' H ' ' HB2' ' A' ' 73' ' ' TRP . . . -71.93 1.66 30.34 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-O 118.448 -1.196 . . . . 0.0 114.742 -175.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.429 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 18.0 mm100 -84.53 -51.7 0.55 Allowed Pre-proline 0 N--CA 1.442 -0.834 0 C-N-CA 126.369 1.868 . . . . 0.0 110.937 -179.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.429 ' HD2' ' H ' ' A' ' 75' ' ' GLN . 50.2 Cg_endo -68.56 174.96 7.64 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.032 1.821 . . . . 0.0 109.978 157.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.524 ' CG ' ' H ' ' A' ' 78' ' ' GLY . 7.1 t-160 61.23 -151.98 0.38 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.408 1.083 . . . . 0.0 111.302 176.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.524 ' H ' ' CG ' ' A' ' 77' ' ' HIS . . . 132.97 -43.97 1.24 Allowed Glycine 0 C--O 1.223 -0.545 0 O-C-N 120.422 -1.424 . . . . 0.0 111.593 -173.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.692 0 CA-C-O 117.973 -1.46 . . . . 0.0 114.217 -176.65 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo . . . . . 0 N--CA 1.454 -0.826 0 N-CA-C 109.485 -1.006 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.639 ' CD2' ' H ' ' A' ' 70' ' ' GLY . 22.7 t-80 60.69 165.09 0.08 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.309 1.444 . . . . 0.0 111.695 -162.416 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.639 ' H ' ' CD2' ' A' ' 69' ' ' HIS . . . 155.05 16.98 0.05 OUTLIER Glycine 0 C--N 1.336 0.573 0 CA-C-O 117.62 -1.656 . . . . 0.0 114.741 -155.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 141.19 -68.56 0.47 Allowed Glycine 0 C--N 1.336 0.553 0 CA-C-N 120.187 1.993 . . . . 0.0 110.119 179.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 162.81 23.39 0.02 OUTLIER Glycine 0 CA--C 1.529 0.94 0 CA-C-O 119.528 -0.596 . . . . 0.0 114.463 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -128.63 -113.35 0.26 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.179 0.99 . . . . 0.0 110.821 -162.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -102.87 -2.34 49.18 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-N 119.443 1.019 . . . . 0.0 114.428 -178.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -70.87 -49.74 13.37 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 124.869 1.268 . . . . 0.0 109.304 165.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -71.36 176.14 8.38 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 CA-C-N 120.635 1.263 . . . . 0.0 109.545 163.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.626 ' CD2' ' H ' ' A' ' 78' ' ' GLY 0.275 6.7 t-160 65.23 169.86 0.2 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.086 1.754 . . . . 0.0 111.691 -160.182 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.626 ' H ' ' CD2' ' A' ' 77' ' ' HIS . . . 144.24 18.56 0.2 Allowed Glycine 0 C--N 1.337 0.596 0 CA-C-O 117.45 -1.75 . . . . 0.0 115.698 -147.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.505 0 CA-C-N 119.899 1.85 . . . . 0.0 111.862 171.62 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 . . . . . 0 CA--C 1.533 0.322 0 CA-C-O 122.682 1.229 . . . . 0.0 113.878 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -66.16 38.44 0.15 Allowed Glycine 0 CA--C 1.523 0.574 0 C-N-CA 126.687 2.089 . . . . 0.0 116.93 172.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 125.67 -22.11 6.2 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-N 120.467 2.133 . . . . 0.0 114.13 167.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 135.83 8.74 1.61 Allowed Glycine 0 N--CA 1.469 0.869 0 CA-C-N 118.525 1.162 . . . . 0.0 115.527 168.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -125.18 -101.59 0.38 Allowed 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.566 1.183 . . . . 0.0 111.388 -162.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -98.16 -5.32 57.26 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 123.531 0.586 . . . . 0.0 114.371 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.423 ' N ' ' CD ' ' A' ' 68' ' ' PRO . 3.5 mp0 -81.93 -45.43 1.04 Allowed Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 118.77 1.285 . . . . 0.0 111.613 172.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.423 ' CD ' ' N ' ' A' ' 67' ' ' GLN . 9.5 Cg_endo -62.47 150.34 87.78 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 CA-C-N 120.967 1.381 . . . . 0.0 109.255 167.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 8.0 t-160 38.76 41.7 0.54 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.699 2.0 . . . . 0.0 115.276 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -67.25 42.17 0.22 Allowed Glycine 0 CA--C 1.521 0.425 0 C-N-CA 126.997 2.237 . . . . 0.0 116.775 176.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 124.04 -20.76 7.09 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-N 119.514 1.657 . . . . 0.0 113.765 165.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 142.93 0.95 1.19 Allowed Glycine 0 N--CA 1.471 0.974 0 CA-C-N 118.708 1.254 . . . . 0.0 115.418 166.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -127.08 -111.98 0.28 Allowed 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.611 1.206 . . . . 0.0 111.069 -159.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -81.61 2.41 82.78 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 124.406 1.003 . . . . 0.0 114.419 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.444 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 3.1 mp0 -99.63 -39.7 0.23 Allowed Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 126.299 1.839 . . . . 0.0 111.454 178.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.444 ' HD2' ' H ' ' A' ' 75' ' ' GLN . 34.5 Cg_endo -67.01 -94.32 0.0 OUTLIER 'Trans proline' 0 CA--C 1.541 0.871 0 N-CA-C 108.254 -1.479 . . . . 0.0 108.254 154.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 18.0 t-160 -31.99 112.03 0.1 Allowed 'General case' 0 C--N 1.341 0.208 0 C-N-CA 128.017 2.527 . . . . 0.0 114.86 -175.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -135.46 36.0 2.1 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-O 117.187 -1.896 . . . . 0.0 112.232 -175.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 137.19 -48.26 0.91 Allowed Glycine 0 CA--C 1.526 0.74 0 CA-C-N 119.875 1.837 . . . . 0.0 112.294 177.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 149.47 12.45 0.11 Allowed Glycine 0 CA--C 1.531 1.047 0 CA-C-N 117.474 0.637 . . . . 0.0 114.642 175.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -111.91 -114.59 0.32 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 118.448 1.124 . . . . 0.0 110.648 -163.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -95.65 -12.83 52.73 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-N 119.65 1.114 . . . . 0.0 113.527 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -58.16 -56.33 36.14 Favored Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 125.132 1.373 . . . . 0.0 112.696 168.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo . . . . . 0 C--N 1.35 0.647 0 C-N-CA 122.537 2.158 . . . . 0.0 111.111 176.41 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.418 ' CD2' ' HB3' ' A' ' 67' ' ' GLN . 0.6 OUTLIER . . . . . 0 N--CA 1.448 -0.567 0 CA-C-O 122.357 1.075 . . . . 0.0 110.949 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.52 -20.81 1.61 Allowed Glycine 0 C--O 1.222 -0.61 0 CA-C-O 116.779 -2.123 . . . . 0.0 113.67 167.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 140.21 -23.85 2.7 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 120.069 1.934 . . . . 0.0 115.201 169.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 136.59 19.6 0.65 Allowed Glycine 0 CA--C 1.532 1.122 0 CA-C-N 119.39 1.595 . . . . 0.0 116.321 178.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -126.36 -116.9 0.27 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 119.781 1.79 . . . . 0.0 111.337 -161.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -87.2 -19.43 55.38 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-N 119.115 0.87 . . . . 0.0 113.19 178.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.418 ' HB3' ' CD2' ' A' ' 61' ' ' HIS . 2.9 mp0 -61.04 -57.46 26.14 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 126.985 2.114 . . . . 0.0 111.649 172.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -75.97 -153.47 0.04 OUTLIER 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 123.476 2.784 . . . . 0.0 109.265 171.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 73.85 -61.26 0.5 Allowed 'General case' 0 C--O 1.234 0.263 0 O-C-N 120.677 -1.264 . . . . 0.0 110.912 -173.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 74.98 -26.19 1.18 Allowed Glycine 0 CA--C 1.525 0.71 0 CA-C-O 118.054 -1.414 . . . . 0.0 115.305 165.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 168.62 -41.37 0.22 Allowed Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.424 1.488 . . . . 0.0 110.928 -175.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 137.52 47.53 0.07 OUTLIER Glycine 0 N--CA 1.474 1.194 0 CA-C-N 119.047 1.424 . . . . 0.0 114.189 176.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -140.39 -118.52 0.12 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.983 0.913 . . . . 0.0 110.806 -164.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -107.08 4.63 35.81 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 125.164 1.364 . . . . 0.0 113.666 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -86.61 -21.55 0.27 Allowed Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 126.764 2.026 . . . . 0.0 112.949 172.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -79.21 -177.96 4.28 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 CA-C-N 123.1 2.143 . . . . 0.0 108.658 148.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.607 ' CD2' ' H ' ' A' ' 78' ' ' GLY . 8.0 t-160 65.03 179.23 0.19 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.519 0.728 . . . . 0.0 111.342 -176.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.607 ' H ' ' CD2' ' A' ' 77' ' ' HIS . . . 147.72 12.26 0.16 Allowed Glycine 0 C--N 1.336 0.559 0 CA-C-O 117.058 -1.968 . . . . 0.0 115.939 -157.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 141.96 -67.93 0.46 Allowed Glycine 0 C--N 1.336 0.534 0 CA-C-N 121.081 2.441 . . . . 0.0 110.852 176.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 162.85 22.52 0.02 OUTLIER Glycine 0 CA--C 1.527 0.838 0 CA-C-O 119.252 -0.749 . . . . 0.0 114.259 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -131.57 -130.7 0.19 Allowed 'General case' 0 C--O 1.222 -0.384 0 C-N-CA 124.896 1.278 . . . . 0.0 108.405 -165.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -78.22 -13.97 82.73 Favored Glycine 0 CA--C 1.536 1.38 0 CA-C-N 119.973 1.26 . . . . 0.0 114.344 -174.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -64.0 -52.27 57.48 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 125.288 1.435 . . . . 0.0 113.277 175.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo . . . . . 0 N--CA 1.454 -0.826 0 C-N-CA 122.663 2.242 . . . . 0.0 110.459 167.487 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.538 ' CD2' ' H ' ' A' ' 62' ' ' GLY . 7.4 t-160 . . . . . 0 CA--C 1.546 0.814 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.538 ' H ' ' CD2' ' A' ' 61' ' ' HIS . . . 159.9 -29.65 0.38 Allowed Glycine 0 C--N 1.336 0.548 0 O-C-N 120.576 -1.328 . . . . 0.0 113.266 -166.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 172.77 -29.14 0.1 Allowed Glycine 0 C--N 1.336 0.565 0 CA-C-O 118.337 -1.257 . . . . 0.0 114.353 169.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 145.05 22.65 0.13 Allowed Glycine 0 N--CA 1.471 0.982 0 CA-C-N 119.116 1.458 . . . . 0.0 114.878 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -125.49 -134.28 0.26 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.423 1.489 . . . . 0.0 107.789 -173.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.42 -7.83 85.4 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 115.652 1.021 . . . . 0.0 115.652 -170.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -81.04 -51.5 0.91 Allowed Pre-proline 0 N--CA 1.442 -0.826 0 C-N-CA 125.548 1.539 . . . . 0.0 112.229 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -68.89 -178.27 1.94 Allowed 'Trans proline' 0 N--CA 1.452 -0.918 0 CA-C-N 120.561 1.236 . . . . 0.0 110.289 165.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . 0.277 5.2 t-160 56.79 -82.48 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.464 1.506 . . . . 0.0 114.329 -169.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 71.69 -63.47 1.18 Allowed Glycine 0 CA--C 1.53 0.977 0 CA-C-N 120.414 1.461 . . . . 0.0 113.425 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -161.74 -2.98 0.05 OUTLIER Glycine 0 CA--C 1.531 1.075 0 C-N-CA 125.626 1.584 . . . . 0.0 114.074 -170.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 116.82 20.21 5.02 Favored Glycine 0 N--CA 1.475 1.295 0 CA-C-N 120.387 2.093 . . . . 0.0 114.482 164.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -114.67 -120.29 0.3 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.274 1.429 . . . . 0.0 110.265 -162.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -90.16 -10.16 64.6 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-N 119.573 1.078 . . . . 0.0 114.248 -177.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -74.44 -39.88 4.07 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 126.155 1.782 . . . . 0.0 113.905 174.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.98 -171.57 0.91 Allowed 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 123.074 2.516 . . . . 0.0 109.961 169.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 60.5 -70.04 0.04 OUTLIER 'General case' 0 C--O 1.232 0.153 0 C-N-CA 126.708 2.003 . . . . 0.0 114.353 -172.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 67.31 -22.1 0.22 Allowed Glycine 0 CA--C 1.533 1.213 0 CA-C-O 117.697 -1.613 . . . . 0.0 116.742 172.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 155.22 -14.29 0.47 Allowed Glycine 0 CA--C 1.532 1.142 0 CA-C-N 120.049 1.925 . . . . 0.0 114.251 -169.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 115.96 42.07 0.74 Allowed Glycine 0 N--CA 1.473 1.104 0 CA-C-N 119.826 1.813 . . . . 0.0 114.271 167.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -128.96 -117.0 0.25 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.375 1.47 . . . . 0.0 110.096 -168.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -100.95 -9.81 44.56 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-N 119.646 1.112 . . . . 0.0 113.901 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -67.56 -32.76 4.7 Favored Pre-proline 0 CA--C 1.549 0.932 0 CA-C-O 117.364 -1.303 . . . . 0.0 112.696 172.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo . . . . . 0 C--N 1.354 0.852 0 C-N-CA 123.5 2.8 . . . . 0.0 110.333 174.795 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.517 -0.288 0 CA-C-O 120.967 0.413 . . . . 0.0 110.662 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.77 -36.44 1.03 Allowed Glycine 0 CA--C 1.523 0.548 0 C-N-CA 125.893 1.711 . . . . 0.0 113.838 170.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 145.44 -14.32 1.83 Allowed Glycine 0 CA--C 1.528 0.873 0 CA-C-O 117.788 -1.562 . . . . 0.0 115.81 178.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 125.5 23.23 1.74 Allowed Glycine 0 CA--C 1.531 1.086 0 CA-C-N 120.055 1.927 . . . . 0.0 115.568 174.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -131.66 -123.57 0.2 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.449 1.624 . . . . 0.0 111.128 -164.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.87 -34.97 58.63 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-N 119.812 1.187 . . . . 0.0 113.549 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -42.88 -67.41 0.34 Allowed Pre-proline 0 N--CA 1.464 0.24 0 C-N-CA 127.523 2.329 . . . . 0.0 112.229 168.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.73 91.75 0.61 Allowed 'Trans proline' 0 N--CA 1.44 -1.636 0 C-N-CA 122.351 2.034 . . . . 0.0 110.426 -169.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 21.3 t-160 72.01 -62.39 0.46 Allowed 'General case' 0 C--O 1.236 0.386 0 C-N-CA 127.11 2.164 . . . . 0.0 111.836 -177.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 75.72 -40.89 1.4 Allowed Glycine 0 CA--C 1.529 0.911 0 C-N-CA 124.323 0.963 . . . . 0.0 114.591 174.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 166.6 -9.41 0.06 OUTLIER Glycine 0 CA--C 1.53 1.027 0 CA-C-O 117.844 -1.531 . . . . 0.0 113.953 -169.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 111.85 42.19 1.04 Allowed Glycine 0 N--CA 1.475 1.254 0 CA-C-N 120.047 1.924 . . . . 0.0 113.522 164.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -138.15 -131.97 0.13 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.938 0.895 . . . . 0.0 109.845 -157.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -94.71 -0.45 64.39 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.179 0.895 . . . . 0.0 113.928 -178.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -71.09 -46.36 14.54 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-O 116.937 -1.506 . . . . 0.0 111.334 174.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -77.31 -126.42 0.01 OUTLIER 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 123.894 3.063 . . . . 0.0 109.808 174.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.586 ' CD2' ' H ' ' A' ' 78' ' ' GLY . 9.4 t-80 56.81 -179.69 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.78 0 O-C-N 120.855 -1.153 . . . . 0.0 111.729 -168.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.586 ' H ' ' CD2' ' A' ' 77' ' ' HIS . . . 153.33 9.58 0.08 OUTLIER Glycine 0 CA--C 1.523 0.567 0 CA-C-O 117.509 -1.717 . . . . 0.0 115.298 -161.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 144.92 -56.12 0.54 Allowed Glycine 0 C--N 1.336 0.551 0 CA-C-N 120.109 1.954 . . . . 0.0 110.743 175.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.8 19.35 0.05 OUTLIER Glycine 0 CA--C 1.53 1.012 0 N-CA-C 114.963 0.745 . . . . 0.0 114.963 175.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -129.04 -107.3 0.29 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.231 1.015 . . . . 0.0 110.998 -158.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -88.96 -21.6 41.83 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-N 119.627 1.103 . . . . 0.0 113.745 -177.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.422 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 3.3 mp0 -68.78 -44.58 31.56 Favored Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 126.093 1.757 . . . . 0.0 113.242 -179.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' ' 83' ' ' GLN . 56.9 Cg_endo . . . . . 0 N--CA 1.45 -1.042 0 C-N-CA 123.411 2.741 . . . . 0.0 108.606 171.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.613 ' CG ' ' H ' ' A' ' 62' ' ' GLY . 9.9 t-80 . . . . . 0 CA--C 1.541 0.631 0 CA-C-O 120.253 0.073 . . . . 0.0 111.019 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.613 ' H ' ' CG ' ' A' ' 61' ' ' HIS . . . 155.36 -8.76 0.32 Allowed Glycine 0 CA--C 1.524 0.649 0 CA-C-O 117.779 -1.567 . . . . 0.0 114.955 -170.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 157.05 -23.44 0.46 Allowed Glycine 0 CA--C 1.528 0.895 0 CA-C-N 120.148 1.974 . . . . 0.0 113.51 178.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 123.69 22.28 2.27 Favored Glycine 0 N--CA 1.471 1.032 0 CA-C-N 118.383 1.091 . . . . 0.0 113.282 169.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -118.27 -131.04 0.3 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.911 1.684 . . . . 0.0 109.847 -162.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -87.3 -8.89 73.94 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-N 119.915 1.234 . . . . 0.0 114.319 -177.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -65.06 -59.84 9.23 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 124.525 1.13 . . . . 0.0 108.695 173.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -67.05 161.11 44.17 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 121.556 1.504 . . . . 0.0 110.886 175.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . 0.265 3.2 t-160 60.17 -69.91 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.431 1.092 . . . . 0.0 111.875 -166.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 59.07 15.35 28.77 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-O 117.593 -1.671 . . . . 0.0 116.104 159.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 124.96 -14.95 7.45 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-N 119.873 1.836 . . . . 0.0 114.798 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.49 10.54 6.52 Favored Glycine 0 N--CA 1.473 1.145 0 CA-C-N 119.848 1.824 . . . . 0.0 115.393 164.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -118.64 -99.93 0.44 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.501 1.15 . . . . 0.0 112.107 -159.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -102.75 -0.47 49.17 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.436 1.017 . . . . 0.0 114.019 -178.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.465 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 2.0 mp0 -87.17 -38.41 0.5 Allowed Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 127.31 2.244 . . . . 0.0 111.911 173.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 75' ' ' GLN . 36.7 Cg_endo -74.71 -170.38 0.75 Allowed 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.978 2.452 . . . . 0.0 108.576 161.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 19.1 t-160 67.68 -72.36 0.09 Allowed 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 126.38 1.872 . . . . 0.0 111.931 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 58.94 17.89 37.97 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-O 116.996 -2.002 . . . . 0.0 116.215 161.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 128.06 -16.66 6.06 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-N 120.016 1.908 . . . . 0.0 114.262 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 118.28 13.33 7.01 Favored Glycine 0 N--CA 1.47 0.926 0 CA-C-N 119.242 1.521 . . . . 0.0 114.734 165.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -119.26 -105.98 0.38 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.162 0.981 . . . . 0.0 111.494 -160.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -101.9 4.65 53.03 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.655 1.122 . . . . 0.0 113.566 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.461 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 4.4 mm100 -85.33 -34.49 0.51 Allowed Pre-proline 0 CA--C 1.554 1.111 0 C-N-CA 126.053 1.741 . . . . 0.0 115.232 169.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' A' ' 83' ' ' GLN . 10.1 Cg_endo . . . . . 0 N--CA 1.455 -0.792 1 C-N-CA 125.353 4.035 . . . . 0.0 109.389 166.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.528 ' CD2' ' HB3' ' A' ' 67' ' ' GLN . 1.4 t60 . . . . . 0 C--O 1.225 -0.211 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -123.65 -5.47 7.68 Favored Glycine 0 C--O 1.222 -0.597 0 C-N-CA 124.192 0.901 . . . . 0.0 110.882 -173.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 152.19 -11.37 0.67 Allowed Glycine 0 CA--C 1.525 0.657 0 CA-C-O 118.308 -1.274 . . . . 0.0 113.751 -172.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 113.53 32.03 2.22 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-N 119.223 1.511 . . . . 0.0 114.761 170.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -117.35 -121.67 0.3 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 118.461 1.131 . . . . 0.0 110.854 -166.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -83.11 -17.9 66.14 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-N 119.486 1.039 . . . . 0.0 112.777 176.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.528 ' HB3' ' CD2' ' A' ' 61' ' ' HIS . 1.2 mp0 -62.43 -56.69 28.03 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 125.545 1.538 . . . . 0.0 112.949 177.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -65.33 137.31 50.83 Favored 'Trans proline' 0 N--CA 1.448 -1.171 0 N-CA-C 108.992 -1.196 . . . . 0.0 108.992 173.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 19.1 t-160 47.62 62.54 2.39 Favored 'General case' 0 C--O 1.227 -0.127 0 CA-C-O 124.518 2.104 . . . . 0.0 113.343 -176.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.9 36.76 0.29 Allowed Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 111.414 -2.63 . . . . 0.0 115.716 172.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 123.16 -23.51 6.86 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-N 120.665 2.232 . . . . 0.0 115.093 166.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 140.39 8.87 0.81 Allowed Glycine 0 N--CA 1.469 0.871 0 CA-C-N 118.761 1.281 . . . . 0.0 115.561 166.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -133.3 -110.48 0.23 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.604 1.202 . . . . 0.0 110.74 -158.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -78.36 -26.19 59.91 Favored Glycine 0 CA--C 1.525 0.703 0 O-C-N 120.944 -1.097 . . . . 0.0 112.214 -176.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -64.3 -52.81 51.44 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 118.379 1.09 . . . . 0.0 109.978 -177.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.66 78.96 0.94 Allowed 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 122.135 1.89 . . . . 0.0 110.943 170.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.252 23.6 t-160 63.99 67.0 0.62 Allowed 'General case' 0 C--O 1.226 -0.18 0 CA-C-O 124.653 2.168 . . . . 0.0 113.503 168.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.18 27.35 0.32 Allowed Glycine 0 CA--C 1.526 0.748 0 CA-C-N 111.457 -2.61 . . . . 0.0 115.898 172.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 123.1 -8.01 9.17 Favored Glycine 0 CA--C 1.534 1.219 0 CA-C-N 121.021 2.411 . . . . 0.0 116.317 167.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 134.58 7.72 2.09 Favored Glycine 0 N--CA 1.469 0.874 0 CA-C-N 119.503 1.652 . . . . 0.0 115.128 163.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -133.66 -138.31 0.18 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.5 1.15 . . . . 0.0 110.458 -157.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -65.5 -6.9 30.87 Favored Glycine 0 CA--C 1.532 1.113 0 O-C-N 121.384 -0.822 . . . . 0.0 114.646 -175.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.443 ' CB ' ' CD ' ' A' ' 84' ' ' PRO . 21.6 mm100 -69.73 -67.9 0.63 Allowed Pre-proline 0 N--CA 1.443 -0.809 0 C-N-CA 124.814 1.245 . . . . 0.0 108.308 172.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.443 ' CD ' ' CB ' ' A' ' 83' ' ' GLN . 33.4 Cg_endo . . . . . 0 N--CA 1.454 -0.834 0 C-N-CA 123.259 2.639 . . . . 0.0 112.469 176.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.447 -0.608 0 CA-C-O 121.955 0.883 . . . . 0.0 109.816 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.21 1.7 21.87 Favored Glycine 0 C--O 1.224 -0.497 0 CA-C-O 117.506 -1.719 . . . . 0.0 115.623 158.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 131.24 -16.81 5.17 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-N 119.177 1.488 . . . . 0.0 114.625 170.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 118.54 11.08 8.16 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-N 119.319 1.56 . . . . 0.0 114.814 168.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -121.37 -108.28 0.35 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 118.647 1.224 . . . . 0.0 111.757 -159.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -104.04 6.07 46.83 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 125.219 1.39 . . . . 0.0 114.649 176.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.423 ' HA ' HE21 ' A' ' 67' ' ' GLN . 0.3 OUTLIER -69.6 -60.87 3.51 Favored Pre-proline 0 N--CA 1.448 -0.535 0 C-N-CA 127.638 2.375 . . . . 0.0 109.516 156.856 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.41 ' HD2' ' H ' ' A' ' 67' ' ' GLN . 44.1 Cg_endo -73.15 -172.44 1.01 Allowed 'Trans proline' 0 N--CA 1.447 -1.206 0 C-N-CA 122.787 2.325 . . . . 0.0 109.381 169.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.556 ' CD2' ' H ' ' A' ' 70' ' ' GLY 0.272 6.5 t-160 88.08 175.96 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 128.52 2.728 . . . . 0.0 109.921 -157.352 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.556 ' H ' ' CD2' ' A' ' 69' ' ' HIS . . . 158.46 -2.4 0.11 Allowed Glycine 0 CA--C 1.524 0.61 0 CA-C-O 117.474 -1.737 . . . . 0.0 115.431 -157.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 146.27 -57.31 0.51 Allowed Glycine 0 C--N 1.338 0.642 0 CA-C-N 120.714 2.257 . . . . 0.0 111.704 178.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 151.35 51.49 0.01 OUTLIER Glycine 0 C--N 1.34 0.802 0 CA-C-N 117.941 0.871 . . . . 0.0 112.966 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.405 ' CD1' ' OE1' ' A' ' 75' ' ' GLN . 0.0 OUTLIER -149.89 -114.6 0.06 Allowed 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.827 -0.808 . . . . 0.0 110.21 -168.471 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -99.94 -21.6 13.63 Favored Glycine 0 N--CA 1.473 1.162 0 CA-C-N 119.578 1.081 . . . . 0.0 113.394 -175.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.426 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 4.1 mp0 -59.75 -33.74 17.77 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 128.194 2.598 . . . . 0.0 113.211 176.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.426 ' CD ' ' N ' ' A' ' 75' ' ' GLN . 32.1 Cg_endo -80.28 -71.04 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 123.654 2.903 . . . . 0.0 111.575 173.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 50.0 -74.24 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 117.662 2.467 . . . . 0.0 117.662 176.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.1 -79.15 0.51 Allowed Glycine 0 CA--C 1.525 0.681 0 O-C-N 120.986 -1.071 . . . . 0.0 110.615 -169.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -153.86 3.89 0.29 Allowed Glycine 0 CA--C 1.528 0.882 0 CA-C-O 117.8 -1.555 . . . . 0.0 114.172 -167.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.81 27.86 4.16 Favored Glycine 0 N--CA 1.476 1.364 0 CA-C-N 120.172 1.986 . . . . 0.0 113.305 160.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -121.8 -122.8 0.28 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.468 1.507 . . . . 0.0 108.666 -162.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -91.51 -5.38 67.08 Favored Glycine 0 CA--C 1.531 1.037 0 CA-C-N 119.212 0.915 . . . . 0.0 114.574 -177.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -78.92 -43.7 1.79 Allowed Pre-proline 0 N--CA 1.447 -0.595 0 C-N-CA 125.223 1.409 . . . . 0.0 114.091 174.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo . . . . . 0 N--CA 1.454 -0.833 0 CA-C-N 121.617 1.613 . . . . 0.0 109.523 175.076 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.449 -0.506 0 CA-C-O 122.146 0.974 . . . . 0.0 110.309 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.77 -5.35 7.76 Favored Glycine 0 C--O 1.224 -0.485 0 CA-C-O 117.675 -1.625 . . . . 0.0 114.435 160.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 137.22 -30.03 2.66 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-O 117.851 -1.527 . . . . 0.0 114.365 168.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 128.41 27.11 0.92 Allowed Glycine 0 CA--C 1.529 0.961 0 CA-C-N 119.567 1.684 . . . . 0.0 115.253 177.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -133.14 -109.09 0.24 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.308 1.554 . . . . 0.0 111.618 -166.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -98.61 -12.07 45.47 Favored Glycine 0 CA--C 1.534 1.222 0 CA-C-N 119.388 0.994 . . . . 0.0 114.235 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -62.53 -54.24 50.11 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 126.559 1.944 . . . . 0.0 112.14 164.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -75.02 -171.63 1.04 Allowed 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 122.258 1.972 . . . . 0.0 108.854 166.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.639 ' CD2' ' H ' ' A' ' 70' ' ' GLY 0.27 7.6 t-160 65.74 174.13 0.22 Allowed 'General case' 0 CA--C 1.536 0.429 0 O-C-N 120.975 -1.078 . . . . 0.0 110.852 -152.032 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.639 ' H ' ' CD2' ' A' ' 69' ' ' HIS . . . 149.27 10.05 0.14 Allowed Glycine 0 C--N 1.337 0.62 0 CA-C-O 117.136 -1.924 . . . . 0.0 116.417 -149.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 139.2 -67.73 0.51 Allowed Glycine 0 CA--C 1.522 0.502 0 CA-C-N 120.739 2.269 . . . . 0.0 111.007 177.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 155.59 44.83 0.02 OUTLIER Glycine 0 C--N 1.335 0.521 0 CA-C-O 119.308 -0.718 . . . . 0.0 112.652 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.03 -120.33 0.05 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 117.998 0.899 . . . . 0.0 110.99 -170.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -70.63 -36.93 67.83 Favored Glycine 0 CA--C 1.526 0.767 0 O-C-N 120.289 -1.507 . . . . 0.0 111.941 -178.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -59.08 -42.45 93.71 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 125.409 1.484 . . . . 0.0 113.088 -174.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -82.69 -20.47 5.56 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.299 2.0 . . . . 0.0 116.446 178.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 22.0 t-80 -16.72 117.71 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 128.552 2.741 . . . . 0.0 115.737 175.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -143.56 28.89 2.03 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-O 117.202 -1.888 . . . . 0.0 113.741 -174.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 142.07 -71.49 0.41 Allowed Glycine 0 C--N 1.336 0.534 0 CA-C-N 120.253 2.027 . . . . 0.0 110.012 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 173.69 16.93 0.02 OUTLIER Glycine 0 CA--C 1.526 0.739 0 CA-C-O 119.46 -0.633 . . . . 0.0 114.222 178.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -127.71 -141.03 0.26 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.488 1.144 . . . . 0.0 110.101 -159.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -69.14 11.26 1.46 Allowed Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.41 1.481 . . . . 0.0 114.642 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.407 ' CB ' ' CD ' ' A' ' 84' ' ' PRO . 10.1 mm100 -84.99 -68.42 0.16 Allowed Pre-proline 0 N--CA 1.443 -0.787 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 163.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.407 ' CD ' ' CB ' ' A' ' 83' ' ' GLN . 24.5 Cg_endo . . . . . 0 N--CA 1.451 -0.977 0 C-N-CA 122.671 2.247 . . . . 0.0 112.409 -174.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.44 ' CD2' ' HB3' ' A' ' 67' ' ' GLN . 0.6 OUTLIER . . . . . 0 N--CA 1.454 -0.257 0 CA-C-O 120.511 0.196 . . . . 0.0 110.996 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.61 -4.48 9.28 Favored Glycine 0 CA--C 1.522 0.489 0 CA-C-O 117.932 -1.482 . . . . 0.0 114.949 154.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 127.41 -19.96 5.9 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-O 117.361 -1.799 . . . . 0.0 115.659 165.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 127.77 22.96 1.38 Allowed Glycine 0 N--CA 1.475 1.242 0 CA-C-N 120.242 2.021 . . . . 0.0 116.479 170.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -137.12 -112.58 0.18 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.517 1.659 . . . . 0.0 111.085 -165.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -81.14 -33.61 28.7 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-N 119.167 0.894 . . . . 0.0 112.85 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.44 ' HB3' ' CD2' ' A' ' 61' ' ' HIS . 3.4 mp0 -48.25 -63.32 1.59 Allowed Pre-proline 0 N--CA 1.454 -0.271 0 C-N-CA 126.952 2.101 . . . . 0.0 112.233 171.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -64.46 139.39 64.48 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 120.963 1.109 . . . . 0.0 111.203 -174.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 17.2 t-160 72.25 -53.92 0.69 Allowed 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.409 1.083 . . . . 0.0 112.362 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 72.7 -25.67 0.76 Allowed Glycine 0 CA--C 1.533 1.217 0 C-N-CA 125.356 1.455 . . . . 0.0 115.034 161.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 152.59 -6.92 0.49 Allowed Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.32 1.438 . . . . 0.0 113.393 -169.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.23 40.44 4.54 Favored Glycine 0 N--CA 1.472 1.084 0 CA-C-N 119.79 1.795 . . . . 0.0 113.222 166.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -140.02 -110.16 0.15 Allowed 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.256 1.023 . . . . 0.0 110.615 -160.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -111.79 -0.62 27.35 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 124.494 1.045 . . . . 0.0 112.945 -172.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.0 -65.38 2.21 Favored Pre-proline 0 N--CA 1.436 -1.172 0 C-N-CA 125.767 1.627 . . . . 0.0 108.256 161.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -78.3 69.69 7.5 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 123.84 3.027 . . . . 0.0 111.516 -160.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.278 28.2 t-80 71.37 102.26 0.06 Allowed 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 125.426 1.491 . . . . 0.0 110.83 -160.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.527 ' H ' ' HD3' ' A' ' 84' ' ' PRO . . . -110.04 18.17 28.89 Favored Glycine 0 C--O 1.223 -0.572 0 CA-C-O 116.787 -2.119 . . . . 0.0 113.977 -178.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 134.71 -12.1 4.55 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-N 120.479 2.139 . . . . 0.0 115.553 173.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 125.44 25.27 1.47 Allowed Glycine 0 N--CA 1.469 0.897 0 CA-C-N 119.435 1.618 . . . . 0.0 114.31 167.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -141.7 -155.75 0.62 Allowed 'General case' 0 C--O 1.219 -0.524 0 C-N-CA 125.972 1.709 . . . . 0.0 107.824 -167.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -71.98 16.71 1.47 Allowed Glycine 0 CA--C 1.538 1.473 0 CA-C-O 118.191 -1.338 . . . . 0.0 116.313 -171.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 20.3 mm100 -75.81 -64.24 0.57 Allowed Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 119.31 1.555 . . . . 0.0 107.753 168.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.527 ' HD3' ' H ' ' A' ' 78' ' ' GLY . 44.5 Cg_endo . . . . . 0 N--CA 1.454 -0.842 0 C-N-CA 123.44 2.76 . . . . 0.0 108.687 161.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.624 ' CD2' ' H ' ' A' ' 62' ' ' GLY . 45.9 t-80 . . . . . 0 CA--C 1.545 0.786 0 CA-C-O 122.672 1.225 . . . . 0.0 113.632 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.624 ' H ' ' CD2' ' A' ' 61' ' ' HIS . . . 165.64 19.12 0.02 OUTLIER Glycine 0 CA--C 1.524 0.615 0 CA-C-O 117.681 -1.622 . . . . 0.0 114.128 -158.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 138.68 -70.41 0.47 Allowed Glycine 0 C--N 1.338 0.652 0 CA-C-N 120.218 2.009 . . . . 0.0 109.88 -177.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 168.74 17.67 0.02 OUTLIER Glycine 0 CA--C 1.528 0.873 0 N-CA-C 115.79 1.076 . . . . 0.0 115.79 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -128.66 -104.41 0.31 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 118.517 1.159 . . . . 0.0 111.322 -155.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -98.43 -6.71 56.44 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-N 119.358 0.981 . . . . 0.0 114.377 -177.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -76.37 -50.88 2.7 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 126.679 1.992 . . . . 0.0 110.608 173.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -76.16 -168.97 0.61 Allowed 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.494 2.13 . . . . 0.0 109.459 172.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 14.1 t-160 53.01 68.98 0.75 Allowed 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 125.049 2.357 . . . . 0.0 113.937 -172.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -76.24 37.27 1.33 Allowed Glycine 0 C--N 1.318 -0.418 0 CA-C-N 111.717 -2.492 . . . . 0.0 115.154 173.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 120.37 -23.03 8.18 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-N 119.988 1.894 . . . . 0.0 115.434 166.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 148.36 9.17 0.18 Allowed Glycine 0 N--CA 1.471 1.025 0 CA-C-N 119.395 1.597 . . . . 0.0 116.531 163.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -136.55 -112.34 0.19 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 118.879 1.34 . . . . 0.0 110.808 -157.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.12 -44.51 95.64 Favored Glycine 0 CA--C 1.529 0.929 0 O-C-N 121.073 -1.017 . . . . 0.0 111.453 177.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -56.52 -46.91 99.77 Favored Pre-proline 0 N--CA 1.45 -0.442 0 C-N-CA 124.166 0.986 . . . . 0.0 111.597 -170.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.05 55.35 2.33 Favored 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 122.583 2.189 . . . . 0.0 112.737 167.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 20.8 t-160 64.25 69.43 0.52 Allowed 'General case' 0 C--N 1.342 0.249 0 CA-C-O 124.434 2.064 . . . . 0.0 114.042 166.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.41 28.27 0.17 Allowed Glycine 0 CA--C 1.525 0.678 0 CA-C-N 111.457 -2.61 . . . . 0.0 116.569 170.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 124.38 -20.75 6.94 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-N 121.655 2.727 . . . . 0.0 116.442 165.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 145.02 10.14 0.3 Allowed Glycine 0 N--CA 1.471 1.024 0 CA-C-N 119.739 1.769 . . . . 0.0 115.965 166.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -130.67 -116.84 0.23 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.938 1.369 . . . . 0.0 110.876 -159.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -94.5 -7.15 60.64 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-N 119.451 1.023 . . . . 0.0 114.346 -177.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -65.17 -58.9 11.07 Favored Pre-proline 0 N--CA 1.448 -0.565 0 C-N-CA 125.542 1.537 . . . . 0.0 110.138 168.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 N--CA 1.454 -0.834 0 N-CA-C 108.508 -1.381 . . . . 0.0 108.508 166.026 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 . . . . . 0 CA--C 1.535 0.392 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 63.94 -17.69 0.1 Allowed Glycine 0 CA--C 1.534 1.248 0 C-N-CA 126.436 1.97 . . . . 0.0 117.219 175.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 154.19 -13.52 0.54 Allowed Glycine 0 CA--C 1.531 1.079 0 CA-C-N 120.33 2.065 . . . . 0.0 114.113 -169.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 116.37 29.15 2.38 Favored Glycine 0 N--CA 1.474 1.206 0 CA-C-N 119.716 1.758 . . . . 0.0 114.045 164.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -118.9 -110.93 0.34 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.02 1.328 . . . . 0.0 110.452 -161.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -109.71 -0.2 30.58 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-N 119.5 1.045 . . . . 0.0 113.744 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -77.59 -32.66 0.95 Allowed Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 125.661 1.584 . . . . 0.0 111.526 169.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -85.54 173.06 7.7 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 121.945 1.763 . . . . 0.0 109.262 160.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.649 ' CD2' ' H ' ' A' ' 70' ' ' GLY . 13.9 t-80 57.5 169.54 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.471 1.108 . . . . 0.0 112.037 -164.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.649 ' H ' ' CD2' ' A' ' 69' ' ' HIS . . . 145.55 12.45 0.23 Allowed Glycine 0 C--N 1.338 0.646 0 CA-C-O 117.244 -1.864 . . . . 0.0 115.195 -153.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 139.59 -78.9 0.29 Allowed Glycine 0 C--N 1.335 0.519 0 CA-C-N 120.702 2.251 . . . . 0.0 109.821 178.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 176.21 19.23 0.02 OUTLIER Glycine 0 CA--C 1.526 0.781 0 CA-C-N 117.529 0.664 . . . . 0.0 114.247 -175.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -127.92 -133.2 0.23 Allowed 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 124.142 0.977 . . . . 0.0 109.17 -165.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -78.83 2.4 68.95 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-N 118.957 0.799 . . . . 0.0 114.633 -175.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -81.92 -53.83 0.68 Allowed Pre-proline 0 N--CA 1.438 -1.035 0 C-N-CA 126.923 2.089 . . . . 0.0 110.088 173.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -72.77 -171.37 0.75 Allowed 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 122.512 2.141 . . . . 0.0 110.209 160.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.599 ' CG ' ' H ' ' A' ' 78' ' ' GLY 0.284 7.7 t-160 70.9 -168.55 0.15 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.502 1.121 . . . . 0.0 110.068 -166.248 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.599 ' H ' ' CG ' ' A' ' 77' ' ' HIS . . . 163.25 -45.69 0.33 Allowed Glycine 0 CA--C 1.527 0.816 0 O-C-N 121.271 -0.893 . . . . 0.0 112.335 -167.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 151.87 -3.66 0.42 Allowed Glycine 0 CA--C 1.533 1.195 0 CA-C-N 118.434 1.117 . . . . 0.0 114.61 -177.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 109.84 69.01 0.61 Allowed Glycine 0 C--N 1.339 0.731 0 CA-C-N 119.01 1.405 . . . . 0.0 111.558 168.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -158.55 -160.68 0.9 Allowed 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 130.174 3.389 . . . . 0.0 106.697 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -74.41 53.87 2.35 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 126.046 1.784 . . . . 0.0 113.242 177.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.458 ' H ' ' HD2' ' A' ' 84' ' ' PRO . 4.4 mm-40 -121.54 -58.0 0.03 OUTLIER Pre-proline 0 N--CA 1.453 -0.313 0 C-N-CA 126.026 1.73 . . . . 0.0 110.37 168.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.458 ' HD2' ' H ' ' A' ' 83' ' ' GLN . 34.4 Cg_endo . . . . . 0 N--CA 1.455 -0.775 0 C-N-CA 123.883 3.055 . . . . 0.0 109.127 170.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.61 ' CG ' ' H ' ' A' ' 62' ' ' GLY . 5.3 t-160 . . . . . 0 N--CA 1.448 -0.557 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.61 ' H ' ' CG ' ' A' ' 61' ' ' HIS . . . 153.38 -2.51 0.27 Allowed Glycine 0 C--O 1.221 -0.695 0 CA-C-O 116.581 -2.233 . . . . 0.0 115.368 -168.022 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 151.38 -62.43 0.4 Allowed Glycine 0 C--N 1.339 0.735 0 CA-C-N 121.494 2.647 . . . . 0.0 111.446 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.44 32.96 0.03 OUTLIER Glycine 0 CA--C 1.53 0.997 0 CA-C-N 117.557 0.678 . . . . 0.0 113.206 -178.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -138.3 -143.13 0.16 Allowed 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 125.425 1.49 . . . . 0.0 108.938 -167.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.6 -7.71 61.73 Favored Glycine 0 CA--C 1.533 1.167 0 N-CA-C 116.034 1.173 . . . . 0.0 116.034 -171.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.403 ' CB ' ' CD ' ' A' ' 68' ' ' PRO . 19.6 mm100 -64.32 -69.33 0.6 Allowed Pre-proline 0 CA--C 1.549 0.904 0 C-N-CA 125.756 1.622 . . . . 0.0 109.973 173.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.403 ' CD ' ' CB ' ' A' ' 67' ' ' GLN . 55.9 Cg_endo -64.19 105.43 0.58 Allowed 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.646 2.897 . . . . 0.0 110.423 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 22.3 t-160 46.12 64.39 1.5 Allowed 'General case' 0 C--N 1.344 0.341 0 CA-C-O 123.708 1.718 . . . . 0.0 113.959 177.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -63.4 24.73 0.08 OUTLIER Glycine 0 CA--C 1.527 0.821 0 C-N-CA 127.535 2.493 . . . . 0.0 116.75 173.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 124.89 -17.04 7.25 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-N 120.624 2.212 . . . . 0.0 114.72 170.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 132.57 12.97 1.71 Allowed Glycine 0 N--CA 1.473 1.153 0 CA-C-N 119.033 1.416 . . . . 0.0 116.026 163.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -125.61 -102.56 0.36 Allowed 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 118.023 0.912 . . . . 0.0 109.836 -162.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -86.5 -32.11 17.0 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-N 118.526 0.603 . . . . 0.0 113.097 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.409 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 4.1 mp0 -60.33 -43.89 94.52 Favored Pre-proline 0 C--O 1.223 -0.31 0 O-C-N 121.36 -1.082 . . . . 0.0 111.506 -177.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.409 ' CD ' ' N ' ' A' ' 75' ' ' GLN . 93.7 Cg_endo -77.87 42.3 1.16 Allowed 'Trans proline' 0 CA--C 1.548 1.217 0 C-N-CA 122.957 2.438 . . . . 0.0 111.656 169.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.545 ' CD2' ' H ' ' A' ' 78' ' ' GLY . 6.2 t-160 83.31 -179.17 0.04 OUTLIER 'General case' 0 C--N 1.346 0.414 0 C-N-CA 126.899 2.08 . . . . 0.0 112.643 173.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.545 ' H ' ' CD2' ' A' ' 77' ' ' HIS . . . 160.23 1.35 0.07 OUTLIER Glycine 0 C--N 1.336 0.53 0 CA-C-O 116.959 -2.023 . . . . 0.0 115.616 -158.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 148.95 -59.66 0.45 Allowed Glycine 0 C--N 1.339 0.732 0 CA-C-N 121.103 2.452 . . . . 0.0 111.948 175.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 158.51 28.49 0.02 OUTLIER Glycine 0 CA--C 1.529 0.959 0 CA-C-N 117.573 0.686 . . . . 0.0 114.026 175.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -138.43 -131.26 0.13 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.411 1.084 . . . . 0.0 110.944 -158.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -87.66 -10.7 69.65 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 119.789 1.177 . . . . 0.0 114.016 -172.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -55.08 -64.95 1.61 Allowed Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 124.897 1.279 . . . . 0.0 108.451 168.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 N--CA 1.457 -0.669 0 C-N-CA 122.403 2.069 . . . . 0.0 114.494 -176.095 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 23.1 t-80 . . . . . 0 CA--C 1.535 0.372 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -150.02 32.01 1.07 Allowed Glycine 0 C--N 1.335 0.502 0 CA-C-O 118.108 -1.384 . . . . 0.0 112.481 -175.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 128.86 -18.2 5.65 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-N 119.016 1.408 . . . . 0.0 113.274 178.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 126.86 11.86 3.44 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-N 118.716 1.258 . . . . 0.0 115.322 165.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -117.79 -99.68 0.44 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 118.53 1.165 . . . . 0.0 111.501 -162.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -105.33 -2.71 41.27 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 124.3 0.952 . . . . 0.0 114.501 -177.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -75.97 -48.72 3.52 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 125.334 1.454 . . . . 0.0 112.71 165.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -74.36 167.35 27.36 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 122.188 1.925 . . . . 0.0 109.491 168.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.633 ' CD2' ' H ' ' A' ' 70' ' ' GLY . 16.1 t-80 57.57 172.61 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.687 0.795 . . . . 0.0 111.509 -165.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.633 ' H ' ' CD2' ' A' ' 69' ' ' HIS . . . 151.31 14.17 0.08 OUTLIER Glycine 0 C--N 1.337 0.633 0 CA-C-O 117.567 -1.685 . . . . 0.0 115.295 -158.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 142.97 -69.59 0.42 Allowed Glycine 0 C--O 1.224 -0.47 0 CA-C-N 120.359 2.079 . . . . 0.0 110.168 177.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 167.69 18.69 0.02 OUTLIER Glycine 0 CA--C 1.529 0.913 0 N-CA-C 114.687 0.635 . . . . 0.0 114.687 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -127.52 -118.28 0.26 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.093 0.957 . . . . 0.0 110.544 -160.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -94.24 -3.52 63.32 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-N 119.428 1.013 . . . . 0.0 114.444 -178.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.89 -45.82 3.95 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 125.592 1.557 . . . . 0.0 110.567 170.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -75.77 -164.88 0.27 Allowed 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.038 1.825 . . . . 0.0 109.118 157.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.591 ' CD2' ' H ' ' A' ' 78' ' ' GLY 0.268 11.3 t-80 67.46 174.0 0.26 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.04 1.336 . . . . 0.0 110.462 -158.414 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.591 ' H ' ' CD2' ' A' ' 77' ' ' HIS . . . 141.64 9.55 0.63 Allowed Glycine 0 CA--C 1.526 0.751 0 CA-C-O 117.615 -1.659 . . . . 0.0 115.154 -156.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 141.11 -75.95 0.33 Allowed Glycine 0 C--N 1.336 0.562 0 CA-C-N 120.787 2.293 . . . . 0.0 110.405 174.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 177.49 15.35 0.02 OUTLIER Glycine 0 CA--C 1.527 0.839 0 CA-C-N 117.5 0.65 . . . . 0.0 114.283 -174.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -132.29 -138.24 0.19 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 118.475 1.138 . . . . 0.0 108.951 -162.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.42 43.06 1.51 Allowed Glycine 0 CA--C 1.533 1.157 0 C-N-CA 124.769 1.176 . . . . 0.0 112.315 176.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.464 HE21 ' HA ' ' A' ' 83' ' ' GLN . 0.1 OUTLIER -128.49 -55.85 0.03 OUTLIER Pre-proline 0 N--CA 1.438 -1.044 0 C-N-CA 127.864 2.466 . . . . 0.0 109.671 176.301 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo . . . . . 0 N--CA 1.457 -0.676 0 C-N-CA 121.305 1.336 . . . . 0.0 110.137 157.38 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 . . . . . 0 CA--C 1.52 -0.178 0 CA-C-O 123.456 1.598 . . . . 0.0 114.377 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.79 28.81 0.04 OUTLIER Glycine 0 CA--C 1.527 0.822 0 C-N-CA 128.592 2.996 . . . . 0.0 117.64 173.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 127.27 -20.2 5.92 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-N 120.664 2.232 . . . . 0.0 114.19 166.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 137.66 8.2 1.3 Allowed Glycine 0 N--CA 1.472 1.064 0 CA-C-N 118.853 1.326 . . . . 0.0 115.941 166.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -135.09 -117.23 0.18 Allowed 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 118.113 0.957 . . . . 0.0 110.161 -158.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.7 -11.3 72.98 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-O 118.957 -0.913 . . . . 0.0 113.944 -177.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -81.3 -59.94 0.44 Allowed Pre-proline 0 N--CA 1.445 -0.716 0 CA-C-N 118.755 1.277 . . . . 0.0 109.347 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.99 83.65 0.18 Allowed 'Trans proline' 0 CA--C 1.548 1.177 0 C-N-CA 123.059 2.506 . . . . 0.0 112.613 178.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.536 ' H ' ' HB3' ' A' ' 76' ' ' PRO . 9.6 t60 -67.75 132.97 48.44 Favored 'General case' 0 N--CA 1.439 -0.997 0 O-C-N 119.833 -1.792 . . . . 0.0 107.273 173.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.35 -26.93 3.31 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 126.042 1.782 . . . . 0.0 112.646 162.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 162.79 -14.31 0.11 Allowed Glycine 0 CA--C 1.524 0.599 0 CA-C-O 119.124 -0.82 . . . . 0.0 112.754 -175.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.69 26.4 6.82 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-N 118.778 1.289 . . . . 0.0 112.854 172.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -95.95 -113.13 0.13 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.499 2.319 . . . . 0.0 110.384 -173.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -94.71 -28.67 9.99 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-N 119.839 1.2 . . . . 0.0 113.092 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -50.5 -39.0 46.26 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 126.78 2.032 . . . . 0.0 115.612 172.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.536 ' HB3' ' H ' ' A' ' 69' ' ' HIS . 14.6 Cg_endo -83.32 50.9 3.42 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.403 2.068 . . . . 0.0 112.715 -172.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 72.82 120.31 0.04 OUTLIER 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.755 1.222 . . . . 0.0 109.942 -162.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -136.55 33.57 2.33 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 125.316 1.436 . . . . 0.0 112.09 -167.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 131.35 -77.03 0.4 Allowed Glycine 0 C--N 1.331 0.292 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 -175.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 168.87 24.17 0.02 OUTLIER Glycine 0 CA--C 1.526 0.72 0 CA-C-O 119.046 -0.864 . . . . 0.0 114.895 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -138.35 -107.48 0.18 Allowed 'General case' 0 C--O 1.223 -0.328 0 CA-C-N 118.594 1.197 . . . . 0.0 111.238 -158.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -97.21 -4.5 58.49 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-N 119.384 0.993 . . . . 0.0 114.146 -175.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.4 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 3.6 mp0 -78.29 -51.03 1.64 Allowed Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 125.962 1.705 . . . . 0.0 112.325 175.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 83' ' ' GLN . 36.7 Cg_endo . . . . . 0 N--CA 1.45 -1.051 0 C-N-CA 122.971 2.448 . . . . 0.0 108.225 174.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.544 ' CD2' ' H ' ' A' ' 62' ' ' GLY . 7.1 t-160 . . . . . 0 CA--C 1.545 0.772 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.544 ' H ' ' CD2' ' A' ' 61' ' ' HIS . . . 148.02 -1.33 0.66 Allowed Glycine 0 C--N 1.338 0.662 0 CA-C-O 117.147 -1.918 . . . . 0.0 116.467 -154.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.4 ' H ' ' CD2' ' A' ' 61' ' ' HIS . . . 148.86 -64.21 0.41 Allowed Glycine 0 C--N 1.336 0.54 0 CA-C-N 121.026 2.413 . . . . 0.0 112.012 173.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 167.16 21.61 0.02 OUTLIER Glycine 0 CA--C 1.527 0.829 0 CA-C-N 117.712 0.756 . . . . 0.0 114.692 -174.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -130.96 -133.47 0.2 Allowed 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 118.645 1.222 . . . . 0.0 108.818 -167.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.69 -23.66 77.51 Favored Glycine 0 CA--C 1.534 1.26 0 O-C-N 121.646 -0.659 . . . . 0.0 113.487 -174.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.401 HE21 ' CA ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -57.91 -49.74 92.02 Favored Pre-proline 0 N--CA 1.441 -0.905 0 C-N-CA 127.745 2.418 . . . . 0.0 113.363 -179.036 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -79.25 130.98 9.46 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.42 2.747 . . . . 0.0 109.939 166.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 21.8 t-160 57.43 -73.35 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 115.558 1.688 . . . . 0.0 115.558 175.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 68.87 -23.7 0.3 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 126.9 2.19 . . . . 0.0 116.243 171.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 159.08 -11.74 0.19 Allowed Glycine 0 CA--C 1.531 1.093 0 CA-C-N 119.282 1.541 . . . . 0.0 113.867 -170.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 114.93 29.91 2.47 Favored Glycine 0 N--CA 1.475 1.249 0 CA-C-N 119.931 1.865 . . . . 0.0 114.345 166.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -120.86 -113.12 0.32 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.333 1.453 . . . . 0.0 110.526 -163.162 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -101.43 -4.67 52.79 Favored Glycine 0 CA--C 1.536 1.396 0 CA-C-N 119.93 1.241 . . . . 0.0 114.028 -178.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -83.63 -31.79 0.51 Allowed Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 128.535 2.734 . . . . 0.0 112.707 177.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -82.58 -164.05 0.25 Allowed 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 121.991 1.794 . . . . 0.0 107.452 157.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.561 ' CD2' ' H ' ' A' ' 78' ' ' GLY . 11.7 t-80 58.71 -178.31 0.08 Allowed 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.31 -0.869 . . . . 0.0 110.196 -167.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.561 ' H ' ' CD2' ' A' ' 77' ' ' HIS . . . 138.79 8.76 1.04 Allowed Glycine 0 C--N 1.339 0.699 0 CA-C-O 117.258 -1.857 . . . . 0.0 115.826 -156.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 141.25 -69.84 0.44 Allowed Glycine 0 CA--C 1.522 0.477 0 CA-C-N 120.679 2.24 . . . . 0.0 110.697 171.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 172.9 17.11 0.02 OUTLIER Glycine 0 CA--C 1.528 0.868 0 C-N-CA 120.352 -0.928 . . . . 0.0 114.744 -174.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -131.03 -143.79 0.25 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 118.315 1.057 . . . . 0.0 109.331 -165.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -67.94 12.09 0.87 Allowed Glycine 0 CA--C 1.537 1.443 0 C-N-CA 124.521 1.058 . . . . 0.0 114.766 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 5.6 mm100 -94.33 -52.85 0.24 Allowed Pre-proline 0 N--CA 1.442 -0.845 0 C-N-CA 126.514 1.925 . . . . 0.0 110.0 173.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo . . . . . 0 CA--C 1.536 0.598 0 C-N-CA 121.617 1.544 . . . . 0.0 113.284 166.098 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.9 t-160 . . . . . 0 CA--C 1.533 0.304 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.78 -75.01 0.58 Allowed Glycine 0 CA--C 1.526 0.735 0 CA-C-N 118.928 0.785 . . . . 0.0 111.732 -173.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -156.44 -0.68 0.11 Allowed Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.857 1.694 . . . . 0.0 113.397 -170.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.22 51.62 0.71 Allowed Glycine 0 C--N 1.345 1.035 0 CA-C-N 120.057 1.928 . . . . 0.0 112.082 164.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -139.18 -125.09 0.12 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.446 1.498 . . . . 0.0 109.709 -170.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -82.54 -19.28 64.34 Favored Glycine 0 CA--C 1.533 1.208 0 O-C-N 120.331 -1.48 . . . . 0.0 114.129 -177.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -69.48 -35.02 5.2 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 125.418 1.487 . . . . 0.0 114.704 -178.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -75.75 -75.3 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.359 2.04 . . . . 0.0 108.613 169.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.582 ' CG ' ' H ' ' A' ' 70' ' ' GLY . 8.8 t-160 48.13 -162.04 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.827 1.251 . . . . 0.0 112.418 -175.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.582 ' H ' ' CG ' ' A' ' 69' ' ' HIS . . . 145.29 -15.62 1.88 Allowed Glycine 0 C--O 1.221 -0.674 0 O-C-N 120.139 -1.6 . . . . 0.0 114.871 -172.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 159.41 -20.21 0.27 Allowed Glycine 0 CA--C 1.528 0.866 0 CA-C-N 119.384 1.592 . . . . 0.0 113.994 -177.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 118.65 30.57 1.64 Allowed Glycine 0 N--CA 1.473 1.165 0 CA-C-N 119.217 1.509 . . . . 0.0 113.102 170.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.402 ' CD1' ' NE2' ' A' ' 75' ' ' GLN . 0.0 OUTLIER -127.67 -141.63 0.26 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.883 1.673 . . . . 0.0 109.612 -163.765 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.03 -25.32 67.89 Favored Glycine 0 CA--C 1.534 1.231 0 O-C-N 120.091 -1.631 . . . . 0.0 113.569 -178.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.402 ' NE2' ' CD1' ' A' ' 73' ' ' TRP . 2.2 mp0 -68.32 -51.53 24.44 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 124.789 1.236 . . . . 0.0 112.108 -173.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.66 -50.97 1.05 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 121.714 1.609 . . . . 0.0 111.518 175.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 20.5 t-160 60.03 -71.24 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.052 1.741 . . . . 0.0 114.69 -178.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 64.11 -2.67 2.01 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-O 116.996 -2.002 . . . . 0.0 116.264 173.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 128.78 -5.49 6.53 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-N 120.48 2.14 . . . . 0.0 114.345 -177.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 116.17 18.85 5.72 Favored Glycine 0 N--CA 1.476 1.313 0 CA-C-N 119.944 1.872 . . . . 0.0 115.027 156.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -131.49 -99.96 0.3 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.42 1.088 . . . . 0.0 111.62 -157.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -92.44 -12.93 57.88 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 119.147 -0.807 . . . . 0.0 113.646 -177.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -74.92 -41.54 4.22 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-N 120.109 1.954 . . . . 0.0 112.012 172.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo . . . . . 0 N--CA 1.452 -0.956 0 C-N-CA 123.479 2.786 . . . . 0.0 114.572 -176.308 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.539 ' CG ' ' H ' ' A' ' 62' ' ' GLY 0.262 4.5 t-160 . . . . . 0 CA--C 1.537 0.479 0 CA-C-O 121.884 0.85 . . . . 0.0 112.235 . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.539 ' H ' ' CG ' ' A' ' 61' ' ' HIS . . . 174.56 -42.93 0.13 Allowed Glycine 0 CA--C 1.525 0.67 0 O-C-N 120.981 -1.074 . . . . 0.0 110.563 -160.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 173.8 -33.79 0.11 Allowed Glycine 0 CA--C 1.526 0.733 0 CA-C-O 118.323 -1.265 . . . . 0.0 113.377 171.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 146.02 45.77 0.04 OUTLIER Glycine 0 C--N 1.343 0.939 0 CA-C-N 118.959 1.38 . . . . 0.0 113.477 171.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -137.04 -133.73 0.14 Allowed 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -171.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -88.36 -2.42 79.87 Favored Glycine 0 CA--C 1.524 0.599 0 O-C-N 121.622 -0.673 . . . . 0.0 112.237 -166.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . 0.288 0.0 OUTLIER -71.2 -71.0 0.27 Allowed Pre-proline 0 N--CA 1.427 -1.599 0 C-N-CA 129.538 3.135 . . . . 0.0 107.26 178.169 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -62.42 88.64 0.11 Allowed 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 125.096 3.864 . . . . 0.0 112.02 -171.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 17.5 t-160 50.0 69.05 0.65 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 124.293 1.996 . . . . 0.0 112.224 -176.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.32 24.23 0.12 Allowed Glycine 0 CA--C 1.526 0.725 0 CA-C-N 111.668 -2.515 . . . . 0.0 116.558 174.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 127.0 -17.34 6.32 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 121.426 2.613 . . . . 0.0 116.058 167.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 146.08 12.7 0.21 Allowed Glycine 0 N--CA 1.476 1.312 0 CA-C-N 119.853 1.826 . . . . 0.0 116.632 165.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -140.54 -117.49 0.12 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 118.583 1.191 . . . . 0.0 110.0 -155.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -81.01 -31.48 34.98 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-N 119.42 1.009 . . . . 0.0 113.23 -175.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -50.36 -48.85 79.88 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 125.652 1.581 . . . . 0.0 111.528 -176.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -71.84 54.84 2.14 Favored 'Trans proline' 0 CA--C 1.55 1.313 0 C-N-CA 122.614 2.209 . . . . 0.0 112.65 168.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.264 16.5 t-160 66.9 67.88 0.42 Allowed 'General case' 0 C--N 1.346 0.413 0 CA-C-O 124.545 2.117 . . . . 0.0 113.287 165.239 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.57 31.39 0.27 Allowed Glycine 0 CA--C 1.524 0.635 0 CA-C-N 111.714 -2.494 . . . . 0.0 116.264 172.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.47 -18.66 8.19 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 121.075 2.438 . . . . 0.0 115.628 167.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 139.94 9.54 0.82 Allowed Glycine 0 N--CA 1.469 0.863 0 CA-C-N 119.209 1.505 . . . . 0.0 115.548 163.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -131.74 -106.93 0.26 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 118.906 1.353 . . . . 0.0 111.406 -155.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -86.56 -25.02 37.03 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-N 119.029 0.832 . . . . 0.0 112.911 -179.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.439 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 4.5 mp0 -63.47 -43.69 79.51 Favored Pre-proline 0 C--O 1.222 -0.362 0 C-N-CA 126.955 2.102 . . . . 0.0 113.427 -177.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.439 ' CD ' ' N ' ' A' ' 83' ' ' GLN . 19.0 Cg_endo . . . . . 0 CA--C 1.553 1.437 0 C-N-CA 124.255 3.303 . . . . 0.0 113.215 174.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.651 ' CD2' ' H ' ' A' ' 62' ' ' GLY . 7.5 t-160 . . . . . 0 CA--C 1.541 0.634 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.651 ' H ' ' CD2' ' A' ' 61' ' ' HIS . . . 146.33 12.49 0.2 Allowed Glycine 0 C--N 1.338 0.68 0 CA-C-O 117.193 -1.893 . . . . 0.0 115.701 -155.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 139.35 -72.78 0.42 Allowed Glycine 0 C--N 1.338 0.648 0 CA-C-N 120.709 2.255 . . . . 0.0 110.836 175.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 168.76 17.26 0.02 OUTLIER Glycine 0 CA--C 1.527 0.826 0 CA-C-O 119.499 -0.612 . . . . 0.0 114.324 -175.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -121.55 -133.48 0.3 Allowed 'General case' 0 C--O 1.222 -0.361 0 C-N-CA 124.86 1.264 . . . . 0.0 108.352 -170.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.67 -7.97 87.91 Favored Glycine 0 CA--C 1.533 1.182 0 CA-C-N 119.294 0.952 . . . . 0.0 114.774 -173.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -67.38 -59.16 7.55 Favored Pre-proline 0 N--CA 1.442 -0.835 0 C-N-CA 126.496 1.919 . . . . 0.0 110.16 174.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -72.22 172.66 14.39 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 121.633 1.556 . . . . 0.0 109.443 161.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 23.0 t-160 60.06 -70.97 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.401 1.88 . . . . 0.0 113.42 -175.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 58.01 12.29 10.9 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-O 117.857 -1.524 . . . . 0.0 116.386 164.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 125.24 -9.89 7.81 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 120.03 1.915 . . . . 0.0 114.867 178.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 119.89 14.58 5.57 Favored Glycine 0 N--CA 1.471 1.032 0 CA-C-N 119.795 1.797 . . . . 0.0 115.159 161.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -121.29 -97.45 0.46 Allowed 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 124.629 1.172 . . . . 0.0 111.863 -162.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -108.16 -1.01 33.56 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.323 0.963 . . . . 0.0 114.554 -178.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.449 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 3.7 mp0 -83.47 -35.66 0.64 Allowed Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 126.286 1.834 . . . . 0.0 112.642 167.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.449 ' CD ' ' N ' ' A' ' 75' ' ' GLN . 30.2 Cg_endo -73.79 177.32 8.23 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.473 2.116 . . . . 0.0 108.871 164.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.571 ' CG ' ' H ' ' A' ' 78' ' ' GLY . 9.3 t-80 62.66 176.89 0.14 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.785 0.834 . . . . 0.0 110.71 -167.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.571 ' H ' ' CG ' ' A' ' 77' ' ' HIS . . . 144.67 4.41 0.63 Allowed Glycine 0 CA--C 1.527 0.784 0 CA-C-O 117.674 -1.626 . . . . 0.0 115.178 -157.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.4 ' H ' ' CD2' ' A' ' 77' ' ' HIS . . . 143.3 -71.13 0.4 Allowed Glycine 0 C--N 1.338 0.676 0 CA-C-N 120.533 2.166 . . . . 0.0 111.195 174.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 172.44 20.09 0.02 OUTLIER Glycine 0 CA--C 1.529 0.918 0 CA-C-N 117.926 0.863 . . . . 0.0 114.642 -172.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -132.47 -138.97 0.19 Allowed 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 118.622 1.211 . . . . 0.0 108.397 -168.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -70.16 0.98 20.61 Favored Glycine 0 CA--C 1.535 1.287 0 O-C-N 121.595 -0.691 . . . . 0.0 114.716 -177.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -82.7 -55.83 0.52 Allowed Pre-proline 0 N--CA 1.441 -0.922 0 C-N-CA 127.299 2.24 . . . . 0.0 111.013 179.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo . . . . . 0 N--CA 1.456 -0.725 0 C-N-CA 121.912 1.741 . . . . 0.0 110.161 165.875 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.686 ' CD2' ' H ' ' A' ' 62' ' ' GLY . 13.1 t-80 . . . . . 0 CA--C 1.544 0.712 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.686 ' H ' ' CD2' ' A' ' 61' ' ' HIS . . . 146.89 17.4 0.13 Allowed Glycine 0 C--N 1.339 0.702 0 CA-C-O 117.145 -1.92 . . . . 0.0 115.378 -157.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 139.55 -52.94 0.7 Allowed Glycine 0 CA--C 1.524 0.617 0 CA-C-N 120.95 2.375 . . . . 0.0 112.181 172.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 147.4 13.66 0.15 Allowed Glycine 0 CA--C 1.53 1.014 0 CA-C-O 119.295 -0.725 . . . . 0.0 114.514 -177.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -118.81 -131.26 0.3 Allowed 'General case' 0 C--O 1.22 -0.453 0 C-N-CA 124.853 1.261 . . . . 0.0 108.731 -172.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -81.92 -3.25 90.64 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-N 119.876 1.216 . . . . 0.0 114.986 -174.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -71.02 -54.74 7.12 Favored Pre-proline 0 N--CA 1.445 -0.679 0 C-N-CA 126.92 2.088 . . . . 0.0 110.59 173.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -69.8 166.55 27.27 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 N-CA-C 108.653 -1.326 . . . . 0.0 108.653 159.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . 0.275 13.0 t-160 45.81 68.05 0.65 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 124.575 2.131 . . . . 0.0 115.406 172.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.419 ' H ' ' HB3' ' A' ' 75' ' ' GLN . . . -86.77 20.05 26.08 Favored Glycine 0 CA--C 1.522 0.522 0 CA-C-N 111.582 -2.553 . . . . 0.0 115.034 175.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 137.29 -71.94 0.46 Allowed Glycine 0 C--N 1.337 0.586 0 CA-C-N 120.558 2.179 . . . . 0.0 112.454 175.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -175.62 15.57 0.04 OUTLIER Glycine 0 N--CA 1.467 0.734 0 CA-C-N 118.508 1.154 . . . . 0.0 115.122 -174.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.405 ' HB2' ' H ' ' A' ' 74' ' ' GLY . 0.1 OUTLIER -126.47 -141.25 0.28 Allowed 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 124.845 1.258 . . . . 0.0 108.413 -168.736 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.405 ' H ' ' HB2' ' A' ' 73' ' ' TRP . . . -71.93 1.66 30.34 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-O 118.448 -1.196 . . . . 0.0 114.742 -175.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.429 ' H ' ' HD2' ' A' ' 76' ' ' PRO . 18.0 mm100 -84.53 -51.7 0.55 Allowed Pre-proline 0 N--CA 1.442 -0.834 0 C-N-CA 126.369 1.868 . . . . 0.0 110.937 -179.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.429 ' HD2' ' H ' ' A' ' 75' ' ' GLN . 50.2 Cg_endo -68.56 174.96 7.64 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.032 1.821 . . . . 0.0 109.978 157.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.524 ' CG ' ' H ' ' A' ' 78' ' ' GLY . 7.1 t-160 61.23 -151.98 0.38 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.408 1.083 . . . . 0.0 111.302 176.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.524 ' H ' ' CG ' ' A' ' 77' ' ' HIS . . . 132.97 -43.97 1.24 Allowed Glycine 0 C--O 1.223 -0.545 0 O-C-N 120.422 -1.424 . . . . 0.0 111.593 -173.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -175.41 -7.17 0.02 OUTLIER Glycine 0 CA--C 1.525 0.692 0 CA-C-O 117.973 -1.46 . . . . 0.0 114.217 -176.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.74 19.31 7.87 Favored Glycine 0 N--CA 1.475 1.25 0 CA-C-N 119.846 1.823 . . . . 0.0 112.938 170.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -113.94 -136.83 0.37 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.339 1.856 . . . . 0.0 108.644 -165.462 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -76.24 1.77 59.15 Favored Glycine 0 CA--C 1.536 1.377 0 CA-C-N 119.434 1.016 . . . . 0.0 115.071 -176.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -98.5 -39.19 0.24 Allowed Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 126.461 1.904 . . . . 0.0 114.343 -172.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo . . . . . 0 CA--C 1.537 0.666 0 CA-C-N 120.859 1.342 . . . . 0.0 110.625 161.18 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 20.1 t-160 . . . . . 0 CA--C 1.534 0.365 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.76 -65.76 0.45 Allowed Glycine 0 CA--C 1.536 1.389 0 C-N-CA 125.074 1.321 . . . . 0.0 112.035 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -167.99 7.42 0.05 OUTLIER Glycine 0 CA--C 1.535 1.289 0 C-N-CA 126.76 2.124 . . . . 0.0 113.969 -176.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.68 36.72 3.42 Favored Glycine 0 C--N 1.344 1.002 0 CA-C-N 119.916 1.858 . . . . 0.0 113.631 168.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -135.27 -137.15 0.16 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.674 1.589 . . . . 0.0 109.175 -166.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -81.82 11.88 44.92 Favored Glycine 0 CA--C 1.532 1.135 0 N-CA-C 115.952 1.141 . . . . 0.0 115.952 -174.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.52 ' H ' ' HD2' ' A' ' 68' ' ' PRO . 18.6 mm100 -88.04 -52.2 0.39 Allowed Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 126.844 2.058 . . . . 0.0 110.862 175.015 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.52 ' HD2' ' H ' ' A' ' 67' ' ' GLN . 45.8 Cg_endo -74.11 124.82 9.34 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 124.447 3.431 . . . . 0.0 109.485 177.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.639 ' CD2' ' H ' ' A' ' 70' ' ' GLY . 22.7 t-80 60.69 165.09 0.08 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.309 1.444 . . . . 0.0 111.695 -162.416 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.639 ' H ' ' CD2' ' A' ' 69' ' ' HIS . . . 155.05 16.98 0.05 OUTLIER Glycine 0 C--N 1.336 0.573 0 CA-C-O 117.62 -1.656 . . . . 0.0 114.741 -155.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 141.19 -68.56 0.47 Allowed Glycine 0 C--N 1.336 0.553 0 CA-C-N 120.187 1.993 . . . . 0.0 110.119 179.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 162.81 23.39 0.02 OUTLIER Glycine 0 CA--C 1.529 0.94 0 CA-C-O 119.528 -0.596 . . . . 0.0 114.463 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -128.63 -113.35 0.26 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.179 0.99 . . . . 0.0 110.821 -162.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -102.87 -2.34 49.18 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-N 119.443 1.019 . . . . 0.0 114.428 -178.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -70.87 -49.74 13.37 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 124.869 1.268 . . . . 0.0 109.304 165.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -71.36 176.14 8.38 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 CA-C-N 120.635 1.263 . . . . 0.0 109.545 163.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.626 ' CD2' ' H ' ' A' ' 78' ' ' GLY 0.275 6.7 t-160 65.23 169.86 0.2 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.086 1.754 . . . . 0.0 111.691 -160.182 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.626 ' H ' ' CD2' ' A' ' 77' ' ' HIS . . . 144.24 18.56 0.2 Allowed Glycine 0 C--N 1.337 0.596 0 CA-C-O 117.45 -1.75 . . . . 0.0 115.698 -147.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 136.18 -51.47 0.81 Allowed Glycine 0 CA--C 1.522 0.505 0 CA-C-N 119.899 1.85 . . . . 0.0 111.862 171.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 155.82 8.17 0.07 OUTLIER Glycine 0 N--CA 1.47 0.923 0 N-CA-C 116.051 1.18 . . . . 0.0 116.051 178.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -131.83 -116.97 0.22 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 118.714 1.257 . . . . 0.0 110.229 -158.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -67.65 -35.96 86.94 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-N 119.033 0.833 . . . . 0.0 112.038 -178.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -60.95 -47.7 94.76 Favored Pre-proline 0 N--CA 1.45 -0.448 0 C-N-CA 123.985 0.914 . . . . 0.0 111.771 -176.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo . . . . . 0 N--CA 1.455 -0.756 0 C-N-CA 121.258 1.305 . . . . 0.0 112.587 171.929 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo . . . . . 0 N--CA 1.453 -0.911 0 N-CA-C 109.255 -1.094 . . . . 0.0 109.255 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 8.0 t-160 38.76 41.7 0.54 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.699 2.0 . . . . 0.0 115.276 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.546 ' H ' ' HB3' ' A' ' 75' ' ' GLN . . . -67.25 42.17 0.22 Allowed Glycine 0 CA--C 1.521 0.425 0 C-N-CA 126.997 2.237 . . . . 0.0 116.775 176.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 124.04 -20.76 7.09 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-N 119.514 1.657 . . . . 0.0 113.765 165.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 142.93 0.95 1.19 Allowed Glycine 0 N--CA 1.471 0.974 0 CA-C-N 118.708 1.254 . . . . 0.0 115.418 166.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -127.08 -111.98 0.28 Allowed 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.611 1.206 . . . . 0.0 111.069 -159.394 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -81.61 2.41 82.78 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 124.406 1.003 . . . . 0.0 114.419 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.546 ' HB3' ' H ' ' A' ' 70' ' ' GLY . 3.1 mp0 -99.63 -39.7 0.23 Allowed Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 126.299 1.839 . . . . 0.0 111.454 178.064 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.511 ' HD2' ' H ' ' A' ' 75' ' ' GLN . 34.5 Cg_endo -67.01 -94.32 0.0 OUTLIER 'Trans proline' 0 CA--C 1.541 0.871 0 N-CA-C 108.254 -1.479 . . . . 0.0 108.254 154.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 18.0 t-160 -31.99 112.03 0.1 Allowed 'General case' 0 C--N 1.341 0.208 0 C-N-CA 128.017 2.527 . . . . 0.0 114.86 -175.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -135.46 36.0 2.1 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-O 117.187 -1.896 . . . . 0.0 112.232 -175.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.74 0 CA-C-N 119.875 1.837 . . . . 0.0 112.294 177.354 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo . . . . . 0 CA--C 1.539 0.746 0 N-CA-C 109.265 -1.091 . . . . 0.0 109.265 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 73.85 -61.26 0.5 Allowed 'General case' 0 C--O 1.234 0.263 0 O-C-N 120.677 -1.264 . . . . 0.0 110.912 -173.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 74.98 -26.19 1.18 Allowed Glycine 0 CA--C 1.525 0.71 0 CA-C-O 118.054 -1.414 . . . . 0.0 115.305 165.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 168.62 -41.37 0.22 Allowed Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.424 1.488 . . . . 0.0 110.928 -175.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 137.52 47.53 0.07 OUTLIER Glycine 0 N--CA 1.474 1.194 0 CA-C-N 119.047 1.424 . . . . 0.0 114.189 176.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -140.39 -118.52 0.12 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.983 0.913 . . . . 0.0 110.806 -164.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -107.08 4.63 35.81 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 125.164 1.364 . . . . 0.0 113.666 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -86.61 -21.55 0.27 Allowed Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 126.764 2.026 . . . . 0.0 112.949 172.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -79.21 -177.96 4.28 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 CA-C-N 123.1 2.143 . . . . 0.0 108.658 148.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.53 ' CD2' ' H ' ' A' ' 78' ' ' GLY . 8.0 t-160 65.03 179.23 0.19 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.519 0.728 . . . . 0.0 111.342 -176.161 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.53 ' H ' ' CD2' ' A' ' 77' ' ' HIS . . . 147.72 12.26 0.16 Allowed Glycine 0 C--N 1.336 0.559 0 CA-C-O 117.058 -1.968 . . . . 0.0 115.939 -157.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.534 0 CA-C-N 121.081 2.441 . . . . 0.0 110.852 176.1 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo . . . . . 0 N--CA 1.452 -0.918 0 N-CA-C 110.289 -0.697 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . 0.277 5.2 t-160 56.79 -82.48 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.464 1.506 . . . . 0.0 114.329 -169.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 71.69 -63.47 1.18 Allowed Glycine 0 CA--C 1.53 0.977 0 CA-C-N 120.414 1.461 . . . . 0.0 113.425 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -161.74 -2.98 0.05 OUTLIER Glycine 0 CA--C 1.531 1.075 0 C-N-CA 125.626 1.584 . . . . 0.0 114.074 -170.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 116.82 20.21 5.02 Favored Glycine 0 N--CA 1.475 1.295 0 CA-C-N 120.387 2.093 . . . . 0.0 114.482 164.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -114.67 -120.29 0.3 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.274 1.429 . . . . 0.0 110.265 -162.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -90.16 -10.16 64.6 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-N 119.573 1.078 . . . . 0.0 114.248 -177.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -74.44 -39.88 4.07 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 126.155 1.782 . . . . 0.0 113.905 174.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.98 -171.57 0.91 Allowed 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 123.074 2.516 . . . . 0.0 109.961 169.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 60.5 -70.04 0.04 OUTLIER 'General case' 0 C--O 1.232 0.153 0 C-N-CA 126.708 2.003 . . . . 0.0 114.353 -172.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 67.31 -22.1 0.22 Allowed Glycine 0 CA--C 1.533 1.213 0 CA-C-O 117.697 -1.613 . . . . 0.0 116.742 172.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.142 0 CA-C-N 120.049 1.925 . . . . 0.0 114.251 -169.957 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo . . . . . 0 N--CA 1.44 -1.636 0 N-CA-C 110.426 -0.644 . . . . 0.0 110.426 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 21.3 t-160 72.01 -62.39 0.46 Allowed 'General case' 0 C--O 1.236 0.386 0 C-N-CA 127.11 2.164 . . . . 0.0 111.836 -177.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 75.72 -40.89 1.4 Allowed Glycine 0 CA--C 1.529 0.911 0 C-N-CA 124.323 0.963 . . . . 0.0 114.591 174.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 166.6 -9.41 0.06 OUTLIER Glycine 0 CA--C 1.53 1.027 0 CA-C-O 117.844 -1.531 . . . . 0.0 113.953 -169.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 111.85 42.19 1.04 Allowed Glycine 0 N--CA 1.475 1.254 0 CA-C-N 120.047 1.924 . . . . 0.0 113.522 164.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -138.15 -131.97 0.13 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.938 0.895 . . . . 0.0 109.845 -157.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -94.71 -0.45 64.39 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.179 0.895 . . . . 0.0 113.928 -178.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -71.09 -46.36 14.54 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-O 116.937 -1.506 . . . . 0.0 111.334 174.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -77.31 -126.42 0.01 OUTLIER 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 123.894 3.063 . . . . 0.0 109.808 174.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.531 ' CD2' ' H ' ' A' ' 78' ' ' GLY . 9.4 t-80 56.81 -179.69 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.78 0 O-C-N 120.855 -1.153 . . . . 0.0 111.729 -168.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.531 ' H ' ' CD2' ' A' ' 77' ' ' HIS . . . 153.33 9.58 0.08 OUTLIER Glycine 0 CA--C 1.523 0.567 0 CA-C-O 117.509 -1.717 . . . . 0.0 115.298 -161.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.551 0 CA-C-N 120.109 1.954 . . . . 0.0 110.743 175.703 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo . . . . . 0 N--CA 1.456 -0.705 0 N-CA-C 110.886 -0.467 . . . . 0.0 110.886 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . 0.265 3.2 t-160 60.17 -69.91 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.431 1.092 . . . . 0.0 111.875 -166.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 59.07 15.35 28.77 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-O 117.593 -1.671 . . . . 0.0 116.104 159.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 124.96 -14.95 7.45 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-N 119.873 1.836 . . . . 0.0 114.798 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.49 10.54 6.52 Favored Glycine 0 N--CA 1.473 1.145 0 CA-C-N 119.848 1.824 . . . . 0.0 115.393 164.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -118.64 -99.93 0.44 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.501 1.15 . . . . 0.0 112.107 -159.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -102.75 -0.47 49.17 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.436 1.017 . . . . 0.0 114.019 -178.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.465 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 2.0 mp0 -87.17 -38.41 0.5 Allowed Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 127.31 2.244 . . . . 0.0 111.911 173.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 75' ' ' GLN . 36.7 Cg_endo -74.71 -170.38 0.75 Allowed 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.978 2.452 . . . . 0.0 108.576 161.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.8 t60 67.68 -72.36 0.09 Allowed 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 126.38 1.872 . . . . 0.0 111.931 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 58.94 17.89 37.97 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-O 116.996 -2.002 . . . . 0.0 116.215 161.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.072 0 CA-C-N 120.016 1.908 . . . . 0.0 114.262 178.441 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo . . . . . 0 N--CA 1.448 -1.171 0 N-CA-C 108.992 -1.196 . . . . 0.0 108.992 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 19.1 t-160 47.62 62.54 2.39 Favored 'General case' 0 C--O 1.227 -0.127 0 CA-C-O 124.518 2.104 . . . . 0.0 113.343 -176.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.9 36.76 0.29 Allowed Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 111.414 -2.63 . . . . 0.0 115.716 172.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 123.16 -23.51 6.86 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-N 120.665 2.232 . . . . 0.0 115.093 166.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 140.39 8.87 0.81 Allowed Glycine 0 N--CA 1.469 0.871 0 CA-C-N 118.761 1.281 . . . . 0.0 115.561 166.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -133.3 -110.48 0.23 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.604 1.202 . . . . 0.0 110.74 -158.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -78.36 -26.19 59.91 Favored Glycine 0 CA--C 1.525 0.703 0 O-C-N 120.944 -1.097 . . . . 0.0 112.214 -176.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -64.3 -52.81 51.44 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 118.379 1.09 . . . . 0.0 109.978 -177.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.66 78.96 0.94 Allowed 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 122.135 1.89 . . . . 0.0 110.943 170.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.252 1.6 t60 63.99 67.0 0.62 Allowed 'General case' 0 C--O 1.226 -0.18 0 CA-C-O 124.653 2.168 . . . . 0.0 113.503 168.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.18 27.35 0.32 Allowed Glycine 0 CA--C 1.526 0.748 0 CA-C-N 111.457 -2.61 . . . . 0.0 115.898 172.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.219 0 CA-C-N 121.021 2.411 . . . . 0.0 116.317 167.991 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo . . . . . 0 N--CA 1.447 -1.206 0 N-CA-C 109.381 -1.046 . . . . 0.0 109.381 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.502 ' CD2' ' H ' ' A' ' 70' ' ' GLY 0.272 6.5 t-160 88.08 175.96 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 128.52 2.728 . . . . 0.0 109.921 -157.352 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.502 ' H ' ' CD2' ' A' ' 69' ' ' HIS . . . 158.46 -2.4 0.11 Allowed Glycine 0 CA--C 1.524 0.61 0 CA-C-O 117.474 -1.737 . . . . 0.0 115.431 -157.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 146.27 -57.31 0.51 Allowed Glycine 0 C--N 1.338 0.642 0 CA-C-N 120.714 2.257 . . . . 0.0 111.704 178.084 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 151.35 51.49 0.01 OUTLIER Glycine 0 C--N 1.34 0.802 0 CA-C-N 117.941 0.871 . . . . 0.0 112.966 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.548 ' CD1' ' NE2' ' A' ' 75' ' ' GLN . 0.0 OUTLIER -149.89 -114.6 0.06 Allowed 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.827 -0.808 . . . . 0.0 110.21 -168.471 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -99.94 -21.6 13.63 Favored Glycine 0 N--CA 1.473 1.162 0 CA-C-N 119.578 1.081 . . . . 0.0 113.394 -175.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.548 ' NE2' ' CD1' ' A' ' 73' ' ' TRP . 2.5 mp0 -59.75 -33.74 17.77 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 128.194 2.598 . . . . 0.0 113.211 176.173 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.437 ' HA ' ' H ' ' A' ' 69' ' ' HIS . 32.1 Cg_endo -80.28 -71.04 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 123.654 2.903 . . . . 0.0 111.575 173.503 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 50.0 -74.24 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 117.662 2.467 . . . . 0.0 117.662 176.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.1 -79.15 0.51 Allowed Glycine 0 CA--C 1.525 0.681 0 O-C-N 120.986 -1.071 . . . . 0.0 110.615 -169.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.882 0 CA-C-O 117.8 -1.555 . . . . 0.0 114.172 -167.455 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo . . . . . 0 CA--C 1.544 0.982 0 N-CA-C 108.854 -1.248 . . . . 0.0 108.854 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.519 ' CD2' ' H ' ' A' ' 70' ' ' GLY 0.27 7.6 t-160 65.74 174.13 0.22 Allowed 'General case' 0 CA--C 1.536 0.429 0 O-C-N 120.975 -1.078 . . . . 0.0 110.852 -152.032 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.519 ' H ' ' CD2' ' A' ' 69' ' ' HIS . . . 149.27 10.05 0.14 Allowed Glycine 0 C--N 1.337 0.62 0 CA-C-O 117.136 -1.924 . . . . 0.0 116.417 -149.137 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 139.2 -67.73 0.51 Allowed Glycine 0 CA--C 1.522 0.502 0 CA-C-N 120.739 2.269 . . . . 0.0 111.007 177.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 155.59 44.83 0.02 OUTLIER Glycine 0 C--N 1.335 0.521 0 CA-C-O 119.308 -0.718 . . . . 0.0 112.652 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.03 -120.33 0.05 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 117.998 0.899 . . . . 0.0 110.99 -170.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -70.63 -36.93 67.83 Favored Glycine 0 CA--C 1.526 0.767 0 O-C-N 120.289 -1.507 . . . . 0.0 111.941 -178.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -59.08 -42.45 93.71 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 125.409 1.484 . . . . 0.0 113.088 -174.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.462 ' HA ' ' H ' ' A' ' 69' ' ' HIS . 44.8 Cg_endo -82.69 -20.47 5.56 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.299 2.0 . . . . 0.0 116.446 178.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 22.0 t-80 -16.72 117.71 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 128.552 2.741 . . . . 0.0 115.737 175.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -143.56 28.89 2.03 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-O 117.202 -1.888 . . . . 0.0 113.741 -174.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.534 0 CA-C-N 120.253 2.027 . . . . 0.0 110.012 -179.903 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo . . . . . 0 N--CA 1.449 -1.134 0 CA-C-O 119.059 -0.475 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 17.2 t-160 72.25 -53.92 0.69 Allowed 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.409 1.083 . . . . 0.0 112.362 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 72.7 -25.67 0.76 Allowed Glycine 0 CA--C 1.533 1.217 0 C-N-CA 125.356 1.455 . . . . 0.0 115.034 161.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 152.59 -6.92 0.49 Allowed Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.32 1.438 . . . . 0.0 113.393 -169.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.23 40.44 4.54 Favored Glycine 0 N--CA 1.472 1.084 0 CA-C-N 119.79 1.795 . . . . 0.0 113.222 166.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -140.02 -110.16 0.15 Allowed 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.256 1.023 . . . . 0.0 110.615 -160.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -111.79 -0.62 27.35 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 124.494 1.045 . . . . 0.0 112.945 -172.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.0 -65.38 2.21 Favored Pre-proline 0 N--CA 1.436 -1.172 0 C-N-CA 125.767 1.627 . . . . 0.0 108.256 161.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -78.3 69.69 7.5 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 123.84 3.027 . . . . 0.0 111.516 -160.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.278 28.2 t-80 71.37 102.26 0.06 Allowed 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 125.426 1.491 . . . . 0.0 110.83 -160.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -110.04 18.17 28.89 Favored Glycine 0 C--O 1.223 -0.572 0 CA-C-O 116.787 -2.119 . . . . 0.0 113.977 -178.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.109 0 CA-C-N 120.479 2.139 . . . . 0.0 115.553 173.868 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo . . . . . 0 CA--C 1.543 0.938 0 N-CA-C 109.459 -1.016 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 14.1 t-160 53.01 68.98 0.75 Allowed 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 125.049 2.357 . . . . 0.0 113.937 -172.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -76.24 37.27 1.33 Allowed Glycine 0 C--N 1.318 -0.418 0 CA-C-N 111.717 -2.492 . . . . 0.0 115.154 173.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 120.37 -23.03 8.18 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-N 119.988 1.894 . . . . 0.0 115.434 166.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 148.36 9.17 0.18 Allowed Glycine 0 N--CA 1.471 1.025 0 CA-C-N 119.395 1.597 . . . . 0.0 116.531 163.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -136.55 -112.34 0.19 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 118.879 1.34 . . . . 0.0 110.808 -157.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.12 -44.51 95.64 Favored Glycine 0 CA--C 1.529 0.929 0 O-C-N 121.073 -1.017 . . . . 0.0 111.453 177.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -56.52 -46.91 99.77 Favored Pre-proline 0 N--CA 1.45 -0.442 0 C-N-CA 124.166 0.986 . . . . 0.0 111.597 -170.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.05 55.35 2.33 Favored 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 122.583 2.189 . . . . 0.0 112.737 167.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 2.1 t60 64.25 69.43 0.52 Allowed 'General case' 0 C--N 1.342 0.249 0 CA-C-O 124.434 2.064 . . . . 0.0 114.042 166.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.41 28.27 0.17 Allowed Glycine 0 CA--C 1.525 0.678 0 CA-C-N 111.457 -2.61 . . . . 0.0 116.569 170.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.028 0 CA-C-N 121.655 2.727 . . . . 0.0 116.442 165.839 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo . . . . . 0 N--CA 1.45 -1.042 0 N-CA-C 109.262 -1.092 . . . . 0.0 109.262 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.577 ' CD2' ' H ' ' A' ' 70' ' ' GLY . 13.9 t-80 57.5 169.54 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.471 1.108 . . . . 0.0 112.037 -164.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.577 ' H ' ' CD2' ' A' ' 69' ' ' HIS . . . 145.55 12.45 0.23 Allowed Glycine 0 C--N 1.338 0.646 0 CA-C-O 117.244 -1.864 . . . . 0.0 115.195 -153.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 139.59 -78.9 0.29 Allowed Glycine 0 C--N 1.335 0.519 0 CA-C-N 120.702 2.251 . . . . 0.0 109.821 178.279 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 176.21 19.23 0.02 OUTLIER Glycine 0 CA--C 1.526 0.781 0 CA-C-N 117.529 0.664 . . . . 0.0 114.247 -175.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -127.92 -133.2 0.23 Allowed 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 124.142 0.977 . . . . 0.0 109.17 -165.298 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -78.83 2.4 68.95 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-N 118.957 0.799 . . . . 0.0 114.633 -175.033 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -81.92 -53.83 0.68 Allowed Pre-proline 0 N--CA 1.438 -1.035 0 C-N-CA 126.923 2.089 . . . . 0.0 110.088 173.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -72.77 -171.37 0.75 Allowed 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 122.512 2.141 . . . . 0.0 110.209 160.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.553 ' CG ' ' H ' ' A' ' 78' ' ' GLY 0.284 7.7 t-160 70.9 -168.55 0.15 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.502 1.121 . . . . 0.0 110.068 -166.248 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.553 ' H ' ' CG ' ' A' ' 77' ' ' HIS . . . 163.25 -45.69 0.33 Allowed Glycine 0 CA--C 1.527 0.816 0 O-C-N 121.271 -0.893 . . . . 0.0 112.335 -167.016 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.195 0 CA-C-N 118.434 1.117 . . . . 0.0 114.61 -177.248 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo . . . . . 0 N--CA 1.459 -0.523 0 N-CA-C 110.423 -0.645 . . . . 0.0 110.423 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 22.3 t-160 46.12 64.39 1.5 Allowed 'General case' 0 C--N 1.344 0.341 0 CA-C-O 123.708 1.718 . . . . 0.0 113.959 177.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -63.4 24.73 0.08 OUTLIER Glycine 0 CA--C 1.527 0.821 0 C-N-CA 127.535 2.493 . . . . 0.0 116.75 173.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 124.89 -17.04 7.25 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-N 120.624 2.212 . . . . 0.0 114.72 170.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 132.57 12.97 1.71 Allowed Glycine 0 N--CA 1.473 1.153 0 CA-C-N 119.033 1.416 . . . . 0.0 116.026 163.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -125.61 -102.56 0.36 Allowed 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 118.023 0.912 . . . . 0.0 109.836 -162.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -86.5 -32.11 17.0 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-N 118.526 0.603 . . . . 0.0 113.097 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.409 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 4.1 mp0 -60.33 -43.89 94.52 Favored Pre-proline 0 C--O 1.223 -0.31 0 O-C-N 121.36 -1.082 . . . . 0.0 111.506 -177.201 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.409 ' CD ' ' N ' ' A' ' 75' ' ' GLN . 93.7 Cg_endo -77.87 42.3 1.16 Allowed 'Trans proline' 0 CA--C 1.548 1.217 0 C-N-CA 122.957 2.438 . . . . 0.0 111.656 169.635 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.472 ' CD2' ' H ' ' A' ' 78' ' ' GLY . 6.2 t-160 83.31 -179.17 0.04 OUTLIER 'General case' 0 C--N 1.346 0.414 0 C-N-CA 126.899 2.08 . . . . 0.0 112.643 173.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.472 ' H ' ' CD2' ' A' ' 77' ' ' HIS . . . 160.23 1.35 0.07 OUTLIER Glycine 0 C--N 1.336 0.53 0 CA-C-O 116.959 -2.023 . . . . 0.0 115.616 -158.325 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.732 0 CA-C-N 121.103 2.452 . . . . 0.0 111.948 175.341 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo . . . . . 0 N--CA 1.452 -0.965 0 N-CA-C 109.491 -1.004 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.569 ' CD2' ' H ' ' A' ' 70' ' ' GLY . 16.1 t-80 57.57 172.61 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.687 0.795 . . . . 0.0 111.509 -165.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.569 ' H ' ' CD2' ' A' ' 69' ' ' HIS . . . 151.31 14.17 0.08 OUTLIER Glycine 0 C--N 1.337 0.633 0 CA-C-O 117.567 -1.685 . . . . 0.0 115.295 -158.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 142.97 -69.59 0.42 Allowed Glycine 0 C--O 1.224 -0.47 0 CA-C-N 120.359 2.079 . . . . 0.0 110.168 177.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 167.69 18.69 0.02 OUTLIER Glycine 0 CA--C 1.529 0.913 0 N-CA-C 114.687 0.635 . . . . 0.0 114.687 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -127.52 -118.28 0.26 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.093 0.957 . . . . 0.0 110.544 -160.359 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -94.24 -3.52 63.32 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-N 119.428 1.013 . . . . 0.0 114.444 -178.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.89 -45.82 3.95 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 125.592 1.557 . . . . 0.0 110.567 170.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -75.77 -164.88 0.27 Allowed 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.038 1.825 . . . . 0.0 109.118 157.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.52 ' CD2' ' H ' ' A' ' 78' ' ' GLY 0.268 11.3 t-80 67.46 174.0 0.26 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.04 1.336 . . . . 0.0 110.462 -158.414 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.52 ' H ' ' CD2' ' A' ' 77' ' ' HIS . . . 141.64 9.55 0.63 Allowed Glycine 0 CA--C 1.526 0.751 0 CA-C-O 117.615 -1.659 . . . . 0.0 115.154 -156.095 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.424 ' H ' ' CD2' ' A' ' 77' ' ' HIS . . . . . . . . 0 C--N 1.336 0.562 0 CA-C-N 120.787 2.293 . . . . 0.0 110.405 174.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.607 ' HA ' ' HB3' ' A' ' 76' ' ' PRO . 55.7 Cg_endo . . . . . 0 CA--C 1.548 1.177 0 CA-C-O 119.004 -0.499 . . . . 0.0 112.613 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.463 ' H ' ' HB3' ' A' ' 76' ' ' PRO . 15.0 t-80 -67.75 132.97 48.44 Favored 'General case' 0 N--CA 1.439 -0.997 0 O-C-N 119.833 -1.792 . . . . 0.0 107.273 173.557 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.35 -26.93 3.31 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 126.042 1.782 . . . . 0.0 112.646 162.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 162.79 -14.31 0.11 Allowed Glycine 0 CA--C 1.524 0.599 0 CA-C-O 119.124 -0.82 . . . . 0.0 112.754 -175.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.69 26.4 6.82 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-N 118.778 1.289 . . . . 0.0 112.854 172.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -95.95 -113.13 0.13 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.499 2.319 . . . . 0.0 110.384 -173.002 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.434 ' C ' ' HD2' ' A' ' 76' ' ' PRO . . . -94.71 -28.67 9.99 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-N 119.839 1.2 . . . . 0.0 113.092 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -50.5 -39.0 46.26 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 126.78 2.032 . . . . 0.0 115.612 172.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.607 ' HB3' ' HA ' ' A' ' 68' ' ' PRO . 14.6 Cg_endo -83.32 50.9 3.42 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.403 2.068 . . . . 0.0 112.715 -172.457 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 72.82 120.31 0.04 OUTLIER 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.755 1.222 . . . . 0.0 109.942 -162.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -136.55 33.57 2.33 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 125.316 1.436 . . . . 0.0 112.09 -167.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.292 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 -175.716 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo . . . . . 0 N--CA 1.459 -0.524 0 N-CA-C 109.939 -0.831 . . . . 0.0 109.939 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 21.8 t-160 57.43 -73.35 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 115.558 1.688 . . . . 0.0 115.558 175.006 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 68.87 -23.7 0.3 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 126.9 2.19 . . . . 0.0 116.243 171.222 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 159.08 -11.74 0.19 Allowed Glycine 0 CA--C 1.531 1.093 0 CA-C-N 119.282 1.541 . . . . 0.0 113.867 -170.102 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 114.93 29.91 2.47 Favored Glycine 0 N--CA 1.475 1.249 0 CA-C-N 119.931 1.865 . . . . 0.0 114.345 166.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -120.86 -113.12 0.32 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.333 1.453 . . . . 0.0 110.526 -163.162 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -101.43 -4.67 52.79 Favored Glycine 0 CA--C 1.536 1.396 0 CA-C-N 119.93 1.241 . . . . 0.0 114.028 -178.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -83.63 -31.79 0.51 Allowed Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 128.535 2.734 . . . . 0.0 112.707 177.259 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -82.58 -164.05 0.25 Allowed 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 121.991 1.794 . . . . 0.0 107.452 157.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.503 ' CD2' ' H ' ' A' ' 78' ' ' GLY . 11.7 t-80 58.71 -178.31 0.08 Allowed 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.31 -0.869 . . . . 0.0 110.196 -167.428 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.503 ' H ' ' CD2' ' A' ' 77' ' ' HIS . . . 138.79 8.76 1.04 Allowed Glycine 0 C--N 1.339 0.699 0 CA-C-O 117.258 -1.857 . . . . 0.0 115.826 -156.371 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.424 ' H ' ' CD2' ' A' ' 77' ' ' HIS . . . . . . . . 0 CA--C 1.522 0.477 0 CA-C-N 120.679 2.24 . . . . 0.0 110.697 171.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo . . . . . 0 N--CA 1.456 -0.703 0 N-CA-C 108.613 -1.341 . . . . 0.0 108.613 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.542 ' CG ' ' H ' ' A' ' 70' ' ' GLY . 8.8 t-160 48.13 -162.04 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.827 1.251 . . . . 0.0 112.418 -175.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.542 ' H ' ' CG ' ' A' ' 69' ' ' HIS . . . 145.29 -15.62 1.88 Allowed Glycine 0 C--O 1.221 -0.674 0 O-C-N 120.139 -1.6 . . . . 0.0 114.871 -172.245 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 159.41 -20.21 0.27 Allowed Glycine 0 CA--C 1.528 0.866 0 CA-C-N 119.384 1.592 . . . . 0.0 113.994 -177.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 118.65 30.57 1.64 Allowed Glycine 0 N--CA 1.473 1.165 0 CA-C-N 119.217 1.509 . . . . 0.0 113.102 170.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.402 ' CD1' ' NE2' ' A' ' 75' ' ' GLN . 0.0 OUTLIER -127.67 -141.63 0.26 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.883 1.673 . . . . 0.0 109.612 -163.765 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.03 -25.32 67.89 Favored Glycine 0 CA--C 1.534 1.231 0 O-C-N 120.091 -1.631 . . . . 0.0 113.569 -178.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.402 ' NE2' ' CD1' ' A' ' 73' ' ' TRP . 2.2 mp0 -68.32 -51.53 24.44 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 124.789 1.236 . . . . 0.0 112.108 -173.59 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.66 -50.97 1.05 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 121.714 1.609 . . . . 0.0 111.518 175.1 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 2.2 t60 60.03 -71.24 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.052 1.741 . . . . 0.0 114.69 -178.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 64.11 -2.67 2.01 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-O 116.996 -2.002 . . . . 0.0 116.264 173.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.114 0 CA-C-N 120.48 2.14 . . . . 0.0 114.345 -177.349 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo . . . . . 0 N--CA 1.458 -0.608 0 CA-C-O 120.549 0.145 . . . . 0.0 112.02 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 17.5 t-160 50.0 69.05 0.65 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 124.293 1.996 . . . . 0.0 112.224 -176.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.32 24.23 0.12 Allowed Glycine 0 CA--C 1.526 0.725 0 CA-C-N 111.668 -2.515 . . . . 0.0 116.558 174.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 127.0 -17.34 6.32 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 121.426 2.613 . . . . 0.0 116.058 167.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 146.08 12.7 0.21 Allowed Glycine 0 N--CA 1.476 1.312 0 CA-C-N 119.853 1.826 . . . . 0.0 116.632 165.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -140.54 -117.49 0.12 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 118.583 1.191 . . . . 0.0 110.0 -155.19 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -81.01 -31.48 34.98 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-N 119.42 1.009 . . . . 0.0 113.23 -175.493 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -50.36 -48.85 79.88 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 125.652 1.581 . . . . 0.0 111.528 -176.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -71.84 54.84 2.14 Favored 'Trans proline' 0 CA--C 1.55 1.313 0 C-N-CA 122.614 2.209 . . . . 0.0 112.65 168.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.264 16.5 t-160 66.9 67.88 0.42 Allowed 'General case' 0 C--N 1.346 0.413 0 CA-C-O 124.545 2.117 . . . . 0.0 113.287 165.239 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.57 31.39 0.27 Allowed Glycine 0 CA--C 1.524 0.635 0 CA-C-N 111.714 -2.494 . . . . 0.0 116.264 172.11 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.932 0 CA-C-N 121.075 2.438 . . . . 0.0 115.628 167.102 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo . . . . . 0 N--CA 1.453 -0.867 0 N-CA-C 109.443 -1.022 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 23.0 t-160 60.06 -70.97 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.401 1.88 . . . . 0.0 113.42 -175.192 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 58.01 12.29 10.9 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-O 117.857 -1.524 . . . . 0.0 116.386 164.005 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 125.24 -9.89 7.81 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 120.03 1.915 . . . . 0.0 114.867 178.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 119.89 14.58 5.57 Favored Glycine 0 N--CA 1.471 1.032 0 CA-C-N 119.795 1.797 . . . . 0.0 115.159 161.174 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -121.29 -97.45 0.46 Allowed 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 124.629 1.172 . . . . 0.0 111.863 -162.501 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -108.16 -1.01 33.56 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.323 0.963 . . . . 0.0 114.554 -178.021 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.449 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 3.7 mp0 -83.47 -35.66 0.64 Allowed Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 126.286 1.834 . . . . 0.0 112.642 167.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.449 ' CD ' ' N ' ' A' ' 75' ' ' GLN . 30.2 Cg_endo -73.79 177.32 8.23 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.473 2.116 . . . . 0.0 108.871 164.225 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.522 ' CG ' ' H ' ' A' ' 78' ' ' GLY . 9.3 t-80 62.66 176.89 0.14 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.785 0.834 . . . . 0.0 110.71 -167.235 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.522 ' H ' ' CG ' ' A' ' 77' ' ' HIS . . . 144.67 4.41 0.63 Allowed Glycine 0 CA--C 1.527 0.784 0 CA-C-O 117.674 -1.626 . . . . 0.0 115.178 -157.143 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.426 ' H ' ' CD2' ' A' ' 77' ' ' HIS . . . . . . . . 0 C--N 1.338 0.676 0 CA-C-N 120.533 2.166 . . . . 0.0 111.195 174.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo . . . . . 0 N--CA 1.454 -0.802 0 N-CA-C 108.653 -1.326 . . . . 0.0 108.653 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . 0.275 13.0 t-160 45.81 68.05 0.65 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 124.575 2.131 . . . . 0.0 115.406 172.107 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.534 ' H ' ' HB3' ' A' ' 75' ' ' GLN . . . -86.77 20.05 26.08 Favored Glycine 0 CA--C 1.522 0.522 0 CA-C-N 111.582 -2.553 . . . . 0.0 115.034 175.458 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 137.29 -71.94 0.46 Allowed Glycine 0 C--N 1.337 0.586 0 CA-C-N 120.558 2.179 . . . . 0.0 112.454 175.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -175.62 15.57 0.04 OUTLIER Glycine 0 N--CA 1.467 0.734 0 CA-C-N 118.508 1.154 . . . . 0.0 115.122 -174.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -126.47 -141.25 0.28 Allowed 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 124.845 1.258 . . . . 0.0 108.413 -168.736 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.93 1.66 30.34 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-O 118.448 -1.196 . . . . 0.0 114.742 -175.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.534 ' HB3' ' H ' ' A' ' 70' ' ' GLY . 18.0 mm100 -84.53 -51.7 0.55 Allowed Pre-proline 0 N--CA 1.442 -0.834 0 C-N-CA 126.369 1.868 . . . . 0.0 110.937 -179.246 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -68.56 174.96 7.64 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.032 1.821 . . . . 0.0 109.978 157.496 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.489 ' CG ' ' H ' ' A' ' 78' ' ' GLY . 7.1 t-160 61.23 -151.98 0.38 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.408 1.083 . . . . 0.0 111.302 176.215 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.489 ' H ' ' CG ' ' A' ' 77' ' ' HIS . . . 132.97 -43.97 1.24 Allowed Glycine 0 C--O 1.223 -0.545 0 O-C-N 120.422 -1.424 . . . . 0.0 111.593 -173.378 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.692 0 CA-C-O 117.973 -1.46 . . . . 0.0 114.217 -176.65 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo . . . . . 0 N--CA 1.454 -0.826 0 N-CA-C 109.485 -1.006 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.564 ' CD2' ' H ' ' A' ' 70' ' ' GLY . 22.7 t-80 60.69 165.09 0.08 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.309 1.444 . . . . 0.0 111.695 -162.416 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.564 ' H ' ' CD2' ' A' ' 69' ' ' HIS . . . 155.05 16.98 0.05 OUTLIER Glycine 0 C--N 1.336 0.573 0 CA-C-O 117.62 -1.656 . . . . 0.0 114.741 -155.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 141.19 -68.56 0.47 Allowed Glycine 0 C--N 1.336 0.553 0 CA-C-N 120.187 1.993 . . . . 0.0 110.119 179.352 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 162.81 23.39 0.02 OUTLIER Glycine 0 CA--C 1.529 0.94 0 CA-C-O 119.528 -0.596 . . . . 0.0 114.463 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -128.63 -113.35 0.26 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.179 0.99 . . . . 0.0 110.821 -162.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -102.87 -2.34 49.18 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-N 119.443 1.019 . . . . 0.0 114.428 -178.042 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -70.87 -49.74 13.37 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 124.869 1.268 . . . . 0.0 109.304 165.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -71.36 176.14 8.38 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 CA-C-N 120.635 1.263 . . . . 0.0 109.545 163.454 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.501 ' CD2' ' H ' ' A' ' 78' ' ' GLY 0.275 6.7 t-160 65.23 169.86 0.2 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.086 1.754 . . . . 0.0 111.691 -160.182 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.501 ' H ' ' CD2' ' A' ' 77' ' ' HIS . . . 144.24 18.56 0.2 Allowed Glycine 0 C--N 1.337 0.596 0 CA-C-O 117.45 -1.75 . . . . 0.0 115.698 -147.678 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.505 0 CA-C-N 119.899 1.85 . . . . 0.0 111.862 171.62 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 . . . . . 0 CA--C 1.533 0.322 0 CA-C-O 122.682 1.229 . . . . 0.0 113.878 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.417 ' H ' ' HB3' ' A' ' 67' ' ' GLN . . . -66.16 38.44 0.15 Allowed Glycine 0 CA--C 1.523 0.574 0 C-N-CA 126.687 2.089 . . . . 0.0 116.93 172.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 125.67 -22.11 6.2 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-N 120.467 2.133 . . . . 0.0 114.13 167.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 135.83 8.74 1.61 Allowed Glycine 0 N--CA 1.469 0.869 0 CA-C-N 118.525 1.162 . . . . 0.0 115.527 168.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -125.18 -101.59 0.38 Allowed 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.566 1.183 . . . . 0.0 111.388 -162.001 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -98.16 -5.32 57.26 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 123.531 0.586 . . . . 0.0 114.371 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.423 ' N ' ' CD ' ' A' ' 68' ' ' PRO . 3.5 mp0 -81.93 -45.43 1.04 Allowed Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 118.77 1.285 . . . . 0.0 111.613 172.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.423 ' CD ' ' N ' ' A' ' 67' ' ' GLN . 9.5 Cg_endo -62.47 150.34 87.78 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 CA-C-N 120.967 1.381 . . . . 0.0 109.255 167.045 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 8.0 t-160 38.76 41.7 0.54 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.699 2.0 . . . . 0.0 115.276 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.546 ' H ' ' HB3' ' A' ' 75' ' ' GLN . . . -67.25 42.17 0.22 Allowed Glycine 0 CA--C 1.521 0.425 0 C-N-CA 126.997 2.237 . . . . 0.0 116.775 176.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 124.04 -20.76 7.09 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-N 119.514 1.657 . . . . 0.0 113.765 165.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 142.93 0.95 1.19 Allowed Glycine 0 N--CA 1.471 0.974 0 CA-C-N 118.708 1.254 . . . . 0.0 115.418 166.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -127.08 -111.98 0.28 Allowed 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.611 1.206 . . . . 0.0 111.069 -159.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -81.61 2.41 82.78 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 124.406 1.003 . . . . 0.0 114.419 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.546 ' HB3' ' H ' ' A' ' 70' ' ' GLY . 3.1 mp0 -99.63 -39.7 0.23 Allowed Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 126.299 1.839 . . . . 0.0 111.454 178.064 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.511 ' HD2' ' H ' ' A' ' 75' ' ' GLN . 34.5 Cg_endo -67.01 -94.32 0.0 OUTLIER 'Trans proline' 0 CA--C 1.541 0.871 0 N-CA-C 108.254 -1.479 . . . . 0.0 108.254 154.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 18.0 t-160 -31.99 112.03 0.1 Allowed 'General case' 0 C--N 1.341 0.208 0 C-N-CA 128.017 2.527 . . . . 0.0 114.86 -175.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -135.46 36.0 2.1 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-O 117.187 -1.896 . . . . 0.0 112.232 -175.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 137.19 -48.26 0.91 Allowed Glycine 0 CA--C 1.526 0.74 0 CA-C-N 119.875 1.837 . . . . 0.0 112.294 177.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 149.47 12.45 0.11 Allowed Glycine 0 CA--C 1.531 1.047 0 CA-C-N 117.474 0.637 . . . . 0.0 114.642 175.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -111.91 -114.59 0.32 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 118.448 1.124 . . . . 0.0 110.648 -163.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -95.65 -12.83 52.73 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-N 119.65 1.114 . . . . 0.0 113.527 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -58.16 -56.33 36.14 Favored Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 125.132 1.373 . . . . 0.0 112.696 168.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo . . . . . 0 C--N 1.35 0.647 0 C-N-CA 122.537 2.158 . . . . 0.0 111.111 176.41 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.567 0 CA-C-O 122.357 1.075 . . . . 0.0 110.949 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.52 -20.81 1.61 Allowed Glycine 0 C--O 1.222 -0.61 0 CA-C-O 116.779 -2.123 . . . . 0.0 113.67 167.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 140.21 -23.85 2.7 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 120.069 1.934 . . . . 0.0 115.201 169.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 136.59 19.6 0.65 Allowed Glycine 0 CA--C 1.532 1.122 0 CA-C-N 119.39 1.595 . . . . 0.0 116.321 178.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -126.36 -116.9 0.27 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 119.781 1.79 . . . . 0.0 111.337 -161.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -87.2 -19.43 55.38 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-N 119.115 0.87 . . . . 0.0 113.19 178.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -61.04 -57.46 26.14 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 126.985 2.114 . . . . 0.0 111.649 172.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -75.97 -153.47 0.04 OUTLIER 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 123.476 2.784 . . . . 0.0 109.265 171.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 73.85 -61.26 0.5 Allowed 'General case' 0 C--O 1.234 0.263 0 O-C-N 120.677 -1.264 . . . . 0.0 110.912 -173.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 74.98 -26.19 1.18 Allowed Glycine 0 CA--C 1.525 0.71 0 CA-C-O 118.054 -1.414 . . . . 0.0 115.305 165.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 168.62 -41.37 0.22 Allowed Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.424 1.488 . . . . 0.0 110.928 -175.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 137.52 47.53 0.07 OUTLIER Glycine 0 N--CA 1.474 1.194 0 CA-C-N 119.047 1.424 . . . . 0.0 114.189 176.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -140.39 -118.52 0.12 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.983 0.913 . . . . 0.0 110.806 -164.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -107.08 4.63 35.81 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 125.164 1.364 . . . . 0.0 113.666 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -86.61 -21.55 0.27 Allowed Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 126.764 2.026 . . . . 0.0 112.949 172.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -79.21 -177.96 4.28 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 CA-C-N 123.1 2.143 . . . . 0.0 108.658 148.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.53 ' CD2' ' H ' ' A' ' 78' ' ' GLY . 8.0 t-160 65.03 179.23 0.19 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.519 0.728 . . . . 0.0 111.342 -176.161 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.53 ' H ' ' CD2' ' A' ' 77' ' ' HIS . . . 147.72 12.26 0.16 Allowed Glycine 0 C--N 1.336 0.559 0 CA-C-O 117.058 -1.968 . . . . 0.0 115.939 -157.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 141.96 -67.93 0.46 Allowed Glycine 0 C--N 1.336 0.534 0 CA-C-N 121.081 2.441 . . . . 0.0 110.852 176.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 162.85 22.52 0.02 OUTLIER Glycine 0 CA--C 1.527 0.838 0 CA-C-O 119.252 -0.749 . . . . 0.0 114.259 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -131.57 -130.7 0.19 Allowed 'General case' 0 C--O 1.222 -0.384 0 C-N-CA 124.896 1.278 . . . . 0.0 108.405 -165.475 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -78.22 -13.97 82.73 Favored Glycine 0 CA--C 1.536 1.38 0 CA-C-N 119.973 1.26 . . . . 0.0 114.344 -174.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -64.0 -52.27 57.48 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 125.288 1.435 . . . . 0.0 113.277 175.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo . . . . . 0 N--CA 1.454 -0.826 0 C-N-CA 122.663 2.242 . . . . 0.0 110.459 167.487 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.1 t60 . . . . . 0 CA--C 1.546 0.814 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 159.9 -29.65 0.38 Allowed Glycine 0 C--N 1.336 0.548 0 O-C-N 120.576 -1.328 . . . . 0.0 113.266 -166.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 172.77 -29.14 0.1 Allowed Glycine 0 C--N 1.336 0.565 0 CA-C-O 118.337 -1.257 . . . . 0.0 114.353 169.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 145.05 22.65 0.13 Allowed Glycine 0 N--CA 1.471 0.982 0 CA-C-N 119.116 1.458 . . . . 0.0 114.878 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -125.49 -134.28 0.26 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.423 1.489 . . . . 0.0 107.789 -173.161 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.42 -7.83 85.4 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 115.652 1.021 . . . . 0.0 115.652 -170.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -81.04 -51.5 0.91 Allowed Pre-proline 0 N--CA 1.442 -0.826 0 C-N-CA 125.548 1.539 . . . . 0.0 112.229 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -68.89 -178.27 1.94 Allowed 'Trans proline' 0 N--CA 1.452 -0.918 0 CA-C-N 120.561 1.236 . . . . 0.0 110.289 165.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . 0.277 5.2 t-160 56.79 -82.48 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.464 1.506 . . . . 0.0 114.329 -169.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 71.69 -63.47 1.18 Allowed Glycine 0 CA--C 1.53 0.977 0 CA-C-N 120.414 1.461 . . . . 0.0 113.425 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -161.74 -2.98 0.05 OUTLIER Glycine 0 CA--C 1.531 1.075 0 C-N-CA 125.626 1.584 . . . . 0.0 114.074 -170.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 116.82 20.21 5.02 Favored Glycine 0 N--CA 1.475 1.295 0 CA-C-N 120.387 2.093 . . . . 0.0 114.482 164.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -114.67 -120.29 0.3 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.274 1.429 . . . . 0.0 110.265 -162.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -90.16 -10.16 64.6 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-N 119.573 1.078 . . . . 0.0 114.248 -177.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -74.44 -39.88 4.07 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 126.155 1.782 . . . . 0.0 113.905 174.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.98 -171.57 0.91 Allowed 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 123.074 2.516 . . . . 0.0 109.961 169.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 60.5 -70.04 0.04 OUTLIER 'General case' 0 C--O 1.232 0.153 0 C-N-CA 126.708 2.003 . . . . 0.0 114.353 -172.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 67.31 -22.1 0.22 Allowed Glycine 0 CA--C 1.533 1.213 0 CA-C-O 117.697 -1.613 . . . . 0.0 116.742 172.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 155.22 -14.29 0.47 Allowed Glycine 0 CA--C 1.532 1.142 0 CA-C-N 120.049 1.925 . . . . 0.0 114.251 -169.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 115.96 42.07 0.74 Allowed Glycine 0 N--CA 1.473 1.104 0 CA-C-N 119.826 1.813 . . . . 0.0 114.271 167.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -128.96 -117.0 0.25 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.375 1.47 . . . . 0.0 110.096 -168.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -100.95 -9.81 44.56 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-N 119.646 1.112 . . . . 0.0 113.901 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -67.56 -32.76 4.7 Favored Pre-proline 0 CA--C 1.549 0.932 0 CA-C-O 117.364 -1.303 . . . . 0.0 112.696 172.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo . . . . . 0 C--N 1.354 0.852 0 C-N-CA 123.5 2.8 . . . . 0.0 110.333 174.795 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.517 -0.288 0 CA-C-O 120.967 0.413 . . . . 0.0 110.662 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.77 -36.44 1.03 Allowed Glycine 0 CA--C 1.523 0.548 0 C-N-CA 125.893 1.711 . . . . 0.0 113.838 170.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 145.44 -14.32 1.83 Allowed Glycine 0 CA--C 1.528 0.873 0 CA-C-O 117.788 -1.562 . . . . 0.0 115.81 178.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 125.5 23.23 1.74 Allowed Glycine 0 CA--C 1.531 1.086 0 CA-C-N 120.055 1.927 . . . . 0.0 115.568 174.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -131.66 -123.57 0.2 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.449 1.624 . . . . 0.0 111.128 -164.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.87 -34.97 58.63 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-N 119.812 1.187 . . . . 0.0 113.549 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -42.88 -67.41 0.34 Allowed Pre-proline 0 N--CA 1.464 0.24 0 C-N-CA 127.523 2.329 . . . . 0.0 112.229 168.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.73 91.75 0.61 Allowed 'Trans proline' 0 N--CA 1.44 -1.636 0 C-N-CA 122.351 2.034 . . . . 0.0 110.426 -169.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 21.3 t-160 72.01 -62.39 0.46 Allowed 'General case' 0 C--O 1.236 0.386 0 C-N-CA 127.11 2.164 . . . . 0.0 111.836 -177.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 75.72 -40.89 1.4 Allowed Glycine 0 CA--C 1.529 0.911 0 C-N-CA 124.323 0.963 . . . . 0.0 114.591 174.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 166.6 -9.41 0.06 OUTLIER Glycine 0 CA--C 1.53 1.027 0 CA-C-O 117.844 -1.531 . . . . 0.0 113.953 -169.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 111.85 42.19 1.04 Allowed Glycine 0 N--CA 1.475 1.254 0 CA-C-N 120.047 1.924 . . . . 0.0 113.522 164.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -138.15 -131.97 0.13 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.938 0.895 . . . . 0.0 109.845 -157.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -94.71 -0.45 64.39 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.179 0.895 . . . . 0.0 113.928 -178.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -71.09 -46.36 14.54 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-O 116.937 -1.506 . . . . 0.0 111.334 174.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -77.31 -126.42 0.01 OUTLIER 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 123.894 3.063 . . . . 0.0 109.808 174.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.531 ' CD2' ' H ' ' A' ' 78' ' ' GLY . 9.4 t-80 56.81 -179.69 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.78 0 O-C-N 120.855 -1.153 . . . . 0.0 111.729 -168.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.531 ' H ' ' CD2' ' A' ' 77' ' ' HIS . . . 153.33 9.58 0.08 OUTLIER Glycine 0 CA--C 1.523 0.567 0 CA-C-O 117.509 -1.717 . . . . 0.0 115.298 -161.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 144.92 -56.12 0.54 Allowed Glycine 0 C--N 1.336 0.551 0 CA-C-N 120.109 1.954 . . . . 0.0 110.743 175.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.8 19.35 0.05 OUTLIER Glycine 0 CA--C 1.53 1.012 0 N-CA-C 114.963 0.745 . . . . 0.0 114.963 175.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -129.04 -107.3 0.29 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.231 1.015 . . . . 0.0 110.998 -158.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -88.96 -21.6 41.83 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-N 119.627 1.103 . . . . 0.0 113.745 -177.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.422 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 3.3 mp0 -68.78 -44.58 31.56 Favored Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 126.093 1.757 . . . . 0.0 113.242 -179.135 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' ' 83' ' ' GLN . 56.9 Cg_endo . . . . . 0 N--CA 1.45 -1.042 0 C-N-CA 123.411 2.741 . . . . 0.0 108.606 171.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.555 ' CG ' ' H ' ' A' ' 62' ' ' GLY . 9.9 t-80 . . . . . 0 CA--C 1.541 0.631 0 CA-C-O 120.253 0.073 . . . . 0.0 111.019 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.555 ' H ' ' CG ' ' A' ' 61' ' ' HIS . . . 155.36 -8.76 0.32 Allowed Glycine 0 CA--C 1.524 0.649 0 CA-C-O 117.779 -1.567 . . . . 0.0 114.955 -170.095 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 157.05 -23.44 0.46 Allowed Glycine 0 CA--C 1.528 0.895 0 CA-C-N 120.148 1.974 . . . . 0.0 113.51 178.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 123.69 22.28 2.27 Favored Glycine 0 N--CA 1.471 1.032 0 CA-C-N 118.383 1.091 . . . . 0.0 113.282 169.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -118.27 -131.04 0.3 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.911 1.684 . . . . 0.0 109.847 -162.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -87.3 -8.89 73.94 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-N 119.915 1.234 . . . . 0.0 114.319 -177.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -65.06 -59.84 9.23 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 124.525 1.13 . . . . 0.0 108.695 173.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -67.05 161.11 44.17 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 121.556 1.504 . . . . 0.0 110.886 175.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . 0.265 3.2 t-160 60.17 -69.91 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.431 1.092 . . . . 0.0 111.875 -166.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 59.07 15.35 28.77 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-O 117.593 -1.671 . . . . 0.0 116.104 159.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 124.96 -14.95 7.45 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-N 119.873 1.836 . . . . 0.0 114.798 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.49 10.54 6.52 Favored Glycine 0 N--CA 1.473 1.145 0 CA-C-N 119.848 1.824 . . . . 0.0 115.393 164.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -118.64 -99.93 0.44 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.501 1.15 . . . . 0.0 112.107 -159.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -102.75 -0.47 49.17 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.436 1.017 . . . . 0.0 114.019 -178.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.465 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 2.0 mp0 -87.17 -38.41 0.5 Allowed Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 127.31 2.244 . . . . 0.0 111.911 173.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 75' ' ' GLN . 36.7 Cg_endo -74.71 -170.38 0.75 Allowed 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.978 2.452 . . . . 0.0 108.576 161.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.8 t60 67.68 -72.36 0.09 Allowed 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 126.38 1.872 . . . . 0.0 111.931 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 58.94 17.89 37.97 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-O 116.996 -2.002 . . . . 0.0 116.215 161.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 128.06 -16.66 6.06 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-N 120.016 1.908 . . . . 0.0 114.262 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 118.28 13.33 7.01 Favored Glycine 0 N--CA 1.47 0.926 0 CA-C-N 119.242 1.521 . . . . 0.0 114.734 165.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -119.26 -105.98 0.38 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.162 0.981 . . . . 0.0 111.494 -160.091 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -101.9 4.65 53.03 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.655 1.122 . . . . 0.0 113.566 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.461 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 4.4 mm100 -85.33 -34.49 0.51 Allowed Pre-proline 0 CA--C 1.554 1.111 0 C-N-CA 126.053 1.741 . . . . 0.0 115.232 169.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' A' ' 83' ' ' GLN . 10.1 Cg_endo . . . . . 0 N--CA 1.455 -0.792 1 C-N-CA 125.353 4.035 . . . . 0.0 109.389 166.148 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.604 ' CD2' ' HB3' ' A' ' 67' ' ' GLN . 1.4 t60 . . . . . 0 C--O 1.225 -0.211 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -123.65 -5.47 7.68 Favored Glycine 0 C--O 1.222 -0.597 0 C-N-CA 124.192 0.901 . . . . 0.0 110.882 -173.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 152.19 -11.37 0.67 Allowed Glycine 0 CA--C 1.525 0.657 0 CA-C-O 118.308 -1.274 . . . . 0.0 113.751 -172.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 113.53 32.03 2.22 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-N 119.223 1.511 . . . . 0.0 114.761 170.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -117.35 -121.67 0.3 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 118.461 1.131 . . . . 0.0 110.854 -166.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -83.11 -17.9 66.14 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-N 119.486 1.039 . . . . 0.0 112.777 176.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.604 ' HB3' ' CD2' ' A' ' 61' ' ' HIS . 1.2 mp0 -62.43 -56.69 28.03 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 125.545 1.538 . . . . 0.0 112.949 177.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -65.33 137.31 50.83 Favored 'Trans proline' 0 N--CA 1.448 -1.171 0 N-CA-C 108.992 -1.196 . . . . 0.0 108.992 173.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 19.1 t-160 47.62 62.54 2.39 Favored 'General case' 0 C--O 1.227 -0.127 0 CA-C-O 124.518 2.104 . . . . 0.0 113.343 -176.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.9 36.76 0.29 Allowed Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 111.414 -2.63 . . . . 0.0 115.716 172.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 123.16 -23.51 6.86 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-N 120.665 2.232 . . . . 0.0 115.093 166.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 140.39 8.87 0.81 Allowed Glycine 0 N--CA 1.469 0.871 0 CA-C-N 118.761 1.281 . . . . 0.0 115.561 166.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -133.3 -110.48 0.23 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.604 1.202 . . . . 0.0 110.74 -158.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -78.36 -26.19 59.91 Favored Glycine 0 CA--C 1.525 0.703 0 O-C-N 120.944 -1.097 . . . . 0.0 112.214 -176.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -64.3 -52.81 51.44 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 118.379 1.09 . . . . 0.0 109.978 -177.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.66 78.96 0.94 Allowed 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 122.135 1.89 . . . . 0.0 110.943 170.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.252 1.6 t60 63.99 67.0 0.62 Allowed 'General case' 0 C--O 1.226 -0.18 0 CA-C-O 124.653 2.168 . . . . 0.0 113.503 168.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.18 27.35 0.32 Allowed Glycine 0 CA--C 1.526 0.748 0 CA-C-N 111.457 -2.61 . . . . 0.0 115.898 172.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 123.1 -8.01 9.17 Favored Glycine 0 CA--C 1.534 1.219 0 CA-C-N 121.021 2.411 . . . . 0.0 116.317 167.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 134.58 7.72 2.09 Favored Glycine 0 N--CA 1.469 0.874 0 CA-C-N 119.503 1.652 . . . . 0.0 115.128 163.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -133.66 -138.31 0.18 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.5 1.15 . . . . 0.0 110.458 -157.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -65.5 -6.9 30.87 Favored Glycine 0 CA--C 1.532 1.113 0 O-C-N 121.384 -0.822 . . . . 0.0 114.646 -175.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.443 ' CB ' ' CD ' ' A' ' 84' ' ' PRO . 21.6 mm100 -69.73 -67.9 0.63 Allowed Pre-proline 0 N--CA 1.443 -0.809 0 C-N-CA 124.814 1.245 . . . . 0.0 108.308 172.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.443 ' CD ' ' CB ' ' A' ' 83' ' ' GLN . 33.4 Cg_endo . . . . . 0 N--CA 1.454 -0.834 0 C-N-CA 123.259 2.639 . . . . 0.0 112.469 176.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.608 0 CA-C-O 121.955 0.883 . . . . 0.0 109.816 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.21 1.7 21.87 Favored Glycine 0 C--O 1.224 -0.497 0 CA-C-O 117.506 -1.719 . . . . 0.0 115.623 158.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 131.24 -16.81 5.17 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-N 119.177 1.488 . . . . 0.0 114.625 170.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 118.54 11.08 8.16 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-N 119.319 1.56 . . . . 0.0 114.814 168.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' TRP . . . . . 0.526 ' HD1' ' H ' ' A' ' 67' ' ' GLN . 0.1 OUTLIER -121.37 -108.28 0.35 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 118.647 1.224 . . . . 0.0 111.757 -159.724 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -104.04 6.07 46.83 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 125.219 1.39 . . . . 0.0 114.649 176.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.526 ' H ' ' HD1' ' A' ' 65' ' ' TRP . 0.3 OUTLIER -69.6 -60.87 3.51 Favored Pre-proline 0 N--CA 1.448 -0.535 0 C-N-CA 127.638 2.375 . . . . 0.0 109.516 156.856 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -73.15 -172.44 1.01 Allowed 'Trans proline' 0 N--CA 1.447 -1.206 0 C-N-CA 122.787 2.325 . . . . 0.0 109.381 169.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.502 ' CD2' ' H ' ' A' ' 70' ' ' GLY 0.272 6.5 t-160 88.08 175.96 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 128.52 2.728 . . . . 0.0 109.921 -157.352 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.502 ' H ' ' CD2' ' A' ' 69' ' ' HIS . . . 158.46 -2.4 0.11 Allowed Glycine 0 CA--C 1.524 0.61 0 CA-C-O 117.474 -1.737 . . . . 0.0 115.431 -157.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 146.27 -57.31 0.51 Allowed Glycine 0 C--N 1.338 0.642 0 CA-C-N 120.714 2.257 . . . . 0.0 111.704 178.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 151.35 51.49 0.01 OUTLIER Glycine 0 C--N 1.34 0.802 0 CA-C-N 117.941 0.871 . . . . 0.0 112.966 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.548 ' CD1' ' NE2' ' A' ' 75' ' ' GLN . 0.0 OUTLIER -149.89 -114.6 0.06 Allowed 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.827 -0.808 . . . . 0.0 110.21 -168.471 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -99.94 -21.6 13.63 Favored Glycine 0 N--CA 1.473 1.162 0 CA-C-N 119.578 1.081 . . . . 0.0 113.394 -175.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.548 ' NE2' ' CD1' ' A' ' 73' ' ' TRP . 2.5 mp0 -59.75 -33.74 17.77 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 128.194 2.598 . . . . 0.0 113.211 176.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.437 ' HA ' ' H ' ' A' ' 69' ' ' HIS . 32.1 Cg_endo -80.28 -71.04 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 123.654 2.903 . . . . 0.0 111.575 173.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 50.0 -74.24 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 117.662 2.467 . . . . 0.0 117.662 176.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.1 -79.15 0.51 Allowed Glycine 0 CA--C 1.525 0.681 0 O-C-N 120.986 -1.071 . . . . 0.0 110.615 -169.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -153.86 3.89 0.29 Allowed Glycine 0 CA--C 1.528 0.882 0 CA-C-O 117.8 -1.555 . . . . 0.0 114.172 -167.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.81 27.86 4.16 Favored Glycine 0 N--CA 1.476 1.364 0 CA-C-N 120.172 1.986 . . . . 0.0 113.305 160.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -121.8 -122.8 0.28 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.468 1.507 . . . . 0.0 108.666 -162.151 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -91.51 -5.38 67.08 Favored Glycine 0 CA--C 1.531 1.037 0 CA-C-N 119.212 0.915 . . . . 0.0 114.574 -177.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -78.92 -43.7 1.79 Allowed Pre-proline 0 N--CA 1.447 -0.595 0 C-N-CA 125.223 1.409 . . . . 0.0 114.091 174.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo . . . . . 0 N--CA 1.454 -0.833 0 CA-C-N 121.617 1.613 . . . . 0.0 109.523 175.076 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.506 0 CA-C-O 122.146 0.974 . . . . 0.0 110.309 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.77 -5.35 7.76 Favored Glycine 0 C--O 1.224 -0.485 0 CA-C-O 117.675 -1.625 . . . . 0.0 114.435 160.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 137.22 -30.03 2.66 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-O 117.851 -1.527 . . . . 0.0 114.365 168.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 128.41 27.11 0.92 Allowed Glycine 0 CA--C 1.529 0.961 0 CA-C-N 119.567 1.684 . . . . 0.0 115.253 177.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -133.14 -109.09 0.24 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.308 1.554 . . . . 0.0 111.618 -166.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -98.61 -12.07 45.47 Favored Glycine 0 CA--C 1.534 1.222 0 CA-C-N 119.388 0.994 . . . . 0.0 114.235 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -62.53 -54.24 50.11 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 126.559 1.944 . . . . 0.0 112.14 164.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -75.02 -171.63 1.04 Allowed 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 122.258 1.972 . . . . 0.0 108.854 166.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.519 ' CD2' ' H ' ' A' ' 70' ' ' GLY 0.27 7.6 t-160 65.74 174.13 0.22 Allowed 'General case' 0 CA--C 1.536 0.429 0 O-C-N 120.975 -1.078 . . . . 0.0 110.852 -152.032 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.519 ' H ' ' CD2' ' A' ' 69' ' ' HIS . . . 149.27 10.05 0.14 Allowed Glycine 0 C--N 1.337 0.62 0 CA-C-O 117.136 -1.924 . . . . 0.0 116.417 -149.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 139.2 -67.73 0.51 Allowed Glycine 0 CA--C 1.522 0.502 0 CA-C-N 120.739 2.269 . . . . 0.0 111.007 177.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 155.59 44.83 0.02 OUTLIER Glycine 0 C--N 1.335 0.521 0 CA-C-O 119.308 -0.718 . . . . 0.0 112.652 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.03 -120.33 0.05 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 117.998 0.899 . . . . 0.0 110.99 -170.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -70.63 -36.93 67.83 Favored Glycine 0 CA--C 1.526 0.767 0 O-C-N 120.289 -1.507 . . . . 0.0 111.941 -178.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -59.08 -42.45 93.71 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 125.409 1.484 . . . . 0.0 113.088 -174.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.462 ' HA ' ' H ' ' A' ' 69' ' ' HIS . 44.8 Cg_endo -82.69 -20.47 5.56 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.299 2.0 . . . . 0.0 116.446 178.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 22.0 t-80 -16.72 117.71 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 128.552 2.741 . . . . 0.0 115.737 175.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -143.56 28.89 2.03 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-O 117.202 -1.888 . . . . 0.0 113.741 -174.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 142.07 -71.49 0.41 Allowed Glycine 0 C--N 1.336 0.534 0 CA-C-N 120.253 2.027 . . . . 0.0 110.012 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 173.69 16.93 0.02 OUTLIER Glycine 0 CA--C 1.526 0.739 0 CA-C-O 119.46 -0.633 . . . . 0.0 114.222 178.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 0.408 ' HB2' ' H ' ' A' ' 82' ' ' GLY . 0.1 OUTLIER -127.71 -141.03 0.26 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.488 1.144 . . . . 0.0 110.101 -159.308 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.408 ' H ' ' HB2' ' A' ' 81' ' ' TRP . . . -69.14 11.26 1.46 Allowed Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.41 1.481 . . . . 0.0 114.642 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.407 ' CB ' ' CD ' ' A' ' 84' ' ' PRO . 10.1 mm100 -84.99 -68.42 0.16 Allowed Pre-proline 0 N--CA 1.443 -0.787 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 163.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.407 ' CD ' ' CB ' ' A' ' 83' ' ' GLN . 24.5 Cg_endo . . . . . 0 N--CA 1.451 -0.977 0 C-N-CA 122.671 2.247 . . . . 0.0 112.409 -174.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.452 ' CD2' ' HB3' ' A' ' 67' ' ' GLN . 0.6 OUTLIER . . . . . 0 N--CA 1.454 -0.257 0 CA-C-O 120.511 0.196 . . . . 0.0 110.996 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.61 -4.48 9.28 Favored Glycine 0 CA--C 1.522 0.489 0 CA-C-O 117.932 -1.482 . . . . 0.0 114.949 154.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 127.41 -19.96 5.9 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-O 117.361 -1.799 . . . . 0.0 115.659 165.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 127.77 22.96 1.38 Allowed Glycine 0 N--CA 1.475 1.242 0 CA-C-N 120.242 2.021 . . . . 0.0 116.479 170.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -137.12 -112.58 0.18 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.517 1.659 . . . . 0.0 111.085 -165.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -81.14 -33.61 28.7 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-N 119.167 0.894 . . . . 0.0 112.85 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.452 ' HB3' ' CD2' ' A' ' 61' ' ' HIS . 3.4 mp0 -48.25 -63.32 1.59 Allowed Pre-proline 0 N--CA 1.454 -0.271 0 C-N-CA 126.952 2.101 . . . . 0.0 112.233 171.008 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -64.46 139.39 64.48 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 120.963 1.109 . . . . 0.0 111.203 -174.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 17.2 t-160 72.25 -53.92 0.69 Allowed 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.409 1.083 . . . . 0.0 112.362 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 72.7 -25.67 0.76 Allowed Glycine 0 CA--C 1.533 1.217 0 C-N-CA 125.356 1.455 . . . . 0.0 115.034 161.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 152.59 -6.92 0.49 Allowed Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.32 1.438 . . . . 0.0 113.393 -169.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.23 40.44 4.54 Favored Glycine 0 N--CA 1.472 1.084 0 CA-C-N 119.79 1.795 . . . . 0.0 113.222 166.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -140.02 -110.16 0.15 Allowed 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.256 1.023 . . . . 0.0 110.615 -160.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -111.79 -0.62 27.35 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 124.494 1.045 . . . . 0.0 112.945 -172.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.0 -65.38 2.21 Favored Pre-proline 0 N--CA 1.436 -1.172 0 C-N-CA 125.767 1.627 . . . . 0.0 108.256 161.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -78.3 69.69 7.5 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 123.84 3.027 . . . . 0.0 111.516 -160.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.278 28.2 t-80 71.37 102.26 0.06 Allowed 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 125.426 1.491 . . . . 0.0 110.83 -160.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.555 ' H ' ' HD3' ' A' ' 84' ' ' PRO . . . -110.04 18.17 28.89 Favored Glycine 0 C--O 1.223 -0.572 0 CA-C-O 116.787 -2.119 . . . . 0.0 113.977 -178.329 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 134.71 -12.1 4.55 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-N 120.479 2.139 . . . . 0.0 115.553 173.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 125.44 25.27 1.47 Allowed Glycine 0 N--CA 1.469 0.897 0 CA-C-N 119.435 1.618 . . . . 0.0 114.31 167.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -141.7 -155.75 0.62 Allowed 'General case' 0 C--O 1.219 -0.524 0 C-N-CA 125.972 1.709 . . . . 0.0 107.824 -167.348 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -71.98 16.71 1.47 Allowed Glycine 0 CA--C 1.538 1.473 0 CA-C-O 118.191 -1.338 . . . . 0.0 116.313 -171.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 20.3 mm100 -75.81 -64.24 0.57 Allowed Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 119.31 1.555 . . . . 0.0 107.753 168.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.555 ' HD3' ' H ' ' A' ' 78' ' ' GLY . 44.5 Cg_endo . . . . . 0 N--CA 1.454 -0.842 0 C-N-CA 123.44 2.76 . . . . 0.0 108.687 161.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.606 ' CD2' ' H ' ' A' ' 62' ' ' GLY . 45.9 t-80 . . . . . 0 CA--C 1.545 0.786 0 CA-C-O 122.672 1.225 . . . . 0.0 113.632 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.606 ' H ' ' CD2' ' A' ' 61' ' ' HIS . . . 165.64 19.12 0.02 OUTLIER Glycine 0 CA--C 1.524 0.615 0 CA-C-O 117.681 -1.622 . . . . 0.0 114.128 -158.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 138.68 -70.41 0.47 Allowed Glycine 0 C--N 1.338 0.652 0 CA-C-N 120.218 2.009 . . . . 0.0 109.88 -177.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 168.74 17.67 0.02 OUTLIER Glycine 0 CA--C 1.528 0.873 0 N-CA-C 115.79 1.076 . . . . 0.0 115.79 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -128.66 -104.41 0.31 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 118.517 1.159 . . . . 0.0 111.322 -155.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -98.43 -6.71 56.44 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-N 119.358 0.981 . . . . 0.0 114.377 -177.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -76.37 -50.88 2.7 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 126.679 1.992 . . . . 0.0 110.608 173.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -76.16 -168.97 0.61 Allowed 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.494 2.13 . . . . 0.0 109.459 172.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 14.1 t-160 53.01 68.98 0.75 Allowed 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 125.049 2.357 . . . . 0.0 113.937 -172.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -76.24 37.27 1.33 Allowed Glycine 0 C--N 1.318 -0.418 0 CA-C-N 111.717 -2.492 . . . . 0.0 115.154 173.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 120.37 -23.03 8.18 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-N 119.988 1.894 . . . . 0.0 115.434 166.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 148.36 9.17 0.18 Allowed Glycine 0 N--CA 1.471 1.025 0 CA-C-N 119.395 1.597 . . . . 0.0 116.531 163.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -136.55 -112.34 0.19 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 118.879 1.34 . . . . 0.0 110.808 -157.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.12 -44.51 95.64 Favored Glycine 0 CA--C 1.529 0.929 0 O-C-N 121.073 -1.017 . . . . 0.0 111.453 177.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -56.52 -46.91 99.77 Favored Pre-proline 0 N--CA 1.45 -0.442 0 C-N-CA 124.166 0.986 . . . . 0.0 111.597 -170.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.05 55.35 2.33 Favored 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 122.583 2.189 . . . . 0.0 112.737 167.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 20.8 t-160 64.25 69.43 0.52 Allowed 'General case' 0 C--N 1.342 0.249 0 CA-C-O 124.434 2.064 . . . . 0.0 114.042 166.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.41 28.27 0.17 Allowed Glycine 0 CA--C 1.525 0.678 0 CA-C-N 111.457 -2.61 . . . . 0.0 116.569 170.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 124.38 -20.75 6.94 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-N 121.655 2.727 . . . . 0.0 116.442 165.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 145.02 10.14 0.3 Allowed Glycine 0 N--CA 1.471 1.024 0 CA-C-N 119.739 1.769 . . . . 0.0 115.965 166.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -130.67 -116.84 0.23 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.938 1.369 . . . . 0.0 110.876 -159.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -94.5 -7.15 60.64 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-N 119.451 1.023 . . . . 0.0 114.346 -177.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -65.17 -58.9 11.07 Favored Pre-proline 0 N--CA 1.448 -0.565 0 C-N-CA 125.542 1.537 . . . . 0.0 110.138 168.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 N--CA 1.454 -0.834 0 N-CA-C 108.508 -1.381 . . . . 0.0 108.508 166.026 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 6.4 t60 . . . . . 0 CA--C 1.535 0.392 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 63.94 -17.69 0.1 Allowed Glycine 0 CA--C 1.534 1.248 0 C-N-CA 126.436 1.97 . . . . 0.0 117.219 175.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 154.19 -13.52 0.54 Allowed Glycine 0 CA--C 1.531 1.079 0 CA-C-N 120.33 2.065 . . . . 0.0 114.113 -169.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 116.37 29.15 2.38 Favored Glycine 0 N--CA 1.474 1.206 0 CA-C-N 119.716 1.758 . . . . 0.0 114.045 164.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -118.9 -110.93 0.34 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.02 1.328 . . . . 0.0 110.452 -161.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -109.71 -0.2 30.58 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-N 119.5 1.045 . . . . 0.0 113.744 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -77.59 -32.66 0.95 Allowed Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 125.661 1.584 . . . . 0.0 111.526 169.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -85.54 173.06 7.7 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 121.945 1.763 . . . . 0.0 109.262 160.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.577 ' CD2' ' H ' ' A' ' 70' ' ' GLY . 13.9 t-80 57.5 169.54 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.471 1.108 . . . . 0.0 112.037 -164.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.577 ' H ' ' CD2' ' A' ' 69' ' ' HIS . . . 145.55 12.45 0.23 Allowed Glycine 0 C--N 1.338 0.646 0 CA-C-O 117.244 -1.864 . . . . 0.0 115.195 -153.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 139.59 -78.9 0.29 Allowed Glycine 0 C--N 1.335 0.519 0 CA-C-N 120.702 2.251 . . . . 0.0 109.821 178.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 176.21 19.23 0.02 OUTLIER Glycine 0 CA--C 1.526 0.781 0 CA-C-N 117.529 0.664 . . . . 0.0 114.247 -175.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -127.92 -133.2 0.23 Allowed 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 124.142 0.977 . . . . 0.0 109.17 -165.298 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -78.83 2.4 68.95 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-N 118.957 0.799 . . . . 0.0 114.633 -175.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -81.92 -53.83 0.68 Allowed Pre-proline 0 N--CA 1.438 -1.035 0 C-N-CA 126.923 2.089 . . . . 0.0 110.088 173.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -72.77 -171.37 0.75 Allowed 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 122.512 2.141 . . . . 0.0 110.209 160.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.553 ' CG ' ' H ' ' A' ' 78' ' ' GLY 0.284 7.7 t-160 70.9 -168.55 0.15 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.502 1.121 . . . . 0.0 110.068 -166.248 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.553 ' H ' ' CG ' ' A' ' 77' ' ' HIS . . . 163.25 -45.69 0.33 Allowed Glycine 0 CA--C 1.527 0.816 0 O-C-N 121.271 -0.893 . . . . 0.0 112.335 -167.016 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 151.87 -3.66 0.42 Allowed Glycine 0 CA--C 1.533 1.195 0 CA-C-N 118.434 1.117 . . . . 0.0 114.61 -177.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 109.84 69.01 0.61 Allowed Glycine 0 C--N 1.339 0.731 0 CA-C-N 119.01 1.405 . . . . 0.0 111.558 168.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -158.55 -160.68 0.9 Allowed 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 130.174 3.389 . . . . 0.0 106.697 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -74.41 53.87 2.35 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 126.046 1.784 . . . . 0.0 113.242 177.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.569 ' H ' ' HD2' ' A' ' 84' ' ' PRO . 4.4 mm-40 -121.54 -58.0 0.03 OUTLIER Pre-proline 0 N--CA 1.453 -0.313 0 C-N-CA 126.026 1.73 . . . . 0.0 110.37 168.466 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.569 ' HD2' ' H ' ' A' ' 83' ' ' GLN . 34.4 Cg_endo . . . . . 0 N--CA 1.455 -0.775 0 C-N-CA 123.883 3.055 . . . . 0.0 109.127 170.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.567 ' CG ' ' H ' ' A' ' 62' ' ' GLY . 5.3 t-160 . . . . . 0 N--CA 1.448 -0.557 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.567 ' H ' ' CG ' ' A' ' 61' ' ' HIS . . . 153.38 -2.51 0.27 Allowed Glycine 0 C--O 1.221 -0.695 0 CA-C-O 116.581 -2.233 . . . . 0.0 115.368 -168.022 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 151.38 -62.43 0.4 Allowed Glycine 0 C--N 1.339 0.735 0 CA-C-N 121.494 2.647 . . . . 0.0 111.446 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.44 32.96 0.03 OUTLIER Glycine 0 CA--C 1.53 0.997 0 CA-C-N 117.557 0.678 . . . . 0.0 113.206 -178.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -138.3 -143.13 0.16 Allowed 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 125.425 1.49 . . . . 0.0 108.938 -167.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.6 -7.71 61.73 Favored Glycine 0 CA--C 1.533 1.167 0 N-CA-C 116.034 1.173 . . . . 0.0 116.034 -171.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.403 ' CB ' ' CD ' ' A' ' 68' ' ' PRO . 19.6 mm100 -64.32 -69.33 0.6 Allowed Pre-proline 0 CA--C 1.549 0.904 0 C-N-CA 125.756 1.622 . . . . 0.0 109.973 173.266 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.403 ' CD ' ' CB ' ' A' ' 67' ' ' GLN . 55.9 Cg_endo -64.19 105.43 0.58 Allowed 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.646 2.897 . . . . 0.0 110.423 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 22.3 t-160 46.12 64.39 1.5 Allowed 'General case' 0 C--N 1.344 0.341 0 CA-C-O 123.708 1.718 . . . . 0.0 113.959 177.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -63.4 24.73 0.08 OUTLIER Glycine 0 CA--C 1.527 0.821 0 C-N-CA 127.535 2.493 . . . . 0.0 116.75 173.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 124.89 -17.04 7.25 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-N 120.624 2.212 . . . . 0.0 114.72 170.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 132.57 12.97 1.71 Allowed Glycine 0 N--CA 1.473 1.153 0 CA-C-N 119.033 1.416 . . . . 0.0 116.026 163.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -125.61 -102.56 0.36 Allowed 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 118.023 0.912 . . . . 0.0 109.836 -162.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -86.5 -32.11 17.0 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-N 118.526 0.603 . . . . 0.0 113.097 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.409 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 4.1 mp0 -60.33 -43.89 94.52 Favored Pre-proline 0 C--O 1.223 -0.31 0 O-C-N 121.36 -1.082 . . . . 0.0 111.506 -177.201 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.409 ' CD ' ' N ' ' A' ' 75' ' ' GLN . 93.7 Cg_endo -77.87 42.3 1.16 Allowed 'Trans proline' 0 CA--C 1.548 1.217 0 C-N-CA 122.957 2.438 . . . . 0.0 111.656 169.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.472 ' CD2' ' H ' ' A' ' 78' ' ' GLY . 6.2 t-160 83.31 -179.17 0.04 OUTLIER 'General case' 0 C--N 1.346 0.414 0 C-N-CA 126.899 2.08 . . . . 0.0 112.643 173.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.472 ' H ' ' CD2' ' A' ' 77' ' ' HIS . . . 160.23 1.35 0.07 OUTLIER Glycine 0 C--N 1.336 0.53 0 CA-C-O 116.959 -2.023 . . . . 0.0 115.616 -158.325 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 148.95 -59.66 0.45 Allowed Glycine 0 C--N 1.339 0.732 0 CA-C-N 121.103 2.452 . . . . 0.0 111.948 175.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 158.51 28.49 0.02 OUTLIER Glycine 0 CA--C 1.529 0.959 0 CA-C-N 117.573 0.686 . . . . 0.0 114.026 175.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -138.43 -131.26 0.13 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.411 1.084 . . . . 0.0 110.944 -158.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -87.66 -10.7 69.65 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 119.789 1.177 . . . . 0.0 114.016 -172.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -55.08 -64.95 1.61 Allowed Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 124.897 1.279 . . . . 0.0 108.451 168.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 N--CA 1.457 -0.669 0 C-N-CA 122.403 2.069 . . . . 0.0 114.494 -176.095 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 23.1 t-80 . . . . . 0 CA--C 1.535 0.372 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -150.02 32.01 1.07 Allowed Glycine 0 C--N 1.335 0.502 0 CA-C-O 118.108 -1.384 . . . . 0.0 112.481 -175.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 128.86 -18.2 5.65 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-N 119.016 1.408 . . . . 0.0 113.274 178.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 126.86 11.86 3.44 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-N 118.716 1.258 . . . . 0.0 115.322 165.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -117.79 -99.68 0.44 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 118.53 1.165 . . . . 0.0 111.501 -162.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -105.33 -2.71 41.27 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 124.3 0.952 . . . . 0.0 114.501 -177.145 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -75.97 -48.72 3.52 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 125.334 1.454 . . . . 0.0 112.71 165.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -74.36 167.35 27.36 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 122.188 1.925 . . . . 0.0 109.491 168.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.569 ' CD2' ' H ' ' A' ' 70' ' ' GLY . 16.1 t-80 57.57 172.61 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.687 0.795 . . . . 0.0 111.509 -165.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.569 ' H ' ' CD2' ' A' ' 69' ' ' HIS . . . 151.31 14.17 0.08 OUTLIER Glycine 0 C--N 1.337 0.633 0 CA-C-O 117.567 -1.685 . . . . 0.0 115.295 -158.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 142.97 -69.59 0.42 Allowed Glycine 0 C--O 1.224 -0.47 0 CA-C-N 120.359 2.079 . . . . 0.0 110.168 177.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 167.69 18.69 0.02 OUTLIER Glycine 0 CA--C 1.529 0.913 0 N-CA-C 114.687 0.635 . . . . 0.0 114.687 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -127.52 -118.28 0.26 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.093 0.957 . . . . 0.0 110.544 -160.359 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -94.24 -3.52 63.32 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-N 119.428 1.013 . . . . 0.0 114.444 -178.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.89 -45.82 3.95 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 125.592 1.557 . . . . 0.0 110.567 170.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -75.77 -164.88 0.27 Allowed 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.038 1.825 . . . . 0.0 109.118 157.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.52 ' CD2' ' H ' ' A' ' 78' ' ' GLY 0.268 11.3 t-80 67.46 174.0 0.26 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.04 1.336 . . . . 0.0 110.462 -158.414 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.52 ' H ' ' CD2' ' A' ' 77' ' ' HIS . . . 141.64 9.55 0.63 Allowed Glycine 0 CA--C 1.526 0.751 0 CA-C-O 117.615 -1.659 . . . . 0.0 115.154 -156.095 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.424 ' H ' ' CD2' ' A' ' 77' ' ' HIS . . . 141.11 -75.95 0.33 Allowed Glycine 0 C--N 1.336 0.562 0 CA-C-N 120.787 2.293 . . . . 0.0 110.405 174.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 177.49 15.35 0.02 OUTLIER Glycine 0 CA--C 1.527 0.839 0 CA-C-N 117.5 0.65 . . . . 0.0 114.283 -174.034 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -132.29 -138.24 0.19 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 118.475 1.138 . . . . 0.0 108.951 -162.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.42 43.06 1.51 Allowed Glycine 0 CA--C 1.533 1.157 0 C-N-CA 124.769 1.176 . . . . 0.0 112.315 176.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.451 ' H ' ' HD2' ' A' ' 84' ' ' PRO . 5.2 mm-40 -128.49 -55.85 0.03 OUTLIER Pre-proline 0 N--CA 1.438 -1.044 0 C-N-CA 127.864 2.466 . . . . 0.0 109.671 176.301 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.451 ' HD2' ' H ' ' A' ' 83' ' ' GLN . 73.9 Cg_endo . . . . . 0 N--CA 1.457 -0.676 0 C-N-CA 121.305 1.336 . . . . 0.0 110.137 157.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 . . . . . 0 CA--C 1.52 -0.178 0 CA-C-O 123.456 1.598 . . . . 0.0 114.377 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.79 28.81 0.04 OUTLIER Glycine 0 CA--C 1.527 0.822 0 C-N-CA 128.592 2.996 . . . . 0.0 117.64 173.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 127.27 -20.2 5.92 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-N 120.664 2.232 . . . . 0.0 114.19 166.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 137.66 8.2 1.3 Allowed Glycine 0 N--CA 1.472 1.064 0 CA-C-N 118.853 1.326 . . . . 0.0 115.941 166.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -135.09 -117.23 0.18 Allowed 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 118.113 0.957 . . . . 0.0 110.161 -158.539 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.7 -11.3 72.98 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-O 118.957 -0.913 . . . . 0.0 113.944 -177.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -81.3 -59.94 0.44 Allowed Pre-proline 0 N--CA 1.445 -0.716 0 CA-C-N 118.755 1.277 . . . . 0.0 109.347 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.607 ' HA ' ' HB3' ' A' ' 76' ' ' PRO . 55.7 Cg_endo -64.99 83.65 0.18 Allowed 'Trans proline' 0 CA--C 1.548 1.177 0 C-N-CA 123.059 2.506 . . . . 0.0 112.613 178.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.463 ' H ' ' HB3' ' A' ' 76' ' ' PRO . 15.0 t-80 -67.75 132.97 48.44 Favored 'General case' 0 N--CA 1.439 -0.997 0 O-C-N 119.833 -1.792 . . . . 0.0 107.273 173.557 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.35 -26.93 3.31 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 126.042 1.782 . . . . 0.0 112.646 162.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 162.79 -14.31 0.11 Allowed Glycine 0 CA--C 1.524 0.599 0 CA-C-O 119.124 -0.82 . . . . 0.0 112.754 -175.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.69 26.4 6.82 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-N 118.778 1.289 . . . . 0.0 112.854 172.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -95.95 -113.13 0.13 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.499 2.319 . . . . 0.0 110.384 -173.002 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.434 ' C ' ' HD2' ' A' ' 76' ' ' PRO . . . -94.71 -28.67 9.99 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-N 119.839 1.2 . . . . 0.0 113.092 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -50.5 -39.0 46.26 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 126.78 2.032 . . . . 0.0 115.612 172.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.607 ' HB3' ' HA ' ' A' ' 68' ' ' PRO . 14.6 Cg_endo -83.32 50.9 3.42 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.403 2.068 . . . . 0.0 112.715 -172.457 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 72.82 120.31 0.04 OUTLIER 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.755 1.222 . . . . 0.0 109.942 -162.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -136.55 33.57 2.33 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 125.316 1.436 . . . . 0.0 112.09 -167.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 131.35 -77.03 0.4 Allowed Glycine 0 C--N 1.331 0.292 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 -175.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 168.87 24.17 0.02 OUTLIER Glycine 0 CA--C 1.526 0.72 0 CA-C-O 119.046 -0.864 . . . . 0.0 114.895 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -138.35 -107.48 0.18 Allowed 'General case' 0 C--O 1.223 -0.328 0 CA-C-N 118.594 1.197 . . . . 0.0 111.238 -158.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -97.21 -4.5 58.49 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-N 119.384 0.993 . . . . 0.0 114.146 -175.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.4 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 3.6 mp0 -78.29 -51.03 1.64 Allowed Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 125.962 1.705 . . . . 0.0 112.325 175.421 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 83' ' ' GLN . 36.7 Cg_endo . . . . . 0 N--CA 1.45 -1.051 0 C-N-CA 122.971 2.448 . . . . 0.0 108.225 174.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.478 ' CG ' ' H ' ' A' ' 62' ' ' GLY . 7.1 t-160 . . . . . 0 CA--C 1.545 0.772 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.478 ' H ' ' CG ' ' A' ' 61' ' ' HIS . . . 148.02 -1.33 0.66 Allowed Glycine 0 C--N 1.338 0.662 0 CA-C-O 117.147 -1.918 . . . . 0.0 116.467 -154.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.423 ' H ' ' CD2' ' A' ' 61' ' ' HIS . . . 148.86 -64.21 0.41 Allowed Glycine 0 C--N 1.336 0.54 0 CA-C-N 121.026 2.413 . . . . 0.0 112.012 173.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 167.16 21.61 0.02 OUTLIER Glycine 0 CA--C 1.527 0.829 0 CA-C-N 117.712 0.756 . . . . 0.0 114.692 -174.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -130.96 -133.47 0.2 Allowed 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 118.645 1.222 . . . . 0.0 108.818 -167.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.69 -23.66 77.51 Favored Glycine 0 CA--C 1.534 1.26 0 O-C-N 121.646 -0.659 . . . . 0.0 113.487 -174.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 -57.91 -49.74 92.02 Favored Pre-proline 0 N--CA 1.441 -0.905 0 C-N-CA 127.745 2.418 . . . . 0.0 113.363 -179.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -79.25 130.98 9.46 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.42 2.747 . . . . 0.0 109.939 166.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 21.8 t-160 57.43 -73.35 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 115.558 1.688 . . . . 0.0 115.558 175.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 68.87 -23.7 0.3 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 126.9 2.19 . . . . 0.0 116.243 171.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 159.08 -11.74 0.19 Allowed Glycine 0 CA--C 1.531 1.093 0 CA-C-N 119.282 1.541 . . . . 0.0 113.867 -170.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 114.93 29.91 2.47 Favored Glycine 0 N--CA 1.475 1.249 0 CA-C-N 119.931 1.865 . . . . 0.0 114.345 166.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -120.86 -113.12 0.32 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.333 1.453 . . . . 0.0 110.526 -163.162 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -101.43 -4.67 52.79 Favored Glycine 0 CA--C 1.536 1.396 0 CA-C-N 119.93 1.241 . . . . 0.0 114.028 -178.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -83.63 -31.79 0.51 Allowed Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 128.535 2.734 . . . . 0.0 112.707 177.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -82.58 -164.05 0.25 Allowed 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 121.991 1.794 . . . . 0.0 107.452 157.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.503 ' CD2' ' H ' ' A' ' 78' ' ' GLY . 11.7 t-80 58.71 -178.31 0.08 Allowed 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.31 -0.869 . . . . 0.0 110.196 -167.428 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.503 ' H ' ' CD2' ' A' ' 77' ' ' HIS . . . 138.79 8.76 1.04 Allowed Glycine 0 C--N 1.339 0.699 0 CA-C-O 117.258 -1.857 . . . . 0.0 115.826 -156.371 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.424 ' H ' ' CD2' ' A' ' 77' ' ' HIS . . . 141.25 -69.84 0.44 Allowed Glycine 0 CA--C 1.522 0.477 0 CA-C-N 120.679 2.24 . . . . 0.0 110.697 171.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 172.9 17.11 0.02 OUTLIER Glycine 0 CA--C 1.528 0.868 0 C-N-CA 120.352 -0.928 . . . . 0.0 114.744 -174.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 0.448 ' HB2' ' H ' ' A' ' 82' ' ' GLY . 0.1 OUTLIER -131.03 -143.79 0.25 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 118.315 1.057 . . . . 0.0 109.331 -165.268 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.448 ' H ' ' HB2' ' A' ' 81' ' ' TRP . . . -67.94 12.09 0.87 Allowed Glycine 0 CA--C 1.537 1.443 0 C-N-CA 124.521 1.058 . . . . 0.0 114.766 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 5.6 mm100 -94.33 -52.85 0.24 Allowed Pre-proline 0 N--CA 1.442 -0.845 0 C-N-CA 126.514 1.925 . . . . 0.0 110.0 173.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo . . . . . 0 CA--C 1.536 0.598 0 C-N-CA 121.617 1.544 . . . . 0.0 113.284 166.098 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.9 t-160 . . . . . 0 CA--C 1.533 0.304 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.78 -75.01 0.58 Allowed Glycine 0 CA--C 1.526 0.735 0 CA-C-N 118.928 0.785 . . . . 0.0 111.732 -173.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -156.44 -0.68 0.11 Allowed Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.857 1.694 . . . . 0.0 113.397 -170.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.22 51.62 0.71 Allowed Glycine 0 C--N 1.345 1.035 0 CA-C-N 120.057 1.928 . . . . 0.0 112.082 164.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -139.18 -125.09 0.12 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.446 1.498 . . . . 0.0 109.709 -170.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -82.54 -19.28 64.34 Favored Glycine 0 CA--C 1.533 1.208 0 O-C-N 120.331 -1.48 . . . . 0.0 114.129 -177.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -69.48 -35.02 5.2 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 125.418 1.487 . . . . 0.0 114.704 -178.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -75.75 -75.3 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.359 2.04 . . . . 0.0 108.613 169.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.542 ' CG ' ' H ' ' A' ' 70' ' ' GLY . 8.8 t-160 48.13 -162.04 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.827 1.251 . . . . 0.0 112.418 -175.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.542 ' H ' ' CG ' ' A' ' 69' ' ' HIS . . . 145.29 -15.62 1.88 Allowed Glycine 0 C--O 1.221 -0.674 0 O-C-N 120.139 -1.6 . . . . 0.0 114.871 -172.245 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 159.41 -20.21 0.27 Allowed Glycine 0 CA--C 1.528 0.866 0 CA-C-N 119.384 1.592 . . . . 0.0 113.994 -177.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 118.65 30.57 1.64 Allowed Glycine 0 N--CA 1.473 1.165 0 CA-C-N 119.217 1.509 . . . . 0.0 113.102 170.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.402 ' CD1' ' NE2' ' A' ' 75' ' ' GLN . 0.0 OUTLIER -127.67 -141.63 0.26 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.883 1.673 . . . . 0.0 109.612 -163.765 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.03 -25.32 67.89 Favored Glycine 0 CA--C 1.534 1.231 0 O-C-N 120.091 -1.631 . . . . 0.0 113.569 -178.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.402 ' NE2' ' CD1' ' A' ' 73' ' ' TRP . 2.2 mp0 -68.32 -51.53 24.44 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 124.789 1.236 . . . . 0.0 112.108 -173.59 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.66 -50.97 1.05 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 121.714 1.609 . . . . 0.0 111.518 175.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 2.2 t60 60.03 -71.24 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.052 1.741 . . . . 0.0 114.69 -178.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 64.11 -2.67 2.01 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-O 116.996 -2.002 . . . . 0.0 116.264 173.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 128.78 -5.49 6.53 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-N 120.48 2.14 . . . . 0.0 114.345 -177.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 116.17 18.85 5.72 Favored Glycine 0 N--CA 1.476 1.313 0 CA-C-N 119.944 1.872 . . . . 0.0 115.027 156.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -131.49 -99.96 0.3 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.42 1.088 . . . . 0.0 111.62 -157.261 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -92.44 -12.93 57.88 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 119.147 -0.807 . . . . 0.0 113.646 -177.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -74.92 -41.54 4.22 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-N 120.109 1.954 . . . . 0.0 112.012 172.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo . . . . . 0 N--CA 1.452 -0.956 0 C-N-CA 123.479 2.786 . . . . 0.0 114.572 -176.308 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.485 ' CG ' ' H ' ' A' ' 62' ' ' GLY 0.262 4.5 t-160 . . . . . 0 CA--C 1.537 0.479 0 CA-C-O 121.884 0.85 . . . . 0.0 112.235 . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.485 ' H ' ' CG ' ' A' ' 61' ' ' HIS . . . 174.56 -42.93 0.13 Allowed Glycine 0 CA--C 1.525 0.67 0 O-C-N 120.981 -1.074 . . . . 0.0 110.563 -160.502 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 173.8 -33.79 0.11 Allowed Glycine 0 CA--C 1.526 0.733 0 CA-C-O 118.323 -1.265 . . . . 0.0 113.377 171.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 146.02 45.77 0.04 OUTLIER Glycine 0 C--N 1.343 0.939 0 CA-C-N 118.959 1.38 . . . . 0.0 113.477 171.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -137.04 -133.73 0.14 Allowed 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -171.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -88.36 -2.42 79.87 Favored Glycine 0 CA--C 1.524 0.599 0 O-C-N 121.622 -0.673 . . . . 0.0 112.237 -166.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . 0.288 0.0 OUTLIER -71.2 -71.0 0.27 Allowed Pre-proline 0 N--CA 1.427 -1.599 0 C-N-CA 129.538 3.135 . . . . 0.0 107.26 178.169 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -62.42 88.64 0.11 Allowed 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 125.096 3.864 . . . . 0.0 112.02 -171.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 17.5 t-160 50.0 69.05 0.65 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 124.293 1.996 . . . . 0.0 112.224 -176.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.32 24.23 0.12 Allowed Glycine 0 CA--C 1.526 0.725 0 CA-C-N 111.668 -2.515 . . . . 0.0 116.558 174.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 127.0 -17.34 6.32 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 121.426 2.613 . . . . 0.0 116.058 167.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 146.08 12.7 0.21 Allowed Glycine 0 N--CA 1.476 1.312 0 CA-C-N 119.853 1.826 . . . . 0.0 116.632 165.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -140.54 -117.49 0.12 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 118.583 1.191 . . . . 0.0 110.0 -155.19 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -81.01 -31.48 34.98 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-N 119.42 1.009 . . . . 0.0 113.23 -175.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -50.36 -48.85 79.88 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 125.652 1.581 . . . . 0.0 111.528 -176.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -71.84 54.84 2.14 Favored 'Trans proline' 0 CA--C 1.55 1.313 0 C-N-CA 122.614 2.209 . . . . 0.0 112.65 168.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.264 16.5 t-160 66.9 67.88 0.42 Allowed 'General case' 0 C--N 1.346 0.413 0 CA-C-O 124.545 2.117 . . . . 0.0 113.287 165.239 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.57 31.39 0.27 Allowed Glycine 0 CA--C 1.524 0.635 0 CA-C-N 111.714 -2.494 . . . . 0.0 116.264 172.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.47 -18.66 8.19 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 121.075 2.438 . . . . 0.0 115.628 167.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 139.94 9.54 0.82 Allowed Glycine 0 N--CA 1.469 0.863 0 CA-C-N 119.209 1.505 . . . . 0.0 115.548 163.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -131.74 -106.93 0.26 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 118.906 1.353 . . . . 0.0 111.406 -155.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -86.56 -25.02 37.03 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-N 119.029 0.832 . . . . 0.0 112.911 -179.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.439 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 4.5 mp0 -63.47 -43.69 79.51 Favored Pre-proline 0 C--O 1.222 -0.362 0 C-N-CA 126.955 2.102 . . . . 0.0 113.427 -177.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.439 ' CD ' ' N ' ' A' ' 83' ' ' GLN . 19.0 Cg_endo . . . . . 0 CA--C 1.553 1.437 0 C-N-CA 124.255 3.303 . . . . 0.0 113.215 174.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.584 ' CD2' ' H ' ' A' ' 62' ' ' GLY . 7.5 t-160 . . . . . 0 CA--C 1.541 0.634 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.584 ' H ' ' CD2' ' A' ' 61' ' ' HIS . . . 146.33 12.49 0.2 Allowed Glycine 0 C--N 1.338 0.68 0 CA-C-O 117.193 -1.893 . . . . 0.0 115.701 -155.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 139.35 -72.78 0.42 Allowed Glycine 0 C--N 1.338 0.648 0 CA-C-N 120.709 2.255 . . . . 0.0 110.836 175.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 168.76 17.26 0.02 OUTLIER Glycine 0 CA--C 1.527 0.826 0 CA-C-O 119.499 -0.612 . . . . 0.0 114.324 -175.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -121.55 -133.48 0.3 Allowed 'General case' 0 C--O 1.222 -0.361 0 C-N-CA 124.86 1.264 . . . . 0.0 108.352 -170.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.67 -7.97 87.91 Favored Glycine 0 CA--C 1.533 1.182 0 CA-C-N 119.294 0.952 . . . . 0.0 114.774 -173.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -67.38 -59.16 7.55 Favored Pre-proline 0 N--CA 1.442 -0.835 0 C-N-CA 126.496 1.919 . . . . 0.0 110.16 174.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -72.22 172.66 14.39 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 121.633 1.556 . . . . 0.0 109.443 161.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 23.0 t-160 60.06 -70.97 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.401 1.88 . . . . 0.0 113.42 -175.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 58.01 12.29 10.9 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-O 117.857 -1.524 . . . . 0.0 116.386 164.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 125.24 -9.89 7.81 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 120.03 1.915 . . . . 0.0 114.867 178.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 119.89 14.58 5.57 Favored Glycine 0 N--CA 1.471 1.032 0 CA-C-N 119.795 1.797 . . . . 0.0 115.159 161.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -121.29 -97.45 0.46 Allowed 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 124.629 1.172 . . . . 0.0 111.863 -162.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -108.16 -1.01 33.56 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.323 0.963 . . . . 0.0 114.554 -178.021 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.449 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 3.7 mp0 -83.47 -35.66 0.64 Allowed Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 126.286 1.834 . . . . 0.0 112.642 167.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.449 ' CD ' ' N ' ' A' ' 75' ' ' GLN . 30.2 Cg_endo -73.79 177.32 8.23 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.473 2.116 . . . . 0.0 108.871 164.225 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.522 ' CG ' ' H ' ' A' ' 78' ' ' GLY . 9.3 t-80 62.66 176.89 0.14 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.785 0.834 . . . . 0.0 110.71 -167.235 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.522 ' H ' ' CG ' ' A' ' 77' ' ' HIS . . . 144.67 4.41 0.63 Allowed Glycine 0 CA--C 1.527 0.784 0 CA-C-O 117.674 -1.626 . . . . 0.0 115.178 -157.143 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.426 ' H ' ' CD2' ' A' ' 77' ' ' HIS . . . 143.3 -71.13 0.4 Allowed Glycine 0 C--N 1.338 0.676 0 CA-C-N 120.533 2.166 . . . . 0.0 111.195 174.533 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 172.44 20.09 0.02 OUTLIER Glycine 0 CA--C 1.529 0.918 0 CA-C-N 117.926 0.863 . . . . 0.0 114.642 -172.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -132.47 -138.97 0.19 Allowed 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 118.622 1.211 . . . . 0.0 108.397 -168.619 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -70.16 0.98 20.61 Favored Glycine 0 CA--C 1.535 1.287 0 O-C-N 121.595 -0.691 . . . . 0.0 114.716 -177.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -82.7 -55.83 0.52 Allowed Pre-proline 0 N--CA 1.441 -0.922 0 C-N-CA 127.299 2.24 . . . . 0.0 111.013 179.17 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.414 ' HA ' ' H ' ' A' ' 77' ' ' HIS . 34.8 Cg_endo . . . . . 0 N--CA 1.456 -0.725 0 C-N-CA 121.912 1.741 . . . . 0.0 110.161 165.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.631 ' CD2' ' H ' ' A' ' 62' ' ' GLY . 13.1 t-80 . . . . . 0 CA--C 1.544 0.712 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.631 ' H ' ' CD2' ' A' ' 61' ' ' HIS . . . 146.89 17.4 0.13 Allowed Glycine 0 C--N 1.339 0.702 0 CA-C-O 117.145 -1.92 . . . . 0.0 115.378 -157.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 139.55 -52.94 0.7 Allowed Glycine 0 CA--C 1.524 0.617 0 CA-C-N 120.95 2.375 . . . . 0.0 112.181 172.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 147.4 13.66 0.15 Allowed Glycine 0 CA--C 1.53 1.014 0 CA-C-O 119.295 -0.725 . . . . 0.0 114.514 -177.064 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -118.81 -131.26 0.3 Allowed 'General case' 0 C--O 1.22 -0.453 0 C-N-CA 124.853 1.261 . . . . 0.0 108.731 -172.432 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -81.92 -3.25 90.64 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-N 119.876 1.216 . . . . 0.0 114.986 -174.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -71.02 -54.74 7.12 Favored Pre-proline 0 N--CA 1.445 -0.679 0 C-N-CA 126.92 2.088 . . . . 0.0 110.59 173.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -69.8 166.55 27.27 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 N-CA-C 108.653 -1.326 . . . . 0.0 108.653 159.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . 0.275 13.0 t-160 45.81 68.05 0.65 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 124.575 2.131 . . . . 0.0 115.406 172.107 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.534 ' H ' ' HB3' ' A' ' 75' ' ' GLN . . . -86.77 20.05 26.08 Favored Glycine 0 CA--C 1.522 0.522 0 CA-C-N 111.582 -2.553 . . . . 0.0 115.034 175.458 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 137.29 -71.94 0.46 Allowed Glycine 0 C--N 1.337 0.586 0 CA-C-N 120.558 2.179 . . . . 0.0 112.454 175.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -175.62 15.57 0.04 OUTLIER Glycine 0 N--CA 1.467 0.734 0 CA-C-N 118.508 1.154 . . . . 0.0 115.122 -174.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -126.47 -141.25 0.28 Allowed 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 124.845 1.258 . . . . 0.0 108.413 -168.736 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.93 1.66 30.34 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-O 118.448 -1.196 . . . . 0.0 114.742 -175.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.534 ' HB3' ' H ' ' A' ' 70' ' ' GLY . 18.0 mm100 -84.53 -51.7 0.55 Allowed Pre-proline 0 N--CA 1.442 -0.834 0 C-N-CA 126.369 1.868 . . . . 0.0 110.937 -179.246 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -68.56 174.96 7.64 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.032 1.821 . . . . 0.0 109.978 157.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.489 ' CG ' ' H ' ' A' ' 78' ' ' GLY . 7.1 t-160 61.23 -151.98 0.38 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.408 1.083 . . . . 0.0 111.302 176.215 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.489 ' H ' ' CG ' ' A' ' 77' ' ' HIS . . . 132.97 -43.97 1.24 Allowed Glycine 0 C--O 1.223 -0.545 0 O-C-N 120.422 -1.424 . . . . 0.0 111.593 -173.378 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -175.41 -7.17 0.02 OUTLIER Glycine 0 CA--C 1.525 0.692 0 CA-C-O 117.973 -1.46 . . . . 0.0 114.217 -176.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.74 19.31 7.87 Favored Glycine 0 N--CA 1.475 1.25 0 CA-C-N 119.846 1.823 . . . . 0.0 112.938 170.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -113.94 -136.83 0.37 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.339 1.856 . . . . 0.0 108.644 -165.462 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -76.24 1.77 59.15 Favored Glycine 0 CA--C 1.536 1.377 0 CA-C-N 119.434 1.016 . . . . 0.0 115.071 -176.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.512 ' H ' ' HD2' ' A' ' 84' ' ' PRO . 69.1 mt-30 -98.5 -39.19 0.24 Allowed Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 126.461 1.904 . . . . 0.0 114.343 -172.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.512 ' HD2' ' H ' ' A' ' 83' ' ' GLN . 32.5 Cg_endo . . . . . 0 CA--C 1.537 0.666 0 CA-C-N 120.859 1.342 . . . . 0.0 110.625 161.18 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.43 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 20.1 t-160 . . . . . 0 CA--C 1.534 0.365 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.76 -65.76 0.45 Allowed Glycine 0 CA--C 1.536 1.389 0 C-N-CA 125.074 1.321 . . . . 0.0 112.035 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -167.99 7.42 0.05 OUTLIER Glycine 0 CA--C 1.535 1.289 0 C-N-CA 126.76 2.124 . . . . 0.0 113.969 -176.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.68 36.72 3.42 Favored Glycine 0 C--N 1.344 1.002 0 CA-C-N 119.916 1.858 . . . . 0.0 113.631 168.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -135.27 -137.15 0.16 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.674 1.589 . . . . 0.0 109.175 -166.007 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -81.82 11.88 44.92 Favored Glycine 0 CA--C 1.532 1.135 0 N-CA-C 115.952 1.141 . . . . 0.0 115.952 -174.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.4 ' H ' ' HD2' ' A' ' 68' ' ' PRO . 18.6 mm100 -88.04 -52.2 0.39 Allowed Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 126.844 2.058 . . . . 0.0 110.862 175.015 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.43 ' HD3' ' O ' ' A' ' 61' ' ' HIS . 45.8 Cg_endo -74.11 124.82 9.34 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 124.447 3.431 . . . . 0.0 109.485 177.644 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.564 ' CD2' ' H ' ' A' ' 70' ' ' GLY . 22.7 t-80 60.69 165.09 0.08 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.309 1.444 . . . . 0.0 111.695 -162.416 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.564 ' H ' ' CD2' ' A' ' 69' ' ' HIS . . . 155.05 16.98 0.05 OUTLIER Glycine 0 C--N 1.336 0.573 0 CA-C-O 117.62 -1.656 . . . . 0.0 114.741 -155.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 141.19 -68.56 0.47 Allowed Glycine 0 C--N 1.336 0.553 0 CA-C-N 120.187 1.993 . . . . 0.0 110.119 179.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 162.81 23.39 0.02 OUTLIER Glycine 0 CA--C 1.529 0.94 0 CA-C-O 119.528 -0.596 . . . . 0.0 114.463 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -128.63 -113.35 0.26 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.179 0.99 . . . . 0.0 110.821 -162.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -102.87 -2.34 49.18 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-N 119.443 1.019 . . . . 0.0 114.428 -178.042 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -70.87 -49.74 13.37 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 124.869 1.268 . . . . 0.0 109.304 165.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -71.36 176.14 8.38 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 CA-C-N 120.635 1.263 . . . . 0.0 109.545 163.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.501 ' CD2' ' H ' ' A' ' 78' ' ' GLY 0.275 6.7 t-160 65.23 169.86 0.2 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.086 1.754 . . . . 0.0 111.691 -160.182 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.501 ' H ' ' CD2' ' A' ' 77' ' ' HIS . . . 144.24 18.56 0.2 Allowed Glycine 0 C--N 1.337 0.596 0 CA-C-O 117.45 -1.75 . . . . 0.0 115.698 -147.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 136.18 -51.47 0.81 Allowed Glycine 0 CA--C 1.522 0.505 0 CA-C-N 119.899 1.85 . . . . 0.0 111.862 171.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 155.82 8.17 0.07 OUTLIER Glycine 0 N--CA 1.47 0.923 0 N-CA-C 116.051 1.18 . . . . 0.0 116.051 178.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -131.83 -116.97 0.22 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 118.714 1.257 . . . . 0.0 110.229 -158.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -67.65 -35.96 86.94 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-N 119.033 0.833 . . . . 0.0 112.038 -178.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -60.95 -47.7 94.76 Favored Pre-proline 0 N--CA 1.45 -0.448 0 C-N-CA 123.985 0.914 . . . . 0.0 111.771 -176.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.493 ' HA ' ' H ' ' A' ' 77' ' ' HIS . 44.3 Cg_endo . . . . . 0 N--CA 1.455 -0.756 0 C-N-CA 121.258 1.305 . . . . 0.0 112.587 171.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo . . . . . 0 N--CA 1.453 -0.911 0 N-CA-C 109.255 -1.094 . . . . 0.0 109.255 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 8.0 t-160 38.76 41.7 0.54 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.699 2.0 . . . . 0.0 115.276 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.546 ' H ' ' HB3' ' A' ' 75' ' ' GLN . . . -67.25 42.17 0.22 Allowed Glycine 0 CA--C 1.521 0.425 0 C-N-CA 126.997 2.237 . . . . 0.0 116.775 176.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 124.04 -20.76 7.09 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-N 119.514 1.657 . . . . 0.0 113.765 165.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 142.93 0.95 1.19 Allowed Glycine 0 N--CA 1.471 0.974 0 CA-C-N 118.708 1.254 . . . . 0.0 115.418 166.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -127.08 -111.98 0.28 Allowed 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.611 1.206 . . . . 0.0 111.069 -159.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -81.61 2.41 82.78 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 124.406 1.003 . . . . 0.0 114.419 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.546 ' HB3' ' H ' ' A' ' 70' ' ' GLY . 3.1 mp0 -99.63 -39.7 0.23 Allowed Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 126.299 1.839 . . . . 0.0 111.454 178.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.511 ' HD2' ' H ' ' A' ' 75' ' ' GLN . 34.5 Cg_endo -67.01 -94.32 0.0 OUTLIER 'Trans proline' 0 CA--C 1.541 0.871 0 N-CA-C 108.254 -1.479 . . . . 0.0 108.254 154.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 18.0 t-160 -31.99 112.03 0.1 Allowed 'General case' 0 C--N 1.341 0.208 0 C-N-CA 128.017 2.527 . . . . 0.0 114.86 -175.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -135.46 36.0 2.1 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-O 117.187 -1.896 . . . . 0.0 112.232 -175.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.74 0 CA-C-N 119.875 1.837 . . . . 0.0 112.294 177.354 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo . . . . . 0 CA--C 1.539 0.746 0 N-CA-C 109.265 -1.091 . . . . 0.0 109.265 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 73.85 -61.26 0.5 Allowed 'General case' 0 C--O 1.234 0.263 0 O-C-N 120.677 -1.264 . . . . 0.0 110.912 -173.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 74.98 -26.19 1.18 Allowed Glycine 0 CA--C 1.525 0.71 0 CA-C-O 118.054 -1.414 . . . . 0.0 115.305 165.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 168.62 -41.37 0.22 Allowed Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.424 1.488 . . . . 0.0 110.928 -175.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 137.52 47.53 0.07 OUTLIER Glycine 0 N--CA 1.474 1.194 0 CA-C-N 119.047 1.424 . . . . 0.0 114.189 176.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -140.39 -118.52 0.12 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.983 0.913 . . . . 0.0 110.806 -164.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -107.08 4.63 35.81 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 125.164 1.364 . . . . 0.0 113.666 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -86.61 -21.55 0.27 Allowed Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 126.764 2.026 . . . . 0.0 112.949 172.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -79.21 -177.96 4.28 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 CA-C-N 123.1 2.143 . . . . 0.0 108.658 148.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.53 ' CD2' ' H ' ' A' ' 78' ' ' GLY . 8.0 t-160 65.03 179.23 0.19 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.519 0.728 . . . . 0.0 111.342 -176.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.53 ' H ' ' CD2' ' A' ' 77' ' ' HIS . . . 147.72 12.26 0.16 Allowed Glycine 0 C--N 1.336 0.559 0 CA-C-O 117.058 -1.968 . . . . 0.0 115.939 -157.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.534 0 CA-C-N 121.081 2.441 . . . . 0.0 110.852 176.1 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo . . . . . 0 N--CA 1.452 -0.918 0 N-CA-C 110.289 -0.697 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . 0.277 5.2 t-160 56.79 -82.48 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.464 1.506 . . . . 0.0 114.329 -169.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 71.69 -63.47 1.18 Allowed Glycine 0 CA--C 1.53 0.977 0 CA-C-N 120.414 1.461 . . . . 0.0 113.425 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -161.74 -2.98 0.05 OUTLIER Glycine 0 CA--C 1.531 1.075 0 C-N-CA 125.626 1.584 . . . . 0.0 114.074 -170.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 116.82 20.21 5.02 Favored Glycine 0 N--CA 1.475 1.295 0 CA-C-N 120.387 2.093 . . . . 0.0 114.482 164.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -114.67 -120.29 0.3 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.274 1.429 . . . . 0.0 110.265 -162.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -90.16 -10.16 64.6 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-N 119.573 1.078 . . . . 0.0 114.248 -177.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -74.44 -39.88 4.07 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 126.155 1.782 . . . . 0.0 113.905 174.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.98 -171.57 0.91 Allowed 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 123.074 2.516 . . . . 0.0 109.961 169.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 60.5 -70.04 0.04 OUTLIER 'General case' 0 C--O 1.232 0.153 0 C-N-CA 126.708 2.003 . . . . 0.0 114.353 -172.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 67.31 -22.1 0.22 Allowed Glycine 0 CA--C 1.533 1.213 0 CA-C-O 117.697 -1.613 . . . . 0.0 116.742 172.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.142 0 CA-C-N 120.049 1.925 . . . . 0.0 114.251 -169.957 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo . . . . . 0 N--CA 1.44 -1.636 0 N-CA-C 110.426 -0.644 . . . . 0.0 110.426 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 21.3 t-160 72.01 -62.39 0.46 Allowed 'General case' 0 C--O 1.236 0.386 0 C-N-CA 127.11 2.164 . . . . 0.0 111.836 -177.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 75.72 -40.89 1.4 Allowed Glycine 0 CA--C 1.529 0.911 0 C-N-CA 124.323 0.963 . . . . 0.0 114.591 174.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 166.6 -9.41 0.06 OUTLIER Glycine 0 CA--C 1.53 1.027 0 CA-C-O 117.844 -1.531 . . . . 0.0 113.953 -169.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 111.85 42.19 1.04 Allowed Glycine 0 N--CA 1.475 1.254 0 CA-C-N 120.047 1.924 . . . . 0.0 113.522 164.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -138.15 -131.97 0.13 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.938 0.895 . . . . 0.0 109.845 -157.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -94.71 -0.45 64.39 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.179 0.895 . . . . 0.0 113.928 -178.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -71.09 -46.36 14.54 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-O 116.937 -1.506 . . . . 0.0 111.334 174.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -77.31 -126.42 0.01 OUTLIER 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 123.894 3.063 . . . . 0.0 109.808 174.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.531 ' CD2' ' H ' ' A' ' 78' ' ' GLY . 9.4 t-80 56.81 -179.69 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.78 0 O-C-N 120.855 -1.153 . . . . 0.0 111.729 -168.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.531 ' H ' ' CD2' ' A' ' 77' ' ' HIS . . . 153.33 9.58 0.08 OUTLIER Glycine 0 CA--C 1.523 0.567 0 CA-C-O 117.509 -1.717 . . . . 0.0 115.298 -161.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.551 0 CA-C-N 120.109 1.954 . . . . 0.0 110.743 175.703 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo . . . . . 0 N--CA 1.456 -0.705 0 N-CA-C 110.886 -0.467 . . . . 0.0 110.886 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . 0.265 3.2 t-160 60.17 -69.91 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.431 1.092 . . . . 0.0 111.875 -166.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 59.07 15.35 28.77 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-O 117.593 -1.671 . . . . 0.0 116.104 159.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 124.96 -14.95 7.45 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-N 119.873 1.836 . . . . 0.0 114.798 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.49 10.54 6.52 Favored Glycine 0 N--CA 1.473 1.145 0 CA-C-N 119.848 1.824 . . . . 0.0 115.393 164.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -118.64 -99.93 0.44 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.501 1.15 . . . . 0.0 112.107 -159.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -102.75 -0.47 49.17 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.436 1.017 . . . . 0.0 114.019 -178.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.465 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 2.0 mp0 -87.17 -38.41 0.5 Allowed Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 127.31 2.244 . . . . 0.0 111.911 173.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 75' ' ' GLN . 36.7 Cg_endo -74.71 -170.38 0.75 Allowed 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.978 2.452 . . . . 0.0 108.576 161.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 19.1 t-160 67.68 -72.36 0.09 Allowed 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 126.38 1.872 . . . . 0.0 111.931 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 58.94 17.89 37.97 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-O 116.996 -2.002 . . . . 0.0 116.215 161.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.072 0 CA-C-N 120.016 1.908 . . . . 0.0 114.262 178.441 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo . . . . . 0 N--CA 1.448 -1.171 0 N-CA-C 108.992 -1.196 . . . . 0.0 108.992 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 19.1 t-160 47.62 62.54 2.39 Favored 'General case' 0 C--O 1.227 -0.127 0 CA-C-O 124.518 2.104 . . . . 0.0 113.343 -176.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.9 36.76 0.29 Allowed Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 111.414 -2.63 . . . . 0.0 115.716 172.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 123.16 -23.51 6.86 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-N 120.665 2.232 . . . . 0.0 115.093 166.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 140.39 8.87 0.81 Allowed Glycine 0 N--CA 1.469 0.871 0 CA-C-N 118.761 1.281 . . . . 0.0 115.561 166.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -133.3 -110.48 0.23 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.604 1.202 . . . . 0.0 110.74 -158.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -78.36 -26.19 59.91 Favored Glycine 0 CA--C 1.525 0.703 0 O-C-N 120.944 -1.097 . . . . 0.0 112.214 -176.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -64.3 -52.81 51.44 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 118.379 1.09 . . . . 0.0 109.978 -177.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.66 78.96 0.94 Allowed 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 122.135 1.89 . . . . 0.0 110.943 170.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.252 23.6 t-160 63.99 67.0 0.62 Allowed 'General case' 0 C--O 1.226 -0.18 0 CA-C-O 124.653 2.168 . . . . 0.0 113.503 168.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.18 27.35 0.32 Allowed Glycine 0 CA--C 1.526 0.748 0 CA-C-N 111.457 -2.61 . . . . 0.0 115.898 172.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.219 0 CA-C-N 121.021 2.411 . . . . 0.0 116.317 167.991 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo . . . . . 0 N--CA 1.447 -1.206 0 N-CA-C 109.381 -1.046 . . . . 0.0 109.381 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.502 ' CD2' ' H ' ' A' ' 70' ' ' GLY 0.272 6.5 t-160 88.08 175.96 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 128.52 2.728 . . . . 0.0 109.921 -157.352 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.502 ' H ' ' CD2' ' A' ' 69' ' ' HIS . . . 158.46 -2.4 0.11 Allowed Glycine 0 CA--C 1.524 0.61 0 CA-C-O 117.474 -1.737 . . . . 0.0 115.431 -157.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 146.27 -57.31 0.51 Allowed Glycine 0 C--N 1.338 0.642 0 CA-C-N 120.714 2.257 . . . . 0.0 111.704 178.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 151.35 51.49 0.01 OUTLIER Glycine 0 C--N 1.34 0.802 0 CA-C-N 117.941 0.871 . . . . 0.0 112.966 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.405 ' CD1' ' OE1' ' A' ' 75' ' ' GLN . 0.0 OUTLIER -149.89 -114.6 0.06 Allowed 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.827 -0.808 . . . . 0.0 110.21 -168.471 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -99.94 -21.6 13.63 Favored Glycine 0 N--CA 1.473 1.162 0 CA-C-N 119.578 1.081 . . . . 0.0 113.394 -175.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.426 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 4.1 mp0 -59.75 -33.74 17.77 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 128.194 2.598 . . . . 0.0 113.211 176.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.437 ' HA ' ' H ' ' A' ' 69' ' ' HIS . 32.1 Cg_endo -80.28 -71.04 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 123.654 2.903 . . . . 0.0 111.575 173.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 50.0 -74.24 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 117.662 2.467 . . . . 0.0 117.662 176.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.1 -79.15 0.51 Allowed Glycine 0 CA--C 1.525 0.681 0 O-C-N 120.986 -1.071 . . . . 0.0 110.615 -169.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.882 0 CA-C-O 117.8 -1.555 . . . . 0.0 114.172 -167.455 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo . . . . . 0 CA--C 1.544 0.982 0 N-CA-C 108.854 -1.248 . . . . 0.0 108.854 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.519 ' CD2' ' H ' ' A' ' 70' ' ' GLY 0.27 7.6 t-160 65.74 174.13 0.22 Allowed 'General case' 0 CA--C 1.536 0.429 0 O-C-N 120.975 -1.078 . . . . 0.0 110.852 -152.032 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.519 ' H ' ' CD2' ' A' ' 69' ' ' HIS . . . 149.27 10.05 0.14 Allowed Glycine 0 C--N 1.337 0.62 0 CA-C-O 117.136 -1.924 . . . . 0.0 116.417 -149.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 139.2 -67.73 0.51 Allowed Glycine 0 CA--C 1.522 0.502 0 CA-C-N 120.739 2.269 . . . . 0.0 111.007 177.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 155.59 44.83 0.02 OUTLIER Glycine 0 C--N 1.335 0.521 0 CA-C-O 119.308 -0.718 . . . . 0.0 112.652 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.03 -120.33 0.05 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 117.998 0.899 . . . . 0.0 110.99 -170.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -70.63 -36.93 67.83 Favored Glycine 0 CA--C 1.526 0.767 0 O-C-N 120.289 -1.507 . . . . 0.0 111.941 -178.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -59.08 -42.45 93.71 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 125.409 1.484 . . . . 0.0 113.088 -174.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.462 ' HA ' ' H ' ' A' ' 69' ' ' HIS . 44.8 Cg_endo -82.69 -20.47 5.56 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.299 2.0 . . . . 0.0 116.446 178.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 22.0 t-80 -16.72 117.71 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 128.552 2.741 . . . . 0.0 115.737 175.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -143.56 28.89 2.03 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-O 117.202 -1.888 . . . . 0.0 113.741 -174.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.534 0 CA-C-N 120.253 2.027 . . . . 0.0 110.012 -179.903 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo . . . . . 0 N--CA 1.449 -1.134 0 CA-C-O 119.059 -0.475 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 17.2 t-160 72.25 -53.92 0.69 Allowed 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.409 1.083 . . . . 0.0 112.362 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 72.7 -25.67 0.76 Allowed Glycine 0 CA--C 1.533 1.217 0 C-N-CA 125.356 1.455 . . . . 0.0 115.034 161.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 152.59 -6.92 0.49 Allowed Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.32 1.438 . . . . 0.0 113.393 -169.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.23 40.44 4.54 Favored Glycine 0 N--CA 1.472 1.084 0 CA-C-N 119.79 1.795 . . . . 0.0 113.222 166.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -140.02 -110.16 0.15 Allowed 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.256 1.023 . . . . 0.0 110.615 -160.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -111.79 -0.62 27.35 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 124.494 1.045 . . . . 0.0 112.945 -172.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.0 -65.38 2.21 Favored Pre-proline 0 N--CA 1.436 -1.172 0 C-N-CA 125.767 1.627 . . . . 0.0 108.256 161.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -78.3 69.69 7.5 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 123.84 3.027 . . . . 0.0 111.516 -160.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.278 28.2 t-80 71.37 102.26 0.06 Allowed 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 125.426 1.491 . . . . 0.0 110.83 -160.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -110.04 18.17 28.89 Favored Glycine 0 C--O 1.223 -0.572 0 CA-C-O 116.787 -2.119 . . . . 0.0 113.977 -178.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.109 0 CA-C-N 120.479 2.139 . . . . 0.0 115.553 173.868 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo . . . . . 0 CA--C 1.543 0.938 0 N-CA-C 109.459 -1.016 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 14.1 t-160 53.01 68.98 0.75 Allowed 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 125.049 2.357 . . . . 0.0 113.937 -172.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -76.24 37.27 1.33 Allowed Glycine 0 C--N 1.318 -0.418 0 CA-C-N 111.717 -2.492 . . . . 0.0 115.154 173.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 120.37 -23.03 8.18 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-N 119.988 1.894 . . . . 0.0 115.434 166.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 148.36 9.17 0.18 Allowed Glycine 0 N--CA 1.471 1.025 0 CA-C-N 119.395 1.597 . . . . 0.0 116.531 163.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -136.55 -112.34 0.19 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 118.879 1.34 . . . . 0.0 110.808 -157.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.12 -44.51 95.64 Favored Glycine 0 CA--C 1.529 0.929 0 O-C-N 121.073 -1.017 . . . . 0.0 111.453 177.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -56.52 -46.91 99.77 Favored Pre-proline 0 N--CA 1.45 -0.442 0 C-N-CA 124.166 0.986 . . . . 0.0 111.597 -170.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.05 55.35 2.33 Favored 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 122.583 2.189 . . . . 0.0 112.737 167.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 20.8 t-160 64.25 69.43 0.52 Allowed 'General case' 0 C--N 1.342 0.249 0 CA-C-O 124.434 2.064 . . . . 0.0 114.042 166.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.41 28.27 0.17 Allowed Glycine 0 CA--C 1.525 0.678 0 CA-C-N 111.457 -2.61 . . . . 0.0 116.569 170.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.028 0 CA-C-N 121.655 2.727 . . . . 0.0 116.442 165.839 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo . . . . . 0 N--CA 1.45 -1.042 0 N-CA-C 109.262 -1.092 . . . . 0.0 109.262 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.577 ' CD2' ' H ' ' A' ' 70' ' ' GLY . 13.9 t-80 57.5 169.54 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.471 1.108 . . . . 0.0 112.037 -164.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.577 ' H ' ' CD2' ' A' ' 69' ' ' HIS . . . 145.55 12.45 0.23 Allowed Glycine 0 C--N 1.338 0.646 0 CA-C-O 117.244 -1.864 . . . . 0.0 115.195 -153.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 139.59 -78.9 0.29 Allowed Glycine 0 C--N 1.335 0.519 0 CA-C-N 120.702 2.251 . . . . 0.0 109.821 178.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 176.21 19.23 0.02 OUTLIER Glycine 0 CA--C 1.526 0.781 0 CA-C-N 117.529 0.664 . . . . 0.0 114.247 -175.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -127.92 -133.2 0.23 Allowed 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 124.142 0.977 . . . . 0.0 109.17 -165.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -78.83 2.4 68.95 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-N 118.957 0.799 . . . . 0.0 114.633 -175.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -81.92 -53.83 0.68 Allowed Pre-proline 0 N--CA 1.438 -1.035 0 C-N-CA 126.923 2.089 . . . . 0.0 110.088 173.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -72.77 -171.37 0.75 Allowed 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 122.512 2.141 . . . . 0.0 110.209 160.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.553 ' CG ' ' H ' ' A' ' 78' ' ' GLY 0.284 7.7 t-160 70.9 -168.55 0.15 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.502 1.121 . . . . 0.0 110.068 -166.248 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.553 ' H ' ' CG ' ' A' ' 77' ' ' HIS . . . 163.25 -45.69 0.33 Allowed Glycine 0 CA--C 1.527 0.816 0 O-C-N 121.271 -0.893 . . . . 0.0 112.335 -167.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.195 0 CA-C-N 118.434 1.117 . . . . 0.0 114.61 -177.248 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo . . . . . 0 N--CA 1.459 -0.523 0 N-CA-C 110.423 -0.645 . . . . 0.0 110.423 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 22.3 t-160 46.12 64.39 1.5 Allowed 'General case' 0 C--N 1.344 0.341 0 CA-C-O 123.708 1.718 . . . . 0.0 113.959 177.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -63.4 24.73 0.08 OUTLIER Glycine 0 CA--C 1.527 0.821 0 C-N-CA 127.535 2.493 . . . . 0.0 116.75 173.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 124.89 -17.04 7.25 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-N 120.624 2.212 . . . . 0.0 114.72 170.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 132.57 12.97 1.71 Allowed Glycine 0 N--CA 1.473 1.153 0 CA-C-N 119.033 1.416 . . . . 0.0 116.026 163.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -125.61 -102.56 0.36 Allowed 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 118.023 0.912 . . . . 0.0 109.836 -162.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -86.5 -32.11 17.0 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-N 118.526 0.603 . . . . 0.0 113.097 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.409 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 4.1 mp0 -60.33 -43.89 94.52 Favored Pre-proline 0 C--O 1.223 -0.31 0 O-C-N 121.36 -1.082 . . . . 0.0 111.506 -177.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.409 ' CD ' ' N ' ' A' ' 75' ' ' GLN . 93.7 Cg_endo -77.87 42.3 1.16 Allowed 'Trans proline' 0 CA--C 1.548 1.217 0 C-N-CA 122.957 2.438 . . . . 0.0 111.656 169.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.472 ' CD2' ' H ' ' A' ' 78' ' ' GLY . 6.2 t-160 83.31 -179.17 0.04 OUTLIER 'General case' 0 C--N 1.346 0.414 0 C-N-CA 126.899 2.08 . . . . 0.0 112.643 173.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.472 ' H ' ' CD2' ' A' ' 77' ' ' HIS . . . 160.23 1.35 0.07 OUTLIER Glycine 0 C--N 1.336 0.53 0 CA-C-O 116.959 -2.023 . . . . 0.0 115.616 -158.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.732 0 CA-C-N 121.103 2.452 . . . . 0.0 111.948 175.341 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo . . . . . 0 N--CA 1.452 -0.965 0 N-CA-C 109.491 -1.004 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.569 ' CD2' ' H ' ' A' ' 70' ' ' GLY . 16.1 t-80 57.57 172.61 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.687 0.795 . . . . 0.0 111.509 -165.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.569 ' H ' ' CD2' ' A' ' 69' ' ' HIS . . . 151.31 14.17 0.08 OUTLIER Glycine 0 C--N 1.337 0.633 0 CA-C-O 117.567 -1.685 . . . . 0.0 115.295 -158.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 142.97 -69.59 0.42 Allowed Glycine 0 C--O 1.224 -0.47 0 CA-C-N 120.359 2.079 . . . . 0.0 110.168 177.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 167.69 18.69 0.02 OUTLIER Glycine 0 CA--C 1.529 0.913 0 N-CA-C 114.687 0.635 . . . . 0.0 114.687 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -127.52 -118.28 0.26 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.093 0.957 . . . . 0.0 110.544 -160.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -94.24 -3.52 63.32 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-N 119.428 1.013 . . . . 0.0 114.444 -178.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.89 -45.82 3.95 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 125.592 1.557 . . . . 0.0 110.567 170.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -75.77 -164.88 0.27 Allowed 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.038 1.825 . . . . 0.0 109.118 157.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.52 ' CD2' ' H ' ' A' ' 78' ' ' GLY 0.268 11.3 t-80 67.46 174.0 0.26 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.04 1.336 . . . . 0.0 110.462 -158.414 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.52 ' H ' ' CD2' ' A' ' 77' ' ' HIS . . . 141.64 9.55 0.63 Allowed Glycine 0 CA--C 1.526 0.751 0 CA-C-O 117.615 -1.659 . . . . 0.0 115.154 -156.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.424 ' H ' ' CD2' ' A' ' 77' ' ' HIS . . . . . . . . 0 C--N 1.336 0.562 0 CA-C-N 120.787 2.293 . . . . 0.0 110.405 174.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.607 ' HA ' ' HB3' ' A' ' 76' ' ' PRO . 55.7 Cg_endo . . . . . 0 CA--C 1.548 1.177 0 CA-C-O 119.004 -0.499 . . . . 0.0 112.613 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.463 ' H ' ' HB3' ' A' ' 76' ' ' PRO . 9.6 t60 -67.75 132.97 48.44 Favored 'General case' 0 N--CA 1.439 -0.997 0 O-C-N 119.833 -1.792 . . . . 0.0 107.273 173.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.35 -26.93 3.31 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 126.042 1.782 . . . . 0.0 112.646 162.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 162.79 -14.31 0.11 Allowed Glycine 0 CA--C 1.524 0.599 0 CA-C-O 119.124 -0.82 . . . . 0.0 112.754 -175.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.69 26.4 6.82 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-N 118.778 1.289 . . . . 0.0 112.854 172.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -95.95 -113.13 0.13 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.499 2.319 . . . . 0.0 110.384 -173.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.434 ' C ' ' HD2' ' A' ' 76' ' ' PRO . . . -94.71 -28.67 9.99 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-N 119.839 1.2 . . . . 0.0 113.092 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -50.5 -39.0 46.26 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 126.78 2.032 . . . . 0.0 115.612 172.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.607 ' HB3' ' HA ' ' A' ' 68' ' ' PRO . 14.6 Cg_endo -83.32 50.9 3.42 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.403 2.068 . . . . 0.0 112.715 -172.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 72.82 120.31 0.04 OUTLIER 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.755 1.222 . . . . 0.0 109.942 -162.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -136.55 33.57 2.33 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 125.316 1.436 . . . . 0.0 112.09 -167.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.292 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 -175.716 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo . . . . . 0 N--CA 1.459 -0.524 0 N-CA-C 109.939 -0.831 . . . . 0.0 109.939 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 21.8 t-160 57.43 -73.35 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 115.558 1.688 . . . . 0.0 115.558 175.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 68.87 -23.7 0.3 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 126.9 2.19 . . . . 0.0 116.243 171.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 159.08 -11.74 0.19 Allowed Glycine 0 CA--C 1.531 1.093 0 CA-C-N 119.282 1.541 . . . . 0.0 113.867 -170.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 114.93 29.91 2.47 Favored Glycine 0 N--CA 1.475 1.249 0 CA-C-N 119.931 1.865 . . . . 0.0 114.345 166.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -120.86 -113.12 0.32 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.333 1.453 . . . . 0.0 110.526 -163.162 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -101.43 -4.67 52.79 Favored Glycine 0 CA--C 1.536 1.396 0 CA-C-N 119.93 1.241 . . . . 0.0 114.028 -178.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -83.63 -31.79 0.51 Allowed Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 128.535 2.734 . . . . 0.0 112.707 177.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -82.58 -164.05 0.25 Allowed 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 121.991 1.794 . . . . 0.0 107.452 157.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.503 ' CD2' ' H ' ' A' ' 78' ' ' GLY . 11.7 t-80 58.71 -178.31 0.08 Allowed 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.31 -0.869 . . . . 0.0 110.196 -167.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.503 ' H ' ' CD2' ' A' ' 77' ' ' HIS . . . 138.79 8.76 1.04 Allowed Glycine 0 C--N 1.339 0.699 0 CA-C-O 117.258 -1.857 . . . . 0.0 115.826 -156.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.424 ' H ' ' CD2' ' A' ' 77' ' ' HIS . . . . . . . . 0 CA--C 1.522 0.477 0 CA-C-N 120.679 2.24 . . . . 0.0 110.697 171.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo . . . . . 0 N--CA 1.456 -0.703 0 N-CA-C 108.613 -1.341 . . . . 0.0 108.613 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.542 ' CG ' ' H ' ' A' ' 70' ' ' GLY . 8.8 t-160 48.13 -162.04 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.827 1.251 . . . . 0.0 112.418 -175.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.542 ' H ' ' CG ' ' A' ' 69' ' ' HIS . . . 145.29 -15.62 1.88 Allowed Glycine 0 C--O 1.221 -0.674 0 O-C-N 120.139 -1.6 . . . . 0.0 114.871 -172.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 159.41 -20.21 0.27 Allowed Glycine 0 CA--C 1.528 0.866 0 CA-C-N 119.384 1.592 . . . . 0.0 113.994 -177.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 118.65 30.57 1.64 Allowed Glycine 0 N--CA 1.473 1.165 0 CA-C-N 119.217 1.509 . . . . 0.0 113.102 170.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.402 ' CD1' ' NE2' ' A' ' 75' ' ' GLN . 0.0 OUTLIER -127.67 -141.63 0.26 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.883 1.673 . . . . 0.0 109.612 -163.765 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.03 -25.32 67.89 Favored Glycine 0 CA--C 1.534 1.231 0 O-C-N 120.091 -1.631 . . . . 0.0 113.569 -178.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.402 ' NE2' ' CD1' ' A' ' 73' ' ' TRP . 2.2 mp0 -68.32 -51.53 24.44 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 124.789 1.236 . . . . 0.0 112.108 -173.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.66 -50.97 1.05 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 121.714 1.609 . . . . 0.0 111.518 175.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 20.5 t-160 60.03 -71.24 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.052 1.741 . . . . 0.0 114.69 -178.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 64.11 -2.67 2.01 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-O 116.996 -2.002 . . . . 0.0 116.264 173.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.114 0 CA-C-N 120.48 2.14 . . . . 0.0 114.345 -177.349 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo . . . . . 0 N--CA 1.458 -0.608 0 CA-C-O 120.549 0.145 . . . . 0.0 112.02 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 17.5 t-160 50.0 69.05 0.65 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 124.293 1.996 . . . . 0.0 112.224 -176.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.32 24.23 0.12 Allowed Glycine 0 CA--C 1.526 0.725 0 CA-C-N 111.668 -2.515 . . . . 0.0 116.558 174.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 127.0 -17.34 6.32 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 121.426 2.613 . . . . 0.0 116.058 167.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 146.08 12.7 0.21 Allowed Glycine 0 N--CA 1.476 1.312 0 CA-C-N 119.853 1.826 . . . . 0.0 116.632 165.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -140.54 -117.49 0.12 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 118.583 1.191 . . . . 0.0 110.0 -155.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -81.01 -31.48 34.98 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-N 119.42 1.009 . . . . 0.0 113.23 -175.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -50.36 -48.85 79.88 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 125.652 1.581 . . . . 0.0 111.528 -176.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -71.84 54.84 2.14 Favored 'Trans proline' 0 CA--C 1.55 1.313 0 C-N-CA 122.614 2.209 . . . . 0.0 112.65 168.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.264 16.5 t-160 66.9 67.88 0.42 Allowed 'General case' 0 C--N 1.346 0.413 0 CA-C-O 124.545 2.117 . . . . 0.0 113.287 165.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.57 31.39 0.27 Allowed Glycine 0 CA--C 1.524 0.635 0 CA-C-N 111.714 -2.494 . . . . 0.0 116.264 172.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.932 0 CA-C-N 121.075 2.438 . . . . 0.0 115.628 167.102 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo . . . . . 0 N--CA 1.453 -0.867 0 N-CA-C 109.443 -1.022 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 23.0 t-160 60.06 -70.97 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.401 1.88 . . . . 0.0 113.42 -175.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 58.01 12.29 10.9 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-O 117.857 -1.524 . . . . 0.0 116.386 164.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 125.24 -9.89 7.81 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 120.03 1.915 . . . . 0.0 114.867 178.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 119.89 14.58 5.57 Favored Glycine 0 N--CA 1.471 1.032 0 CA-C-N 119.795 1.797 . . . . 0.0 115.159 161.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -121.29 -97.45 0.46 Allowed 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 124.629 1.172 . . . . 0.0 111.863 -162.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -108.16 -1.01 33.56 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.323 0.963 . . . . 0.0 114.554 -178.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.449 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 3.7 mp0 -83.47 -35.66 0.64 Allowed Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 126.286 1.834 . . . . 0.0 112.642 167.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.449 ' CD ' ' N ' ' A' ' 75' ' ' GLN . 30.2 Cg_endo -73.79 177.32 8.23 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.473 2.116 . . . . 0.0 108.871 164.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.522 ' CG ' ' H ' ' A' ' 78' ' ' GLY . 9.3 t-80 62.66 176.89 0.14 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.785 0.834 . . . . 0.0 110.71 -167.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.522 ' H ' ' CG ' ' A' ' 77' ' ' HIS . . . 144.67 4.41 0.63 Allowed Glycine 0 CA--C 1.527 0.784 0 CA-C-O 117.674 -1.626 . . . . 0.0 115.178 -157.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.426 ' H ' ' CD2' ' A' ' 77' ' ' HIS . . . . . . . . 0 C--N 1.338 0.676 0 CA-C-N 120.533 2.166 . . . . 0.0 111.195 174.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo . . . . . 0 N--CA 1.454 -0.802 0 N-CA-C 108.653 -1.326 . . . . 0.0 108.653 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . 0.275 13.0 t-160 45.81 68.05 0.65 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 124.575 2.131 . . . . 0.0 115.406 172.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.534 ' H ' ' HB3' ' A' ' 75' ' ' GLN . . . -86.77 20.05 26.08 Favored Glycine 0 CA--C 1.522 0.522 0 CA-C-N 111.582 -2.553 . . . . 0.0 115.034 175.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 137.29 -71.94 0.46 Allowed Glycine 0 C--N 1.337 0.586 0 CA-C-N 120.558 2.179 . . . . 0.0 112.454 175.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -175.62 15.57 0.04 OUTLIER Glycine 0 N--CA 1.467 0.734 0 CA-C-N 118.508 1.154 . . . . 0.0 115.122 -174.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -126.47 -141.25 0.28 Allowed 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 124.845 1.258 . . . . 0.0 108.413 -168.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.93 1.66 30.34 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-O 118.448 -1.196 . . . . 0.0 114.742 -175.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.534 ' HB3' ' H ' ' A' ' 70' ' ' GLY . 18.0 mm100 -84.53 -51.7 0.55 Allowed Pre-proline 0 N--CA 1.442 -0.834 0 C-N-CA 126.369 1.868 . . . . 0.0 110.937 -179.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -68.56 174.96 7.64 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.032 1.821 . . . . 0.0 109.978 157.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.489 ' CG ' ' H ' ' A' ' 78' ' ' GLY . 7.1 t-160 61.23 -151.98 0.38 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.408 1.083 . . . . 0.0 111.302 176.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.489 ' H ' ' CG ' ' A' ' 77' ' ' HIS . . . 132.97 -43.97 1.24 Allowed Glycine 0 C--O 1.223 -0.545 0 O-C-N 120.422 -1.424 . . . . 0.0 111.593 -173.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.692 0 CA-C-O 117.973 -1.46 . . . . 0.0 114.217 -176.65 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo . . . . . 0 N--CA 1.454 -0.826 0 N-CA-C 109.485 -1.006 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.564 ' CD2' ' H ' ' A' ' 70' ' ' GLY . 22.7 t-80 60.69 165.09 0.08 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.309 1.444 . . . . 0.0 111.695 -162.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.564 ' H ' ' CD2' ' A' ' 69' ' ' HIS . . . 155.05 16.98 0.05 OUTLIER Glycine 0 C--N 1.336 0.573 0 CA-C-O 117.62 -1.656 . . . . 0.0 114.741 -155.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 141.19 -68.56 0.47 Allowed Glycine 0 C--N 1.336 0.553 0 CA-C-N 120.187 1.993 . . . . 0.0 110.119 179.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 162.81 23.39 0.02 OUTLIER Glycine 0 CA--C 1.529 0.94 0 CA-C-O 119.528 -0.596 . . . . 0.0 114.463 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -128.63 -113.35 0.26 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.179 0.99 . . . . 0.0 110.821 -162.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -102.87 -2.34 49.18 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-N 119.443 1.019 . . . . 0.0 114.428 -178.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -70.87 -49.74 13.37 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 124.869 1.268 . . . . 0.0 109.304 165.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -71.36 176.14 8.38 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 CA-C-N 120.635 1.263 . . . . 0.0 109.545 163.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.501 ' CD2' ' H ' ' A' ' 78' ' ' GLY 0.275 6.7 t-160 65.23 169.86 0.2 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.086 1.754 . . . . 0.0 111.691 -160.182 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.501 ' H ' ' CD2' ' A' ' 77' ' ' HIS . . . 144.24 18.56 0.2 Allowed Glycine 0 C--N 1.337 0.596 0 CA-C-O 117.45 -1.75 . . . . 0.0 115.698 -147.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.505 0 CA-C-N 119.899 1.85 . . . . 0.0 111.862 171.62 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 . . . . . 0 CA--C 1.533 0.322 0 CA-C-O 122.682 1.229 . . . . 0.0 113.878 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.417 ' H ' ' HB3' ' A' ' 67' ' ' GLN . . . -66.16 38.44 0.15 Allowed Glycine 0 CA--C 1.523 0.574 0 C-N-CA 126.687 2.089 . . . . 0.0 116.93 172.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 125.67 -22.11 6.2 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-N 120.467 2.133 . . . . 0.0 114.13 167.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 135.83 8.74 1.61 Allowed Glycine 0 N--CA 1.469 0.869 0 CA-C-N 118.525 1.162 . . . . 0.0 115.527 168.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -125.18 -101.59 0.38 Allowed 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.566 1.183 . . . . 0.0 111.388 -162.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -98.16 -5.32 57.26 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 123.531 0.586 . . . . 0.0 114.371 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.423 ' N ' ' CD ' ' A' ' 68' ' ' PRO . 3.5 mp0 -81.93 -45.43 1.04 Allowed Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 118.77 1.285 . . . . 0.0 111.613 172.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.423 ' CD ' ' N ' ' A' ' 67' ' ' GLN . 9.5 Cg_endo -62.47 150.34 87.78 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 CA-C-N 120.967 1.381 . . . . 0.0 109.255 167.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 8.0 t-160 38.76 41.7 0.54 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.699 2.0 . . . . 0.0 115.276 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.546 ' H ' ' HB3' ' A' ' 75' ' ' GLN . . . -67.25 42.17 0.22 Allowed Glycine 0 CA--C 1.521 0.425 0 C-N-CA 126.997 2.237 . . . . 0.0 116.775 176.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 124.04 -20.76 7.09 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-N 119.514 1.657 . . . . 0.0 113.765 165.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 142.93 0.95 1.19 Allowed Glycine 0 N--CA 1.471 0.974 0 CA-C-N 118.708 1.254 . . . . 0.0 115.418 166.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -127.08 -111.98 0.28 Allowed 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.611 1.206 . . . . 0.0 111.069 -159.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -81.61 2.41 82.78 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 124.406 1.003 . . . . 0.0 114.419 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.546 ' HB3' ' H ' ' A' ' 70' ' ' GLY . 3.1 mp0 -99.63 -39.7 0.23 Allowed Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 126.299 1.839 . . . . 0.0 111.454 178.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.511 ' HD2' ' H ' ' A' ' 75' ' ' GLN . 34.5 Cg_endo -67.01 -94.32 0.0 OUTLIER 'Trans proline' 0 CA--C 1.541 0.871 0 N-CA-C 108.254 -1.479 . . . . 0.0 108.254 154.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 18.0 t-160 -31.99 112.03 0.1 Allowed 'General case' 0 C--N 1.341 0.208 0 C-N-CA 128.017 2.527 . . . . 0.0 114.86 -175.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -135.46 36.0 2.1 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-O 117.187 -1.896 . . . . 0.0 112.232 -175.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 137.19 -48.26 0.91 Allowed Glycine 0 CA--C 1.526 0.74 0 CA-C-N 119.875 1.837 . . . . 0.0 112.294 177.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 149.47 12.45 0.11 Allowed Glycine 0 CA--C 1.531 1.047 0 CA-C-N 117.474 0.637 . . . . 0.0 114.642 175.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -111.91 -114.59 0.32 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 118.448 1.124 . . . . 0.0 110.648 -163.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -95.65 -12.83 52.73 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-N 119.65 1.114 . . . . 0.0 113.527 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -58.16 -56.33 36.14 Favored Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 125.132 1.373 . . . . 0.0 112.696 168.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo . . . . . 0 C--N 1.35 0.647 0 C-N-CA 122.537 2.158 . . . . 0.0 111.111 176.41 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.436 ' CD2' ' HB3' ' A' ' 67' ' ' GLN . 0.6 OUTLIER . . . . . 0 N--CA 1.448 -0.567 0 CA-C-O 122.357 1.075 . . . . 0.0 110.949 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.52 -20.81 1.61 Allowed Glycine 0 C--O 1.222 -0.61 0 CA-C-O 116.779 -2.123 . . . . 0.0 113.67 167.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 140.21 -23.85 2.7 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 120.069 1.934 . . . . 0.0 115.201 169.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 136.59 19.6 0.65 Allowed Glycine 0 CA--C 1.532 1.122 0 CA-C-N 119.39 1.595 . . . . 0.0 116.321 178.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -126.36 -116.9 0.27 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 119.781 1.79 . . . . 0.0 111.337 -161.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -87.2 -19.43 55.38 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-N 119.115 0.87 . . . . 0.0 113.19 178.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.436 ' HB3' ' CD2' ' A' ' 61' ' ' HIS . 2.9 mp0 -61.04 -57.46 26.14 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 126.985 2.114 . . . . 0.0 111.649 172.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -75.97 -153.47 0.04 OUTLIER 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 123.476 2.784 . . . . 0.0 109.265 171.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 73.85 -61.26 0.5 Allowed 'General case' 0 C--O 1.234 0.263 0 O-C-N 120.677 -1.264 . . . . 0.0 110.912 -173.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 74.98 -26.19 1.18 Allowed Glycine 0 CA--C 1.525 0.71 0 CA-C-O 118.054 -1.414 . . . . 0.0 115.305 165.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 168.62 -41.37 0.22 Allowed Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.424 1.488 . . . . 0.0 110.928 -175.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 137.52 47.53 0.07 OUTLIER Glycine 0 N--CA 1.474 1.194 0 CA-C-N 119.047 1.424 . . . . 0.0 114.189 176.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -140.39 -118.52 0.12 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.983 0.913 . . . . 0.0 110.806 -164.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -107.08 4.63 35.81 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 125.164 1.364 . . . . 0.0 113.666 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -86.61 -21.55 0.27 Allowed Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 126.764 2.026 . . . . 0.0 112.949 172.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -79.21 -177.96 4.28 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 CA-C-N 123.1 2.143 . . . . 0.0 108.658 148.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.53 ' CD2' ' H ' ' A' ' 78' ' ' GLY . 8.0 t-160 65.03 179.23 0.19 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.519 0.728 . . . . 0.0 111.342 -176.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.53 ' H ' ' CD2' ' A' ' 77' ' ' HIS . . . 147.72 12.26 0.16 Allowed Glycine 0 C--N 1.336 0.559 0 CA-C-O 117.058 -1.968 . . . . 0.0 115.939 -157.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 141.96 -67.93 0.46 Allowed Glycine 0 C--N 1.336 0.534 0 CA-C-N 121.081 2.441 . . . . 0.0 110.852 176.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 162.85 22.52 0.02 OUTLIER Glycine 0 CA--C 1.527 0.838 0 CA-C-O 119.252 -0.749 . . . . 0.0 114.259 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -131.57 -130.7 0.19 Allowed 'General case' 0 C--O 1.222 -0.384 0 C-N-CA 124.896 1.278 . . . . 0.0 108.405 -165.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -78.22 -13.97 82.73 Favored Glycine 0 CA--C 1.536 1.38 0 CA-C-N 119.973 1.26 . . . . 0.0 114.344 -174.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -64.0 -52.27 57.48 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 125.288 1.435 . . . . 0.0 113.277 175.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo . . . . . 0 N--CA 1.454 -0.826 0 C-N-CA 122.663 2.242 . . . . 0.0 110.459 167.487 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.53 ' CD2' ' H ' ' A' ' 62' ' ' GLY . 7.4 t-160 . . . . . 0 CA--C 1.546 0.814 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.53 ' H ' ' CD2' ' A' ' 61' ' ' HIS . . . 159.9 -29.65 0.38 Allowed Glycine 0 C--N 1.336 0.548 0 O-C-N 120.576 -1.328 . . . . 0.0 113.266 -166.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 172.77 -29.14 0.1 Allowed Glycine 0 C--N 1.336 0.565 0 CA-C-O 118.337 -1.257 . . . . 0.0 114.353 169.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 145.05 22.65 0.13 Allowed Glycine 0 N--CA 1.471 0.982 0 CA-C-N 119.116 1.458 . . . . 0.0 114.878 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -125.49 -134.28 0.26 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.423 1.489 . . . . 0.0 107.789 -173.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.42 -7.83 85.4 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 115.652 1.021 . . . . 0.0 115.652 -170.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -81.04 -51.5 0.91 Allowed Pre-proline 0 N--CA 1.442 -0.826 0 C-N-CA 125.548 1.539 . . . . 0.0 112.229 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -68.89 -178.27 1.94 Allowed 'Trans proline' 0 N--CA 1.452 -0.918 0 CA-C-N 120.561 1.236 . . . . 0.0 110.289 165.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . 0.277 5.2 t-160 56.79 -82.48 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.464 1.506 . . . . 0.0 114.329 -169.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 71.69 -63.47 1.18 Allowed Glycine 0 CA--C 1.53 0.977 0 CA-C-N 120.414 1.461 . . . . 0.0 113.425 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -161.74 -2.98 0.05 OUTLIER Glycine 0 CA--C 1.531 1.075 0 C-N-CA 125.626 1.584 . . . . 0.0 114.074 -170.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 116.82 20.21 5.02 Favored Glycine 0 N--CA 1.475 1.295 0 CA-C-N 120.387 2.093 . . . . 0.0 114.482 164.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -114.67 -120.29 0.3 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.274 1.429 . . . . 0.0 110.265 -162.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -90.16 -10.16 64.6 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-N 119.573 1.078 . . . . 0.0 114.248 -177.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -74.44 -39.88 4.07 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 126.155 1.782 . . . . 0.0 113.905 174.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.98 -171.57 0.91 Allowed 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 123.074 2.516 . . . . 0.0 109.961 169.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 60.5 -70.04 0.04 OUTLIER 'General case' 0 C--O 1.232 0.153 0 C-N-CA 126.708 2.003 . . . . 0.0 114.353 -172.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 67.31 -22.1 0.22 Allowed Glycine 0 CA--C 1.533 1.213 0 CA-C-O 117.697 -1.613 . . . . 0.0 116.742 172.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 155.22 -14.29 0.47 Allowed Glycine 0 CA--C 1.532 1.142 0 CA-C-N 120.049 1.925 . . . . 0.0 114.251 -169.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 115.96 42.07 0.74 Allowed Glycine 0 N--CA 1.473 1.104 0 CA-C-N 119.826 1.813 . . . . 0.0 114.271 167.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -128.96 -117.0 0.25 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.375 1.47 . . . . 0.0 110.096 -168.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -100.95 -9.81 44.56 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-N 119.646 1.112 . . . . 0.0 113.901 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -67.56 -32.76 4.7 Favored Pre-proline 0 CA--C 1.549 0.932 0 CA-C-O 117.364 -1.303 . . . . 0.0 112.696 172.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo . . . . . 0 C--N 1.354 0.852 0 C-N-CA 123.5 2.8 . . . . 0.0 110.333 174.795 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.517 -0.288 0 CA-C-O 120.967 0.413 . . . . 0.0 110.662 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.77 -36.44 1.03 Allowed Glycine 0 CA--C 1.523 0.548 0 C-N-CA 125.893 1.711 . . . . 0.0 113.838 170.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 145.44 -14.32 1.83 Allowed Glycine 0 CA--C 1.528 0.873 0 CA-C-O 117.788 -1.562 . . . . 0.0 115.81 178.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 125.5 23.23 1.74 Allowed Glycine 0 CA--C 1.531 1.086 0 CA-C-N 120.055 1.927 . . . . 0.0 115.568 174.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -131.66 -123.57 0.2 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.449 1.624 . . . . 0.0 111.128 -164.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.87 -34.97 58.63 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-N 119.812 1.187 . . . . 0.0 113.549 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -42.88 -67.41 0.34 Allowed Pre-proline 0 N--CA 1.464 0.24 0 C-N-CA 127.523 2.329 . . . . 0.0 112.229 168.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.73 91.75 0.61 Allowed 'Trans proline' 0 N--CA 1.44 -1.636 0 C-N-CA 122.351 2.034 . . . . 0.0 110.426 -169.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 21.3 t-160 72.01 -62.39 0.46 Allowed 'General case' 0 C--O 1.236 0.386 0 C-N-CA 127.11 2.164 . . . . 0.0 111.836 -177.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 75.72 -40.89 1.4 Allowed Glycine 0 CA--C 1.529 0.911 0 C-N-CA 124.323 0.963 . . . . 0.0 114.591 174.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 166.6 -9.41 0.06 OUTLIER Glycine 0 CA--C 1.53 1.027 0 CA-C-O 117.844 -1.531 . . . . 0.0 113.953 -169.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 111.85 42.19 1.04 Allowed Glycine 0 N--CA 1.475 1.254 0 CA-C-N 120.047 1.924 . . . . 0.0 113.522 164.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -138.15 -131.97 0.13 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.938 0.895 . . . . 0.0 109.845 -157.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -94.71 -0.45 64.39 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.179 0.895 . . . . 0.0 113.928 -178.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -71.09 -46.36 14.54 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-O 116.937 -1.506 . . . . 0.0 111.334 174.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -77.31 -126.42 0.01 OUTLIER 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 123.894 3.063 . . . . 0.0 109.808 174.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.531 ' CD2' ' H ' ' A' ' 78' ' ' GLY . 9.4 t-80 56.81 -179.69 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.78 0 O-C-N 120.855 -1.153 . . . . 0.0 111.729 -168.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.531 ' H ' ' CD2' ' A' ' 77' ' ' HIS . . . 153.33 9.58 0.08 OUTLIER Glycine 0 CA--C 1.523 0.567 0 CA-C-O 117.509 -1.717 . . . . 0.0 115.298 -161.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 144.92 -56.12 0.54 Allowed Glycine 0 C--N 1.336 0.551 0 CA-C-N 120.109 1.954 . . . . 0.0 110.743 175.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.8 19.35 0.05 OUTLIER Glycine 0 CA--C 1.53 1.012 0 N-CA-C 114.963 0.745 . . . . 0.0 114.963 175.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -129.04 -107.3 0.29 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.231 1.015 . . . . 0.0 110.998 -158.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -88.96 -21.6 41.83 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-N 119.627 1.103 . . . . 0.0 113.745 -177.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.422 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 3.3 mp0 -68.78 -44.58 31.56 Favored Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 126.093 1.757 . . . . 0.0 113.242 -179.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' ' 83' ' ' GLN . 56.9 Cg_endo . . . . . 0 N--CA 1.45 -1.042 0 C-N-CA 123.411 2.741 . . . . 0.0 108.606 171.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.555 ' CG ' ' H ' ' A' ' 62' ' ' GLY . 9.9 t-80 . . . . . 0 CA--C 1.541 0.631 0 CA-C-O 120.253 0.073 . . . . 0.0 111.019 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.555 ' H ' ' CG ' ' A' ' 61' ' ' HIS . . . 155.36 -8.76 0.32 Allowed Glycine 0 CA--C 1.524 0.649 0 CA-C-O 117.779 -1.567 . . . . 0.0 114.955 -170.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 157.05 -23.44 0.46 Allowed Glycine 0 CA--C 1.528 0.895 0 CA-C-N 120.148 1.974 . . . . 0.0 113.51 178.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 123.69 22.28 2.27 Favored Glycine 0 N--CA 1.471 1.032 0 CA-C-N 118.383 1.091 . . . . 0.0 113.282 169.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -118.27 -131.04 0.3 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.911 1.684 . . . . 0.0 109.847 -162.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -87.3 -8.89 73.94 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-N 119.915 1.234 . . . . 0.0 114.319 -177.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -65.06 -59.84 9.23 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 124.525 1.13 . . . . 0.0 108.695 173.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -67.05 161.11 44.17 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 121.556 1.504 . . . . 0.0 110.886 175.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . 0.265 3.2 t-160 60.17 -69.91 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.431 1.092 . . . . 0.0 111.875 -166.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 59.07 15.35 28.77 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-O 117.593 -1.671 . . . . 0.0 116.104 159.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 124.96 -14.95 7.45 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-N 119.873 1.836 . . . . 0.0 114.798 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 121.49 10.54 6.52 Favored Glycine 0 N--CA 1.473 1.145 0 CA-C-N 119.848 1.824 . . . . 0.0 115.393 164.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -118.64 -99.93 0.44 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.501 1.15 . . . . 0.0 112.107 -159.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -102.75 -0.47 49.17 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.436 1.017 . . . . 0.0 114.019 -178.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.465 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 2.0 mp0 -87.17 -38.41 0.5 Allowed Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 127.31 2.244 . . . . 0.0 111.911 173.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' A' ' 75' ' ' GLN . 36.7 Cg_endo -74.71 -170.38 0.75 Allowed 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.978 2.452 . . . . 0.0 108.576 161.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 19.1 t-160 67.68 -72.36 0.09 Allowed 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 126.38 1.872 . . . . 0.0 111.931 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 58.94 17.89 37.97 Favored Glycine 0 CA--C 1.527 0.817 0 CA-C-O 116.996 -2.002 . . . . 0.0 116.215 161.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 128.06 -16.66 6.06 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-N 120.016 1.908 . . . . 0.0 114.262 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 118.28 13.33 7.01 Favored Glycine 0 N--CA 1.47 0.926 0 CA-C-N 119.242 1.521 . . . . 0.0 114.734 165.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -119.26 -105.98 0.38 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.162 0.981 . . . . 0.0 111.494 -160.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -101.9 4.65 53.03 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 124.655 1.122 . . . . 0.0 113.566 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.461 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 4.4 mm100 -85.33 -34.49 0.51 Allowed Pre-proline 0 CA--C 1.554 1.111 0 C-N-CA 126.053 1.741 . . . . 0.0 115.232 169.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' A' ' 83' ' ' GLN . 10.1 Cg_endo . . . . . 0 N--CA 1.455 -0.792 1 C-N-CA 125.353 4.035 . . . . 0.0 109.389 166.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.604 ' CD2' ' HB3' ' A' ' 67' ' ' GLN . 1.4 t60 . . . . . 0 C--O 1.225 -0.211 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -123.65 -5.47 7.68 Favored Glycine 0 C--O 1.222 -0.597 0 C-N-CA 124.192 0.901 . . . . 0.0 110.882 -173.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 152.19 -11.37 0.67 Allowed Glycine 0 CA--C 1.525 0.657 0 CA-C-O 118.308 -1.274 . . . . 0.0 113.751 -172.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 113.53 32.03 2.22 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-N 119.223 1.511 . . . . 0.0 114.761 170.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -117.35 -121.67 0.3 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 118.461 1.131 . . . . 0.0 110.854 -166.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -83.11 -17.9 66.14 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-N 119.486 1.039 . . . . 0.0 112.777 176.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.604 ' HB3' ' CD2' ' A' ' 61' ' ' HIS . 1.2 mp0 -62.43 -56.69 28.03 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 125.545 1.538 . . . . 0.0 112.949 177.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -65.33 137.31 50.83 Favored 'Trans proline' 0 N--CA 1.448 -1.171 0 N-CA-C 108.992 -1.196 . . . . 0.0 108.992 173.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 19.1 t-160 47.62 62.54 2.39 Favored 'General case' 0 C--O 1.227 -0.127 0 CA-C-O 124.518 2.104 . . . . 0.0 113.343 -176.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.9 36.76 0.29 Allowed Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 111.414 -2.63 . . . . 0.0 115.716 172.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 123.16 -23.51 6.86 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-N 120.665 2.232 . . . . 0.0 115.093 166.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 140.39 8.87 0.81 Allowed Glycine 0 N--CA 1.469 0.871 0 CA-C-N 118.761 1.281 . . . . 0.0 115.561 166.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -133.3 -110.48 0.23 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.604 1.202 . . . . 0.0 110.74 -158.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -78.36 -26.19 59.91 Favored Glycine 0 CA--C 1.525 0.703 0 O-C-N 120.944 -1.097 . . . . 0.0 112.214 -176.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -64.3 -52.81 51.44 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 118.379 1.09 . . . . 0.0 109.978 -177.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.66 78.96 0.94 Allowed 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 122.135 1.89 . . . . 0.0 110.943 170.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.252 23.6 t-160 63.99 67.0 0.62 Allowed 'General case' 0 C--O 1.226 -0.18 0 CA-C-O 124.653 2.168 . . . . 0.0 113.503 168.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.18 27.35 0.32 Allowed Glycine 0 CA--C 1.526 0.748 0 CA-C-N 111.457 -2.61 . . . . 0.0 115.898 172.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 123.1 -8.01 9.17 Favored Glycine 0 CA--C 1.534 1.219 0 CA-C-N 121.021 2.411 . . . . 0.0 116.317 167.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 134.58 7.72 2.09 Favored Glycine 0 N--CA 1.469 0.874 0 CA-C-N 119.503 1.652 . . . . 0.0 115.128 163.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -133.66 -138.31 0.18 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.5 1.15 . . . . 0.0 110.458 -157.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -65.5 -6.9 30.87 Favored Glycine 0 CA--C 1.532 1.113 0 O-C-N 121.384 -0.822 . . . . 0.0 114.646 -175.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.443 ' CB ' ' CD ' ' A' ' 84' ' ' PRO . 21.6 mm100 -69.73 -67.9 0.63 Allowed Pre-proline 0 N--CA 1.443 -0.809 0 C-N-CA 124.814 1.245 . . . . 0.0 108.308 172.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.443 ' CD ' ' CB ' ' A' ' 83' ' ' GLN . 33.4 Cg_endo . . . . . 0 N--CA 1.454 -0.834 0 C-N-CA 123.259 2.639 . . . . 0.0 112.469 176.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.447 -0.608 0 CA-C-O 121.955 0.883 . . . . 0.0 109.816 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.21 1.7 21.87 Favored Glycine 0 C--O 1.224 -0.497 0 CA-C-O 117.506 -1.719 . . . . 0.0 115.623 158.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 131.24 -16.81 5.17 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-N 119.177 1.488 . . . . 0.0 114.625 170.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 118.54 11.08 8.16 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-N 119.319 1.56 . . . . 0.0 114.814 168.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . 0.526 ' HD1' ' H ' ' A' ' 67' ' ' GLN . 0.1 OUTLIER -121.37 -108.28 0.35 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 118.647 1.224 . . . . 0.0 111.757 -159.724 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -104.04 6.07 46.83 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 125.219 1.39 . . . . 0.0 114.649 176.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.526 ' H ' ' HD1' ' A' ' 65' ' ' TRP . 0.3 OUTLIER -69.6 -60.87 3.51 Favored Pre-proline 0 N--CA 1.448 -0.535 0 C-N-CA 127.638 2.375 . . . . 0.0 109.516 156.856 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -73.15 -172.44 1.01 Allowed 'Trans proline' 0 N--CA 1.447 -1.206 0 C-N-CA 122.787 2.325 . . . . 0.0 109.381 169.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.502 ' CD2' ' H ' ' A' ' 70' ' ' GLY 0.272 6.5 t-160 88.08 175.96 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 128.52 2.728 . . . . 0.0 109.921 -157.352 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.502 ' H ' ' CD2' ' A' ' 69' ' ' HIS . . . 158.46 -2.4 0.11 Allowed Glycine 0 CA--C 1.524 0.61 0 CA-C-O 117.474 -1.737 . . . . 0.0 115.431 -157.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 146.27 -57.31 0.51 Allowed Glycine 0 C--N 1.338 0.642 0 CA-C-N 120.714 2.257 . . . . 0.0 111.704 178.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 151.35 51.49 0.01 OUTLIER Glycine 0 C--N 1.34 0.802 0 CA-C-N 117.941 0.871 . . . . 0.0 112.966 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.405 ' CD1' ' OE1' ' A' ' 75' ' ' GLN . 0.0 OUTLIER -149.89 -114.6 0.06 Allowed 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.827 -0.808 . . . . 0.0 110.21 -168.471 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -99.94 -21.6 13.63 Favored Glycine 0 N--CA 1.473 1.162 0 CA-C-N 119.578 1.081 . . . . 0.0 113.394 -175.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.426 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 4.1 mp0 -59.75 -33.74 17.77 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 128.194 2.598 . . . . 0.0 113.211 176.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.437 ' HA ' ' H ' ' A' ' 69' ' ' HIS . 32.1 Cg_endo -80.28 -71.04 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 123.654 2.903 . . . . 0.0 111.575 173.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 50.0 -74.24 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 117.662 2.467 . . . . 0.0 117.662 176.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 71.1 -79.15 0.51 Allowed Glycine 0 CA--C 1.525 0.681 0 O-C-N 120.986 -1.071 . . . . 0.0 110.615 -169.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -153.86 3.89 0.29 Allowed Glycine 0 CA--C 1.528 0.882 0 CA-C-O 117.8 -1.555 . . . . 0.0 114.172 -167.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.81 27.86 4.16 Favored Glycine 0 N--CA 1.476 1.364 0 CA-C-N 120.172 1.986 . . . . 0.0 113.305 160.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -121.8 -122.8 0.28 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.468 1.507 . . . . 0.0 108.666 -162.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -91.51 -5.38 67.08 Favored Glycine 0 CA--C 1.531 1.037 0 CA-C-N 119.212 0.915 . . . . 0.0 114.574 -177.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -78.92 -43.7 1.79 Allowed Pre-proline 0 N--CA 1.447 -0.595 0 C-N-CA 125.223 1.409 . . . . 0.0 114.091 174.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo . . . . . 0 N--CA 1.454 -0.833 0 CA-C-N 121.617 1.613 . . . . 0.0 109.523 175.076 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.449 -0.506 0 CA-C-O 122.146 0.974 . . . . 0.0 110.309 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.77 -5.35 7.76 Favored Glycine 0 C--O 1.224 -0.485 0 CA-C-O 117.675 -1.625 . . . . 0.0 114.435 160.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 137.22 -30.03 2.66 Favored Glycine 0 CA--C 1.527 0.796 0 CA-C-O 117.851 -1.527 . . . . 0.0 114.365 168.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 128.41 27.11 0.92 Allowed Glycine 0 CA--C 1.529 0.961 0 CA-C-N 119.567 1.684 . . . . 0.0 115.253 177.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -133.14 -109.09 0.24 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.308 1.554 . . . . 0.0 111.618 -166.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -98.61 -12.07 45.47 Favored Glycine 0 CA--C 1.534 1.222 0 CA-C-N 119.388 0.994 . . . . 0.0 114.235 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -62.53 -54.24 50.11 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 126.559 1.944 . . . . 0.0 112.14 164.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -75.02 -171.63 1.04 Allowed 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 122.258 1.972 . . . . 0.0 108.854 166.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.519 ' CD2' ' H ' ' A' ' 70' ' ' GLY 0.27 7.6 t-160 65.74 174.13 0.22 Allowed 'General case' 0 CA--C 1.536 0.429 0 O-C-N 120.975 -1.078 . . . . 0.0 110.852 -152.032 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.519 ' H ' ' CD2' ' A' ' 69' ' ' HIS . . . 149.27 10.05 0.14 Allowed Glycine 0 C--N 1.337 0.62 0 CA-C-O 117.136 -1.924 . . . . 0.0 116.417 -149.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 139.2 -67.73 0.51 Allowed Glycine 0 CA--C 1.522 0.502 0 CA-C-N 120.739 2.269 . . . . 0.0 111.007 177.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 155.59 44.83 0.02 OUTLIER Glycine 0 C--N 1.335 0.521 0 CA-C-O 119.308 -0.718 . . . . 0.0 112.652 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.03 -120.33 0.05 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 117.998 0.899 . . . . 0.0 110.99 -170.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -70.63 -36.93 67.83 Favored Glycine 0 CA--C 1.526 0.767 0 O-C-N 120.289 -1.507 . . . . 0.0 111.941 -178.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -59.08 -42.45 93.71 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 125.409 1.484 . . . . 0.0 113.088 -174.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.462 ' HA ' ' H ' ' A' ' 69' ' ' HIS . 44.8 Cg_endo -82.69 -20.47 5.56 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.299 2.0 . . . . 0.0 116.446 178.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 22.0 t-80 -16.72 117.71 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 128.552 2.741 . . . . 0.0 115.737 175.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -143.56 28.89 2.03 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-O 117.202 -1.888 . . . . 0.0 113.741 -174.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 142.07 -71.49 0.41 Allowed Glycine 0 C--N 1.336 0.534 0 CA-C-N 120.253 2.027 . . . . 0.0 110.012 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 173.69 16.93 0.02 OUTLIER Glycine 0 CA--C 1.526 0.739 0 CA-C-O 119.46 -0.633 . . . . 0.0 114.222 178.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 0.408 ' HB2' ' H ' ' A' ' 82' ' ' GLY . 0.1 OUTLIER -127.71 -141.03 0.26 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.488 1.144 . . . . 0.0 110.101 -159.308 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.408 ' H ' ' HB2' ' A' ' 81' ' ' TRP . . . -69.14 11.26 1.46 Allowed Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.41 1.481 . . . . 0.0 114.642 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.407 ' CB ' ' CD ' ' A' ' 84' ' ' PRO . 10.1 mm100 -84.99 -68.42 0.16 Allowed Pre-proline 0 N--CA 1.443 -0.787 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 163.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.407 ' CD ' ' CB ' ' A' ' 83' ' ' GLN . 24.5 Cg_endo . . . . . 0 N--CA 1.451 -0.977 0 C-N-CA 122.671 2.247 . . . . 0.0 112.409 -174.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.452 ' CD2' ' HB3' ' A' ' 67' ' ' GLN . 0.6 OUTLIER . . . . . 0 N--CA 1.454 -0.257 0 CA-C-O 120.511 0.196 . . . . 0.0 110.996 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.61 -4.48 9.28 Favored Glycine 0 CA--C 1.522 0.489 0 CA-C-O 117.932 -1.482 . . . . 0.0 114.949 154.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 127.41 -19.96 5.9 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-O 117.361 -1.799 . . . . 0.0 115.659 165.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 127.77 22.96 1.38 Allowed Glycine 0 N--CA 1.475 1.242 0 CA-C-N 120.242 2.021 . . . . 0.0 116.479 170.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -137.12 -112.58 0.18 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.517 1.659 . . . . 0.0 111.085 -165.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -81.14 -33.61 28.7 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-N 119.167 0.894 . . . . 0.0 112.85 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.452 ' HB3' ' CD2' ' A' ' 61' ' ' HIS . 3.4 mp0 -48.25 -63.32 1.59 Allowed Pre-proline 0 N--CA 1.454 -0.271 0 C-N-CA 126.952 2.101 . . . . 0.0 112.233 171.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -64.46 139.39 64.48 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 120.963 1.109 . . . . 0.0 111.203 -174.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 17.2 t-160 72.25 -53.92 0.69 Allowed 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.409 1.083 . . . . 0.0 112.362 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 72.7 -25.67 0.76 Allowed Glycine 0 CA--C 1.533 1.217 0 C-N-CA 125.356 1.455 . . . . 0.0 115.034 161.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 152.59 -6.92 0.49 Allowed Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.32 1.438 . . . . 0.0 113.393 -169.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.23 40.44 4.54 Favored Glycine 0 N--CA 1.472 1.084 0 CA-C-N 119.79 1.795 . . . . 0.0 113.222 166.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -140.02 -110.16 0.15 Allowed 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.256 1.023 . . . . 0.0 110.615 -160.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -111.79 -0.62 27.35 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 124.494 1.045 . . . . 0.0 112.945 -172.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.0 -65.38 2.21 Favored Pre-proline 0 N--CA 1.436 -1.172 0 C-N-CA 125.767 1.627 . . . . 0.0 108.256 161.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -78.3 69.69 7.5 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 123.84 3.027 . . . . 0.0 111.516 -160.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.278 28.2 t-80 71.37 102.26 0.06 Allowed 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 125.426 1.491 . . . . 0.0 110.83 -160.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.555 ' H ' ' HD3' ' A' ' 84' ' ' PRO . . . -110.04 18.17 28.89 Favored Glycine 0 C--O 1.223 -0.572 0 CA-C-O 116.787 -2.119 . . . . 0.0 113.977 -178.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 134.71 -12.1 4.55 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-N 120.479 2.139 . . . . 0.0 115.553 173.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 125.44 25.27 1.47 Allowed Glycine 0 N--CA 1.469 0.897 0 CA-C-N 119.435 1.618 . . . . 0.0 114.31 167.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -141.7 -155.75 0.62 Allowed 'General case' 0 C--O 1.219 -0.524 0 C-N-CA 125.972 1.709 . . . . 0.0 107.824 -167.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -71.98 16.71 1.47 Allowed Glycine 0 CA--C 1.538 1.473 0 CA-C-O 118.191 -1.338 . . . . 0.0 116.313 -171.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 20.3 mm100 -75.81 -64.24 0.57 Allowed Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 119.31 1.555 . . . . 0.0 107.753 168.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.555 ' HD3' ' H ' ' A' ' 78' ' ' GLY . 44.5 Cg_endo . . . . . 0 N--CA 1.454 -0.842 0 C-N-CA 123.44 2.76 . . . . 0.0 108.687 161.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.606 ' CD2' ' H ' ' A' ' 62' ' ' GLY . 45.9 t-80 . . . . . 0 CA--C 1.545 0.786 0 CA-C-O 122.672 1.225 . . . . 0.0 113.632 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.606 ' H ' ' CD2' ' A' ' 61' ' ' HIS . . . 165.64 19.12 0.02 OUTLIER Glycine 0 CA--C 1.524 0.615 0 CA-C-O 117.681 -1.622 . . . . 0.0 114.128 -158.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 138.68 -70.41 0.47 Allowed Glycine 0 C--N 1.338 0.652 0 CA-C-N 120.218 2.009 . . . . 0.0 109.88 -177.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 168.74 17.67 0.02 OUTLIER Glycine 0 CA--C 1.528 0.873 0 N-CA-C 115.79 1.076 . . . . 0.0 115.79 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -128.66 -104.41 0.31 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 118.517 1.159 . . . . 0.0 111.322 -155.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -98.43 -6.71 56.44 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-N 119.358 0.981 . . . . 0.0 114.377 -177.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -76.37 -50.88 2.7 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 126.679 1.992 . . . . 0.0 110.608 173.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -76.16 -168.97 0.61 Allowed 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.494 2.13 . . . . 0.0 109.459 172.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 14.1 t-160 53.01 68.98 0.75 Allowed 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 125.049 2.357 . . . . 0.0 113.937 -172.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -76.24 37.27 1.33 Allowed Glycine 0 C--N 1.318 -0.418 0 CA-C-N 111.717 -2.492 . . . . 0.0 115.154 173.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 120.37 -23.03 8.18 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-N 119.988 1.894 . . . . 0.0 115.434 166.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 148.36 9.17 0.18 Allowed Glycine 0 N--CA 1.471 1.025 0 CA-C-N 119.395 1.597 . . . . 0.0 116.531 163.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -136.55 -112.34 0.19 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 118.879 1.34 . . . . 0.0 110.808 -157.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.12 -44.51 95.64 Favored Glycine 0 CA--C 1.529 0.929 0 O-C-N 121.073 -1.017 . . . . 0.0 111.453 177.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -56.52 -46.91 99.77 Favored Pre-proline 0 N--CA 1.45 -0.442 0 C-N-CA 124.166 0.986 . . . . 0.0 111.597 -170.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.05 55.35 2.33 Favored 'Trans proline' 0 CA--C 1.547 1.137 0 C-N-CA 122.583 2.189 . . . . 0.0 112.737 167.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 20.8 t-160 64.25 69.43 0.52 Allowed 'General case' 0 C--N 1.342 0.249 0 CA-C-O 124.434 2.064 . . . . 0.0 114.042 166.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.41 28.27 0.17 Allowed Glycine 0 CA--C 1.525 0.678 0 CA-C-N 111.457 -2.61 . . . . 0.0 116.569 170.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 124.38 -20.75 6.94 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-N 121.655 2.727 . . . . 0.0 116.442 165.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 145.02 10.14 0.3 Allowed Glycine 0 N--CA 1.471 1.024 0 CA-C-N 119.739 1.769 . . . . 0.0 115.965 166.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -130.67 -116.84 0.23 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.938 1.369 . . . . 0.0 110.876 -159.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -94.5 -7.15 60.64 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-N 119.451 1.023 . . . . 0.0 114.346 -177.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -65.17 -58.9 11.07 Favored Pre-proline 0 N--CA 1.448 -0.565 0 C-N-CA 125.542 1.537 . . . . 0.0 110.138 168.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 N--CA 1.454 -0.834 0 N-CA-C 108.508 -1.381 . . . . 0.0 108.508 166.026 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 . . . . . 0 CA--C 1.535 0.392 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 63.94 -17.69 0.1 Allowed Glycine 0 CA--C 1.534 1.248 0 C-N-CA 126.436 1.97 . . . . 0.0 117.219 175.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 154.19 -13.52 0.54 Allowed Glycine 0 CA--C 1.531 1.079 0 CA-C-N 120.33 2.065 . . . . 0.0 114.113 -169.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 116.37 29.15 2.38 Favored Glycine 0 N--CA 1.474 1.206 0 CA-C-N 119.716 1.758 . . . . 0.0 114.045 164.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -118.9 -110.93 0.34 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.02 1.328 . . . . 0.0 110.452 -161.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -109.71 -0.2 30.58 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-N 119.5 1.045 . . . . 0.0 113.744 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -77.59 -32.66 0.95 Allowed Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 125.661 1.584 . . . . 0.0 111.526 169.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -85.54 173.06 7.7 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 121.945 1.763 . . . . 0.0 109.262 160.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.577 ' CD2' ' H ' ' A' ' 70' ' ' GLY . 13.9 t-80 57.5 169.54 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.471 1.108 . . . . 0.0 112.037 -164.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.577 ' H ' ' CD2' ' A' ' 69' ' ' HIS . . . 145.55 12.45 0.23 Allowed Glycine 0 C--N 1.338 0.646 0 CA-C-O 117.244 -1.864 . . . . 0.0 115.195 -153.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 139.59 -78.9 0.29 Allowed Glycine 0 C--N 1.335 0.519 0 CA-C-N 120.702 2.251 . . . . 0.0 109.821 178.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 176.21 19.23 0.02 OUTLIER Glycine 0 CA--C 1.526 0.781 0 CA-C-N 117.529 0.664 . . . . 0.0 114.247 -175.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -127.92 -133.2 0.23 Allowed 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 124.142 0.977 . . . . 0.0 109.17 -165.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -78.83 2.4 68.95 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-N 118.957 0.799 . . . . 0.0 114.633 -175.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -81.92 -53.83 0.68 Allowed Pre-proline 0 N--CA 1.438 -1.035 0 C-N-CA 126.923 2.089 . . . . 0.0 110.088 173.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -72.77 -171.37 0.75 Allowed 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 122.512 2.141 . . . . 0.0 110.209 160.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.553 ' CG ' ' H ' ' A' ' 78' ' ' GLY 0.284 7.7 t-160 70.9 -168.55 0.15 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.502 1.121 . . . . 0.0 110.068 -166.248 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.553 ' H ' ' CG ' ' A' ' 77' ' ' HIS . . . 163.25 -45.69 0.33 Allowed Glycine 0 CA--C 1.527 0.816 0 O-C-N 121.271 -0.893 . . . . 0.0 112.335 -167.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 151.87 -3.66 0.42 Allowed Glycine 0 CA--C 1.533 1.195 0 CA-C-N 118.434 1.117 . . . . 0.0 114.61 -177.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 109.84 69.01 0.61 Allowed Glycine 0 C--N 1.339 0.731 0 CA-C-N 119.01 1.405 . . . . 0.0 111.558 168.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -158.55 -160.68 0.9 Allowed 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 130.174 3.389 . . . . 0.0 106.697 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -74.41 53.87 2.35 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 126.046 1.784 . . . . 0.0 113.242 177.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.569 ' H ' ' HD2' ' A' ' 84' ' ' PRO . 4.4 mm-40 -121.54 -58.0 0.03 OUTLIER Pre-proline 0 N--CA 1.453 -0.313 0 C-N-CA 126.026 1.73 . . . . 0.0 110.37 168.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.569 ' HD2' ' H ' ' A' ' 83' ' ' GLN . 34.4 Cg_endo . . . . . 0 N--CA 1.455 -0.775 0 C-N-CA 123.883 3.055 . . . . 0.0 109.127 170.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.567 ' CG ' ' H ' ' A' ' 62' ' ' GLY . 5.3 t-160 . . . . . 0 N--CA 1.448 -0.557 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.567 ' H ' ' CG ' ' A' ' 61' ' ' HIS . . . 153.38 -2.51 0.27 Allowed Glycine 0 C--O 1.221 -0.695 0 CA-C-O 116.581 -2.233 . . . . 0.0 115.368 -168.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 151.38 -62.43 0.4 Allowed Glycine 0 C--N 1.339 0.735 0 CA-C-N 121.494 2.647 . . . . 0.0 111.446 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.44 32.96 0.03 OUTLIER Glycine 0 CA--C 1.53 0.997 0 CA-C-N 117.557 0.678 . . . . 0.0 113.206 -178.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -138.3 -143.13 0.16 Allowed 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 125.425 1.49 . . . . 0.0 108.938 -167.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.6 -7.71 61.73 Favored Glycine 0 CA--C 1.533 1.167 0 N-CA-C 116.034 1.173 . . . . 0.0 116.034 -171.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.403 ' CB ' ' CD ' ' A' ' 68' ' ' PRO . 19.6 mm100 -64.32 -69.33 0.6 Allowed Pre-proline 0 CA--C 1.549 0.904 0 C-N-CA 125.756 1.622 . . . . 0.0 109.973 173.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.403 ' CD ' ' CB ' ' A' ' 67' ' ' GLN . 55.9 Cg_endo -64.19 105.43 0.58 Allowed 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.646 2.897 . . . . 0.0 110.423 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 22.3 t-160 46.12 64.39 1.5 Allowed 'General case' 0 C--N 1.344 0.341 0 CA-C-O 123.708 1.718 . . . . 0.0 113.959 177.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -63.4 24.73 0.08 OUTLIER Glycine 0 CA--C 1.527 0.821 0 C-N-CA 127.535 2.493 . . . . 0.0 116.75 173.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 124.89 -17.04 7.25 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-N 120.624 2.212 . . . . 0.0 114.72 170.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 132.57 12.97 1.71 Allowed Glycine 0 N--CA 1.473 1.153 0 CA-C-N 119.033 1.416 . . . . 0.0 116.026 163.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -125.61 -102.56 0.36 Allowed 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 118.023 0.912 . . . . 0.0 109.836 -162.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -86.5 -32.11 17.0 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-N 118.526 0.603 . . . . 0.0 113.097 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.409 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 4.1 mp0 -60.33 -43.89 94.52 Favored Pre-proline 0 C--O 1.223 -0.31 0 O-C-N 121.36 -1.082 . . . . 0.0 111.506 -177.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.409 ' CD ' ' N ' ' A' ' 75' ' ' GLN . 93.7 Cg_endo -77.87 42.3 1.16 Allowed 'Trans proline' 0 CA--C 1.548 1.217 0 C-N-CA 122.957 2.438 . . . . 0.0 111.656 169.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.472 ' CD2' ' H ' ' A' ' 78' ' ' GLY . 6.2 t-160 83.31 -179.17 0.04 OUTLIER 'General case' 0 C--N 1.346 0.414 0 C-N-CA 126.899 2.08 . . . . 0.0 112.643 173.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.472 ' H ' ' CD2' ' A' ' 77' ' ' HIS . . . 160.23 1.35 0.07 OUTLIER Glycine 0 C--N 1.336 0.53 0 CA-C-O 116.959 -2.023 . . . . 0.0 115.616 -158.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 148.95 -59.66 0.45 Allowed Glycine 0 C--N 1.339 0.732 0 CA-C-N 121.103 2.452 . . . . 0.0 111.948 175.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 158.51 28.49 0.02 OUTLIER Glycine 0 CA--C 1.529 0.959 0 CA-C-N 117.573 0.686 . . . . 0.0 114.026 175.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -138.43 -131.26 0.13 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.411 1.084 . . . . 0.0 110.944 -158.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -87.66 -10.7 69.65 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 119.789 1.177 . . . . 0.0 114.016 -172.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -55.08 -64.95 1.61 Allowed Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 124.897 1.279 . . . . 0.0 108.451 168.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 N--CA 1.457 -0.669 0 C-N-CA 122.403 2.069 . . . . 0.0 114.494 -176.095 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 23.1 t-80 . . . . . 0 CA--C 1.535 0.372 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -150.02 32.01 1.07 Allowed Glycine 0 C--N 1.335 0.502 0 CA-C-O 118.108 -1.384 . . . . 0.0 112.481 -175.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 128.86 -18.2 5.65 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-N 119.016 1.408 . . . . 0.0 113.274 178.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 126.86 11.86 3.44 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-N 118.716 1.258 . . . . 0.0 115.322 165.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -117.79 -99.68 0.44 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 118.53 1.165 . . . . 0.0 111.501 -162.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -105.33 -2.71 41.27 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 124.3 0.952 . . . . 0.0 114.501 -177.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -75.97 -48.72 3.52 Favored Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 125.334 1.454 . . . . 0.0 112.71 165.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -74.36 167.35 27.36 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 122.188 1.925 . . . . 0.0 109.491 168.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.569 ' CD2' ' H ' ' A' ' 70' ' ' GLY . 16.1 t-80 57.57 172.61 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.687 0.795 . . . . 0.0 111.509 -165.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.569 ' H ' ' CD2' ' A' ' 69' ' ' HIS . . . 151.31 14.17 0.08 OUTLIER Glycine 0 C--N 1.337 0.633 0 CA-C-O 117.567 -1.685 . . . . 0.0 115.295 -158.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 142.97 -69.59 0.42 Allowed Glycine 0 C--O 1.224 -0.47 0 CA-C-N 120.359 2.079 . . . . 0.0 110.168 177.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 167.69 18.69 0.02 OUTLIER Glycine 0 CA--C 1.529 0.913 0 N-CA-C 114.687 0.635 . . . . 0.0 114.687 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -127.52 -118.28 0.26 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.093 0.957 . . . . 0.0 110.544 -160.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -94.24 -3.52 63.32 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-N 119.428 1.013 . . . . 0.0 114.444 -178.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.89 -45.82 3.95 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 125.592 1.557 . . . . 0.0 110.567 170.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -75.77 -164.88 0.27 Allowed 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.038 1.825 . . . . 0.0 109.118 157.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.52 ' CD2' ' H ' ' A' ' 78' ' ' GLY 0.268 11.3 t-80 67.46 174.0 0.26 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.04 1.336 . . . . 0.0 110.462 -158.414 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.52 ' H ' ' CD2' ' A' ' 77' ' ' HIS . . . 141.64 9.55 0.63 Allowed Glycine 0 CA--C 1.526 0.751 0 CA-C-O 117.615 -1.659 . . . . 0.0 115.154 -156.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.424 ' H ' ' CD2' ' A' ' 77' ' ' HIS . . . 141.11 -75.95 0.33 Allowed Glycine 0 C--N 1.336 0.562 0 CA-C-N 120.787 2.293 . . . . 0.0 110.405 174.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 177.49 15.35 0.02 OUTLIER Glycine 0 CA--C 1.527 0.839 0 CA-C-N 117.5 0.65 . . . . 0.0 114.283 -174.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -132.29 -138.24 0.19 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 118.475 1.138 . . . . 0.0 108.951 -162.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -75.42 43.06 1.51 Allowed Glycine 0 CA--C 1.533 1.157 0 C-N-CA 124.769 1.176 . . . . 0.0 112.315 176.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.514 ' HA ' HE21 ' A' ' 83' ' ' GLN . 0.1 OUTLIER -128.49 -55.85 0.03 OUTLIER Pre-proline 0 N--CA 1.438 -1.044 0 C-N-CA 127.864 2.466 . . . . 0.0 109.671 176.301 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.451 ' HD2' ' H ' ' A' ' 83' ' ' GLN . 73.9 Cg_endo . . . . . 0 N--CA 1.457 -0.676 0 C-N-CA 121.305 1.336 . . . . 0.0 110.137 157.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 . . . . . 0 CA--C 1.52 -0.178 0 CA-C-O 123.456 1.598 . . . . 0.0 114.377 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.79 28.81 0.04 OUTLIER Glycine 0 CA--C 1.527 0.822 0 C-N-CA 128.592 2.996 . . . . 0.0 117.64 173.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 127.27 -20.2 5.92 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-N 120.664 2.232 . . . . 0.0 114.19 166.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 137.66 8.2 1.3 Allowed Glycine 0 N--CA 1.472 1.064 0 CA-C-N 118.853 1.326 . . . . 0.0 115.941 166.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -135.09 -117.23 0.18 Allowed 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 118.113 0.957 . . . . 0.0 110.161 -158.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.7 -11.3 72.98 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-O 118.957 -0.913 . . . . 0.0 113.944 -177.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -81.3 -59.94 0.44 Allowed Pre-proline 0 N--CA 1.445 -0.716 0 CA-C-N 118.755 1.277 . . . . 0.0 109.347 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.607 ' HA ' ' HB3' ' A' ' 76' ' ' PRO . 55.7 Cg_endo -64.99 83.65 0.18 Allowed 'Trans proline' 0 CA--C 1.548 1.177 0 C-N-CA 123.059 2.506 . . . . 0.0 112.613 178.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.463 ' H ' ' HB3' ' A' ' 76' ' ' PRO . 9.6 t60 -67.75 132.97 48.44 Favored 'General case' 0 N--CA 1.439 -0.997 0 O-C-N 119.833 -1.792 . . . . 0.0 107.273 173.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.35 -26.93 3.31 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 126.042 1.782 . . . . 0.0 112.646 162.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 162.79 -14.31 0.11 Allowed Glycine 0 CA--C 1.524 0.599 0 CA-C-O 119.124 -0.82 . . . . 0.0 112.754 -175.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.69 26.4 6.82 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-N 118.778 1.289 . . . . 0.0 112.854 172.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -95.95 -113.13 0.13 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.499 2.319 . . . . 0.0 110.384 -173.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.434 ' C ' ' HD2' ' A' ' 76' ' ' PRO . . . -94.71 -28.67 9.99 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-N 119.839 1.2 . . . . 0.0 113.092 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -50.5 -39.0 46.26 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 126.78 2.032 . . . . 0.0 115.612 172.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.607 ' HB3' ' HA ' ' A' ' 68' ' ' PRO . 14.6 Cg_endo -83.32 50.9 3.42 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.403 2.068 . . . . 0.0 112.715 -172.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 72.82 120.31 0.04 OUTLIER 'General case' 0 C--N 1.341 0.233 0 C-N-CA 124.755 1.222 . . . . 0.0 109.942 -162.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -136.55 33.57 2.33 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 125.316 1.436 . . . . 0.0 112.09 -167.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 131.35 -77.03 0.4 Allowed Glycine 0 C--N 1.331 0.292 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 -175.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 168.87 24.17 0.02 OUTLIER Glycine 0 CA--C 1.526 0.72 0 CA-C-O 119.046 -0.864 . . . . 0.0 114.895 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -138.35 -107.48 0.18 Allowed 'General case' 0 C--O 1.223 -0.328 0 CA-C-N 118.594 1.197 . . . . 0.0 111.238 -158.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -97.21 -4.5 58.49 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-N 119.384 0.993 . . . . 0.0 114.146 -175.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.4 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 3.6 mp0 -78.29 -51.03 1.64 Allowed Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 125.962 1.705 . . . . 0.0 112.325 175.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 83' ' ' GLN . 36.7 Cg_endo . . . . . 0 N--CA 1.45 -1.051 0 C-N-CA 122.971 2.448 . . . . 0.0 108.225 174.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.478 ' CG ' ' H ' ' A' ' 62' ' ' GLY . 7.1 t-160 . . . . . 0 CA--C 1.545 0.772 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.478 ' H ' ' CG ' ' A' ' 61' ' ' HIS . . . 148.02 -1.33 0.66 Allowed Glycine 0 C--N 1.338 0.662 0 CA-C-O 117.147 -1.918 . . . . 0.0 116.467 -154.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.423 ' H ' ' CD2' ' A' ' 61' ' ' HIS . . . 148.86 -64.21 0.41 Allowed Glycine 0 C--N 1.336 0.54 0 CA-C-N 121.026 2.413 . . . . 0.0 112.012 173.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 167.16 21.61 0.02 OUTLIER Glycine 0 CA--C 1.527 0.829 0 CA-C-N 117.712 0.756 . . . . 0.0 114.692 -174.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -130.96 -133.47 0.2 Allowed 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 118.645 1.222 . . . . 0.0 108.818 -167.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.69 -23.66 77.51 Favored Glycine 0 CA--C 1.534 1.26 0 O-C-N 121.646 -0.659 . . . . 0.0 113.487 -174.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.458 HE21 ' CA ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -57.91 -49.74 92.02 Favored Pre-proline 0 N--CA 1.441 -0.905 0 C-N-CA 127.745 2.418 . . . . 0.0 113.363 -179.036 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -79.25 130.98 9.46 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.42 2.747 . . . . 0.0 109.939 166.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 21.8 t-160 57.43 -73.35 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 115.558 1.688 . . . . 0.0 115.558 175.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 68.87 -23.7 0.3 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 126.9 2.19 . . . . 0.0 116.243 171.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 159.08 -11.74 0.19 Allowed Glycine 0 CA--C 1.531 1.093 0 CA-C-N 119.282 1.541 . . . . 0.0 113.867 -170.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 114.93 29.91 2.47 Favored Glycine 0 N--CA 1.475 1.249 0 CA-C-N 119.931 1.865 . . . . 0.0 114.345 166.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -120.86 -113.12 0.32 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.333 1.453 . . . . 0.0 110.526 -163.162 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -101.43 -4.67 52.79 Favored Glycine 0 CA--C 1.536 1.396 0 CA-C-N 119.93 1.241 . . . . 0.0 114.028 -178.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -83.63 -31.79 0.51 Allowed Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 128.535 2.734 . . . . 0.0 112.707 177.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -82.58 -164.05 0.25 Allowed 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 121.991 1.794 . . . . 0.0 107.452 157.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.503 ' CD2' ' H ' ' A' ' 78' ' ' GLY . 11.7 t-80 58.71 -178.31 0.08 Allowed 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.31 -0.869 . . . . 0.0 110.196 -167.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.503 ' H ' ' CD2' ' A' ' 77' ' ' HIS . . . 138.79 8.76 1.04 Allowed Glycine 0 C--N 1.339 0.699 0 CA-C-O 117.258 -1.857 . . . . 0.0 115.826 -156.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.424 ' H ' ' CD2' ' A' ' 77' ' ' HIS . . . 141.25 -69.84 0.44 Allowed Glycine 0 CA--C 1.522 0.477 0 CA-C-N 120.679 2.24 . . . . 0.0 110.697 171.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 172.9 17.11 0.02 OUTLIER Glycine 0 CA--C 1.528 0.868 0 C-N-CA 120.352 -0.928 . . . . 0.0 114.744 -174.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 0.448 ' HB2' ' H ' ' A' ' 82' ' ' GLY . 0.1 OUTLIER -131.03 -143.79 0.25 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 118.315 1.057 . . . . 0.0 109.331 -165.268 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.448 ' H ' ' HB2' ' A' ' 81' ' ' TRP . . . -67.94 12.09 0.87 Allowed Glycine 0 CA--C 1.537 1.443 0 C-N-CA 124.521 1.058 . . . . 0.0 114.766 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 5.6 mm100 -94.33 -52.85 0.24 Allowed Pre-proline 0 N--CA 1.442 -0.845 0 C-N-CA 126.514 1.925 . . . . 0.0 110.0 173.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo . . . . . 0 CA--C 1.536 0.598 0 C-N-CA 121.617 1.544 . . . . 0.0 113.284 166.098 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.9 t-160 . . . . . 0 CA--C 1.533 0.304 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.78 -75.01 0.58 Allowed Glycine 0 CA--C 1.526 0.735 0 CA-C-N 118.928 0.785 . . . . 0.0 111.732 -173.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -156.44 -0.68 0.11 Allowed Glycine 0 CA--C 1.529 0.923 0 C-N-CA 125.857 1.694 . . . . 0.0 113.397 -170.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.22 51.62 0.71 Allowed Glycine 0 C--N 1.345 1.035 0 CA-C-N 120.057 1.928 . . . . 0.0 112.082 164.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -139.18 -125.09 0.12 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.446 1.498 . . . . 0.0 109.709 -170.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -82.54 -19.28 64.34 Favored Glycine 0 CA--C 1.533 1.208 0 O-C-N 120.331 -1.48 . . . . 0.0 114.129 -177.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -69.48 -35.02 5.2 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 125.418 1.487 . . . . 0.0 114.704 -178.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -75.75 -75.3 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.359 2.04 . . . . 0.0 108.613 169.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.542 ' CG ' ' H ' ' A' ' 70' ' ' GLY . 8.8 t-160 48.13 -162.04 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.827 1.251 . . . . 0.0 112.418 -175.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.542 ' H ' ' CG ' ' A' ' 69' ' ' HIS . . . 145.29 -15.62 1.88 Allowed Glycine 0 C--O 1.221 -0.674 0 O-C-N 120.139 -1.6 . . . . 0.0 114.871 -172.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 159.41 -20.21 0.27 Allowed Glycine 0 CA--C 1.528 0.866 0 CA-C-N 119.384 1.592 . . . . 0.0 113.994 -177.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 118.65 30.57 1.64 Allowed Glycine 0 N--CA 1.473 1.165 0 CA-C-N 119.217 1.509 . . . . 0.0 113.102 170.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.402 ' CD1' ' NE2' ' A' ' 75' ' ' GLN . 0.0 OUTLIER -127.67 -141.63 0.26 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.883 1.673 . . . . 0.0 109.612 -163.765 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.03 -25.32 67.89 Favored Glycine 0 CA--C 1.534 1.231 0 O-C-N 120.091 -1.631 . . . . 0.0 113.569 -178.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.402 ' NE2' ' CD1' ' A' ' 73' ' ' TRP . 2.2 mp0 -68.32 -51.53 24.44 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 124.789 1.236 . . . . 0.0 112.108 -173.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.66 -50.97 1.05 Allowed 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 121.714 1.609 . . . . 0.0 111.518 175.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 20.5 t-160 60.03 -71.24 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.052 1.741 . . . . 0.0 114.69 -178.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 64.11 -2.67 2.01 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-O 116.996 -2.002 . . . . 0.0 116.264 173.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 128.78 -5.49 6.53 Favored Glycine 0 CA--C 1.532 1.114 0 CA-C-N 120.48 2.14 . . . . 0.0 114.345 -177.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 116.17 18.85 5.72 Favored Glycine 0 N--CA 1.476 1.313 0 CA-C-N 119.944 1.872 . . . . 0.0 115.027 156.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -131.49 -99.96 0.3 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.42 1.088 . . . . 0.0 111.62 -157.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -92.44 -12.93 57.88 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 119.147 -0.807 . . . . 0.0 113.646 -177.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -74.92 -41.54 4.22 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-N 120.109 1.954 . . . . 0.0 112.012 172.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo . . . . . 0 N--CA 1.452 -0.956 0 C-N-CA 123.479 2.786 . . . . 0.0 114.572 -176.308 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.485 ' CG ' ' H ' ' A' ' 62' ' ' GLY 0.262 4.5 t-160 . . . . . 0 CA--C 1.537 0.479 0 CA-C-O 121.884 0.85 . . . . 0.0 112.235 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.485 ' H ' ' CG ' ' A' ' 61' ' ' HIS . . . 174.56 -42.93 0.13 Allowed Glycine 0 CA--C 1.525 0.67 0 O-C-N 120.981 -1.074 . . . . 0.0 110.563 -160.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 173.8 -33.79 0.11 Allowed Glycine 0 CA--C 1.526 0.733 0 CA-C-O 118.323 -1.265 . . . . 0.0 113.377 171.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 146.02 45.77 0.04 OUTLIER Glycine 0 C--N 1.343 0.939 0 CA-C-N 118.959 1.38 . . . . 0.0 113.477 171.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -137.04 -133.73 0.14 Allowed 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -171.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -88.36 -2.42 79.87 Favored Glycine 0 CA--C 1.524 0.599 0 O-C-N 121.622 -0.673 . . . . 0.0 112.237 -166.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . 0.288 0.0 OUTLIER -71.2 -71.0 0.27 Allowed Pre-proline 0 N--CA 1.427 -1.599 0 C-N-CA 129.538 3.135 . . . . 0.0 107.26 178.169 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -62.42 88.64 0.11 Allowed 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 125.096 3.864 . . . . 0.0 112.02 -171.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 17.5 t-160 50.0 69.05 0.65 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 124.293 1.996 . . . . 0.0 112.224 -176.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.32 24.23 0.12 Allowed Glycine 0 CA--C 1.526 0.725 0 CA-C-N 111.668 -2.515 . . . . 0.0 116.558 174.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 127.0 -17.34 6.32 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 121.426 2.613 . . . . 0.0 116.058 167.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 146.08 12.7 0.21 Allowed Glycine 0 N--CA 1.476 1.312 0 CA-C-N 119.853 1.826 . . . . 0.0 116.632 165.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -140.54 -117.49 0.12 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 118.583 1.191 . . . . 0.0 110.0 -155.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -81.01 -31.48 34.98 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-N 119.42 1.009 . . . . 0.0 113.23 -175.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -50.36 -48.85 79.88 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 125.652 1.581 . . . . 0.0 111.528 -176.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -71.84 54.84 2.14 Favored 'Trans proline' 0 CA--C 1.55 1.313 0 C-N-CA 122.614 2.209 . . . . 0.0 112.65 168.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . 0.264 16.5 t-160 66.9 67.88 0.42 Allowed 'General case' 0 C--N 1.346 0.413 0 CA-C-O 124.545 2.117 . . . . 0.0 113.287 165.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.57 31.39 0.27 Allowed Glycine 0 CA--C 1.524 0.635 0 CA-C-N 111.714 -2.494 . . . . 0.0 116.264 172.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 122.47 -18.66 8.19 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 121.075 2.438 . . . . 0.0 115.628 167.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 139.94 9.54 0.82 Allowed Glycine 0 N--CA 1.469 0.863 0 CA-C-N 119.209 1.505 . . . . 0.0 115.548 163.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -131.74 -106.93 0.26 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 118.906 1.353 . . . . 0.0 111.406 -155.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -86.56 -25.02 37.03 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-N 119.029 0.832 . . . . 0.0 112.911 -179.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.439 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 4.5 mp0 -63.47 -43.69 79.51 Favored Pre-proline 0 C--O 1.222 -0.362 0 C-N-CA 126.955 2.102 . . . . 0.0 113.427 -177.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.439 ' CD ' ' N ' ' A' ' 83' ' ' GLN . 19.0 Cg_endo . . . . . 0 CA--C 1.553 1.437 0 C-N-CA 124.255 3.303 . . . . 0.0 113.215 174.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.584 ' CD2' ' H ' ' A' ' 62' ' ' GLY . 7.5 t-160 . . . . . 0 CA--C 1.541 0.634 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.584 ' H ' ' CD2' ' A' ' 61' ' ' HIS . . . 146.33 12.49 0.2 Allowed Glycine 0 C--N 1.338 0.68 0 CA-C-O 117.193 -1.893 . . . . 0.0 115.701 -155.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 139.35 -72.78 0.42 Allowed Glycine 0 C--N 1.338 0.648 0 CA-C-N 120.709 2.255 . . . . 0.0 110.836 175.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 168.76 17.26 0.02 OUTLIER Glycine 0 CA--C 1.527 0.826 0 CA-C-O 119.499 -0.612 . . . . 0.0 114.324 -175.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -121.55 -133.48 0.3 Allowed 'General case' 0 C--O 1.222 -0.361 0 C-N-CA 124.86 1.264 . . . . 0.0 108.352 -170.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.67 -7.97 87.91 Favored Glycine 0 CA--C 1.533 1.182 0 CA-C-N 119.294 0.952 . . . . 0.0 114.774 -173.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -67.38 -59.16 7.55 Favored Pre-proline 0 N--CA 1.442 -0.835 0 C-N-CA 126.496 1.919 . . . . 0.0 110.16 174.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -72.22 172.66 14.39 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 121.633 1.556 . . . . 0.0 109.443 161.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 23.0 t-160 60.06 -70.97 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.401 1.88 . . . . 0.0 113.42 -175.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 58.01 12.29 10.9 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-O 117.857 -1.524 . . . . 0.0 116.386 164.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 125.24 -9.89 7.81 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 120.03 1.915 . . . . 0.0 114.867 178.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 119.89 14.58 5.57 Favored Glycine 0 N--CA 1.471 1.032 0 CA-C-N 119.795 1.797 . . . . 0.0 115.159 161.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -121.29 -97.45 0.46 Allowed 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 124.629 1.172 . . . . 0.0 111.863 -162.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -108.16 -1.01 33.56 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.323 0.963 . . . . 0.0 114.554 -178.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.449 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 3.7 mp0 -83.47 -35.66 0.64 Allowed Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 126.286 1.834 . . . . 0.0 112.642 167.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.449 ' CD ' ' N ' ' A' ' 75' ' ' GLN . 30.2 Cg_endo -73.79 177.32 8.23 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.473 2.116 . . . . 0.0 108.871 164.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.522 ' CG ' ' H ' ' A' ' 78' ' ' GLY . 9.3 t-80 62.66 176.89 0.14 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.785 0.834 . . . . 0.0 110.71 -167.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.522 ' H ' ' CG ' ' A' ' 77' ' ' HIS . . . 144.67 4.41 0.63 Allowed Glycine 0 CA--C 1.527 0.784 0 CA-C-O 117.674 -1.626 . . . . 0.0 115.178 -157.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.426 ' H ' ' CD2' ' A' ' 77' ' ' HIS . . . 143.3 -71.13 0.4 Allowed Glycine 0 C--N 1.338 0.676 0 CA-C-N 120.533 2.166 . . . . 0.0 111.195 174.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 172.44 20.09 0.02 OUTLIER Glycine 0 CA--C 1.529 0.918 0 CA-C-N 117.926 0.863 . . . . 0.0 114.642 -172.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -132.47 -138.97 0.19 Allowed 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 118.622 1.211 . . . . 0.0 108.397 -168.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -70.16 0.98 20.61 Favored Glycine 0 CA--C 1.535 1.287 0 O-C-N 121.595 -0.691 . . . . 0.0 114.716 -177.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -82.7 -55.83 0.52 Allowed Pre-proline 0 N--CA 1.441 -0.922 0 C-N-CA 127.299 2.24 . . . . 0.0 111.013 179.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.414 ' HA ' ' H ' ' A' ' 77' ' ' HIS . 34.8 Cg_endo . . . . . 0 N--CA 1.456 -0.725 0 C-N-CA 121.912 1.741 . . . . 0.0 110.161 165.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.631 ' CD2' ' H ' ' A' ' 62' ' ' GLY . 13.1 t-80 . . . . . 0 CA--C 1.544 0.712 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.631 ' H ' ' CD2' ' A' ' 61' ' ' HIS . . . 146.89 17.4 0.13 Allowed Glycine 0 C--N 1.339 0.702 0 CA-C-O 117.145 -1.92 . . . . 0.0 115.378 -157.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 139.55 -52.94 0.7 Allowed Glycine 0 CA--C 1.524 0.617 0 CA-C-N 120.95 2.375 . . . . 0.0 112.181 172.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 147.4 13.66 0.15 Allowed Glycine 0 CA--C 1.53 1.014 0 CA-C-O 119.295 -0.725 . . . . 0.0 114.514 -177.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -118.81 -131.26 0.3 Allowed 'General case' 0 C--O 1.22 -0.453 0 C-N-CA 124.853 1.261 . . . . 0.0 108.731 -172.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -81.92 -3.25 90.64 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-N 119.876 1.216 . . . . 0.0 114.986 -174.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -71.02 -54.74 7.12 Favored Pre-proline 0 N--CA 1.445 -0.679 0 C-N-CA 126.92 2.088 . . . . 0.0 110.59 173.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -69.8 166.55 27.27 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 N-CA-C 108.653 -1.326 . . . . 0.0 108.653 159.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . 0.275 13.0 t-160 45.81 68.05 0.65 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 124.575 2.131 . . . . 0.0 115.406 172.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.534 ' H ' ' HB3' ' A' ' 75' ' ' GLN . . . -86.77 20.05 26.08 Favored Glycine 0 CA--C 1.522 0.522 0 CA-C-N 111.582 -2.553 . . . . 0.0 115.034 175.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 137.29 -71.94 0.46 Allowed Glycine 0 C--N 1.337 0.586 0 CA-C-N 120.558 2.179 . . . . 0.0 112.454 175.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -175.62 15.57 0.04 OUTLIER Glycine 0 N--CA 1.467 0.734 0 CA-C-N 118.508 1.154 . . . . 0.0 115.122 -174.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -126.47 -141.25 0.28 Allowed 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 124.845 1.258 . . . . 0.0 108.413 -168.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.93 1.66 30.34 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-O 118.448 -1.196 . . . . 0.0 114.742 -175.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.534 ' HB3' ' H ' ' A' ' 70' ' ' GLY . 18.0 mm100 -84.53 -51.7 0.55 Allowed Pre-proline 0 N--CA 1.442 -0.834 0 C-N-CA 126.369 1.868 . . . . 0.0 110.937 -179.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -68.56 174.96 7.64 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.032 1.821 . . . . 0.0 109.978 157.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.489 ' CG ' ' H ' ' A' ' 78' ' ' GLY . 7.1 t-160 61.23 -151.98 0.38 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.408 1.083 . . . . 0.0 111.302 176.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.489 ' H ' ' CG ' ' A' ' 77' ' ' HIS . . . 132.97 -43.97 1.24 Allowed Glycine 0 C--O 1.223 -0.545 0 O-C-N 120.422 -1.424 . . . . 0.0 111.593 -173.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -175.41 -7.17 0.02 OUTLIER Glycine 0 CA--C 1.525 0.692 0 CA-C-O 117.973 -1.46 . . . . 0.0 114.217 -176.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.74 19.31 7.87 Favored Glycine 0 N--CA 1.475 1.25 0 CA-C-N 119.846 1.823 . . . . 0.0 112.938 170.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -113.94 -136.83 0.37 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.339 1.856 . . . . 0.0 108.644 -165.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -76.24 1.77 59.15 Favored Glycine 0 CA--C 1.536 1.377 0 CA-C-N 119.434 1.016 . . . . 0.0 115.071 -176.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.512 ' H ' ' HD2' ' A' ' 84' ' ' PRO . 21.6 mt-30 -98.5 -39.19 0.24 Allowed Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 126.461 1.904 . . . . 0.0 114.343 -172.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.512 ' HD2' ' H ' ' A' ' 83' ' ' GLN . 32.5 Cg_endo . . . . . 0 CA--C 1.537 0.666 0 CA-C-N 120.859 1.342 . . . . 0.0 110.625 161.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.43 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 20.1 t-160 . . . . . 0 CA--C 1.534 0.365 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.76 -65.76 0.45 Allowed Glycine 0 CA--C 1.536 1.389 0 C-N-CA 125.074 1.321 . . . . 0.0 112.035 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -167.99 7.42 0.05 OUTLIER Glycine 0 CA--C 1.535 1.289 0 C-N-CA 126.76 2.124 . . . . 0.0 113.969 -176.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.68 36.72 3.42 Favored Glycine 0 C--N 1.344 1.002 0 CA-C-N 119.916 1.858 . . . . 0.0 113.631 168.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -135.27 -137.15 0.16 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.674 1.589 . . . . 0.0 109.175 -166.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -81.82 11.88 44.92 Favored Glycine 0 CA--C 1.532 1.135 0 N-CA-C 115.952 1.141 . . . . 0.0 115.952 -174.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.4 ' H ' ' HD2' ' A' ' 68' ' ' PRO . 18.6 mm100 -88.04 -52.2 0.39 Allowed Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 126.844 2.058 . . . . 0.0 110.862 175.015 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.43 ' HD3' ' O ' ' A' ' 61' ' ' HIS . 45.8 Cg_endo -74.11 124.82 9.34 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 124.447 3.431 . . . . 0.0 109.485 177.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.564 ' CD2' ' H ' ' A' ' 70' ' ' GLY . 22.7 t-80 60.69 165.09 0.08 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.309 1.444 . . . . 0.0 111.695 -162.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.564 ' H ' ' CD2' ' A' ' 69' ' ' HIS . . . 155.05 16.98 0.05 OUTLIER Glycine 0 C--N 1.336 0.573 0 CA-C-O 117.62 -1.656 . . . . 0.0 114.741 -155.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 141.19 -68.56 0.47 Allowed Glycine 0 C--N 1.336 0.553 0 CA-C-N 120.187 1.993 . . . . 0.0 110.119 179.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 162.81 23.39 0.02 OUTLIER Glycine 0 CA--C 1.529 0.94 0 CA-C-O 119.528 -0.596 . . . . 0.0 114.463 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -128.63 -113.35 0.26 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.179 0.99 . . . . 0.0 110.821 -162.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -102.87 -2.34 49.18 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-N 119.443 1.019 . . . . 0.0 114.428 -178.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -70.87 -49.74 13.37 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 124.869 1.268 . . . . 0.0 109.304 165.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -71.36 176.14 8.38 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 CA-C-N 120.635 1.263 . . . . 0.0 109.545 163.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.501 ' CD2' ' H ' ' A' ' 78' ' ' GLY 0.275 6.7 t-160 65.23 169.86 0.2 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.086 1.754 . . . . 0.0 111.691 -160.182 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.501 ' H ' ' CD2' ' A' ' 77' ' ' HIS . . . 144.24 18.56 0.2 Allowed Glycine 0 C--N 1.337 0.596 0 CA-C-O 117.45 -1.75 . . . . 0.0 115.698 -147.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 136.18 -51.47 0.81 Allowed Glycine 0 CA--C 1.522 0.505 0 CA-C-N 119.899 1.85 . . . . 0.0 111.862 171.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 155.82 8.17 0.07 OUTLIER Glycine 0 N--CA 1.47 0.923 0 N-CA-C 116.051 1.18 . . . . 0.0 116.051 178.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -131.83 -116.97 0.22 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 118.714 1.257 . . . . 0.0 110.229 -158.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -67.65 -35.96 86.94 Favored Glycine 0 CA--C 1.527 0.794 0 CA-C-N 119.033 0.833 . . . . 0.0 112.038 -178.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -60.95 -47.7 94.76 Favored Pre-proline 0 N--CA 1.45 -0.448 0 C-N-CA 123.985 0.914 . . . . 0.0 111.771 -176.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.493 ' HA ' ' H ' ' A' ' 77' ' ' HIS . 44.3 Cg_endo . . . . . 0 N--CA 1.455 -0.756 0 C-N-CA 121.258 1.305 . . . . 0.0 112.587 171.929 . . . . . . . . 1 1 . 1 stop_ save_